var title_f3_44_3776="Contents: Coagulation disorders";
var content_f3_44_3776=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?39/57/40861\">",
"       Hematology",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Coagulation disorders",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Coagulation disorders",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Acquired thrombophilia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/50/14121\">",
"           Clinical manifestations of paroxysmal nocturnal hemoglobinuria",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/31/23034\">",
"           Clinical manifestations of the antiphospholipid syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/43/17082\">",
"           Diagnosis and treatment of paroxysmal nocturnal hemoglobinuria",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/29/27096\">",
"           Diagnosis of the antiphospholipid syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/36/6730\">",
"           Drug-induced thrombosis and vascular disease in patients with malignancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/43/35514\">",
"           Hypercoagulable disorders associated with malignancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/37/19034\">",
"           Overview of homocysteine",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/16/35081\">",
"           Pathogenesis of the antiphospholipid syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/12/1224\">",
"           Pathogenesis of the hypercoagulable state associated with malignancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/6/27754\">",
"           Primary (spontaneous) upper extremity deep vein thrombosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/12/3273\">",
"           Renal vein thrombosis and hypercoagulable state in nephrotic syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/57/29594\">",
"           Thrombotic complications following treatment of multiple myeloma with thalidomide and its analogues",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/12/23754\">",
"           Treatment of the antiphospholipid syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/58/19367\">",
"           Treatment of venous thromboembolism in patients with malignancy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Anticoagulation",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/57/8089\">",
"           Anticoagulant and antiplatelet therapy in patients with an acute or prior intracerebral hemorrhage",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/36/33348\">",
"           Anticoagulant and antiplatelet therapy in patients with an unruptured intracranial aneurysm",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/39/30327\">",
"           Anticoagulant and antiplatelet therapy in patients with brain tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/40/33415\">",
"           Anticoagulant and antiplatelet therapy in patients with infective endocarditis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/44/7881\">",
"           Anticoagulant, antiplatelet, and fibrinolytic (thrombolytic) therapy in patients at high risk for ocular hemorrhage",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/59/37818\">",
"           Anticoagulants other than heparin and warfarin",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/46/18153\">",
"           Anticoagulation during pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/14/1258\">",
"           Anticoagulation in older adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/60/20425\">",
"           Chronic anticoagulation after acute coronary syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/36/4682\">",
"           Clinical use of coagulation tests",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/8/30857\">",
"           Correcting excess anticoagulation after warfarin",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/59/40890\">",
"           Heparin-induced thrombocytopenia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/59/43961\">",
"           Low molecular weight heparin for venous thromboembolic disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/50/35626\">",
"           Management of anticoagulation before and after elective surgery",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/3/10298\">",
"           Management of warfarin-associated intracerebral hemorrhage",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/2/35880\">",
"           Outpatient management of oral anticoagulation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/12/27849\">",
"           Risk of intracerebral hemorrhage in patients treated with warfarin",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/23/44408\">",
"           Therapeutic use of fondaparinux",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/8/33930\">",
"           Therapeutic use of heparin and low molecular weight heparin",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/17/42266\">",
"           Therapeutic use of warfarin",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Antiphospholipid antibody syndrome",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/31/23034\">",
"           Clinical manifestations of the antiphospholipid syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/29/27096\">",
"           Diagnosis of the antiphospholipid syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/11/14522\">",
"           Hematologic manifestations of HIV infection: Thrombocytopenia and coagulation abnormalities",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/0/44041\">",
"           Management of pregnant women with antiphospholipid antibodies or the antiphospholipid syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/2/41000\">",
"           Obstetrical manifestations of the antiphospholipid syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/16/35081\">",
"           Pathogenesis of the antiphospholipid syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/12/23754\">",
"           Treatment of the antiphospholipid syndrome",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Coagulopathy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/26/17832\">",
"           Abnormalities of coagulation and platelet function in preeclampsia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/4/24650\">",
"           Acquired inhibitors of coagulation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/3/5178\">",
"           Approach to the adult patient with a bleeding diathesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/19/15674\">",
"           Approach to the adult patient with thrombocytopenia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/41/1690\">",
"           Approach to the adult with epistaxis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/41/17049\">",
"           Biology and normal function of von Willebrand factor",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/20/25929\">",
"           Clinical features, diagnosis, and treatment of disseminated intravascular coagulation in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/7/33914\">",
"           Coagulation abnormalities in patients with liver disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/25/7576\">",
"           Cryofibrinogenemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/1/8218\">",
"           Disorders of fibrinogen",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/31/31226\">",
"           Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/49/17177\">",
"           Nonselective NSAIDs: Overview of adverse effects",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/56/8073\">",
"           Pathogenesis and etiology of disseminated intravascular coagulation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/44/15048\">",
"           Psychogenic purpura (Gardner-Diamond syndrome)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/60/21450\">",
"           Thrombotic and hemorrhagic disorders due to abnormal fibrinolysis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hemophilia and von Willebrand disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/4/24650\">",
"           Acquired inhibitors of coagulation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/18/22824\">",
"           Biology and normal function of factor VIII and factor IX",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/41/17049\">",
"           Biology and normal function of von Willebrand factor",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/8/44169\">",
"           Classification and pathophysiology of von Willebrand disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/18/1322\">",
"           Clinical manifestations and diagnosis of hemophilia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/13/24794\">",
"           Clinical presentation and diagnosis of von Willebrand disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/56/36746\">",
"           Factor VIII and factor IX inhibitors in patients with hemophilia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/14/37097\">",
"           Factor XI deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/5/33878\">",
"           Genetics of the hemophilias",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/21/16730\">",
"           Rare (recessively inherited) coagulation disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/34/38442\">",
"           Treatment of hemophilia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/22/21866\">",
"           Treatment of von Willebrand disease",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hemostasis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/18/22824\">",
"           Biology and normal function of factor VIII and factor IX",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/41/17049\">",
"           Biology and normal function of von Willebrand factor",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/36/4682\">",
"           Clinical use of coagulation tests",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/35/27194\">",
"           Overview of hemostasis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/43/32439\">",
"           Preoperative assessment of hemostasis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/10/36009\">",
"           The endothelium: A primer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/13/31962\">",
"           Therapeutic uses of recombinant coagulation factor VIIa",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/56/23432\">",
"           Vitamin K and the synthesis of gamma carboxyglutamic acid",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/32/20999\">",
"           Vitamin K, gamma carboxyglutamic acid, and the function of coagulation and other proteins",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Inherited thrombophilia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/35/28218\">",
"           Activated protein C resistance and factor V Leiden",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/36/24136\">",
"           Antithrombin (ATIII) deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/5/26714\">",
"           Inherited thrombophilias in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/12/23752\">",
"           Management of inherited thrombophilia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/52/841\">",
"           Protein C deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/55/13176\">",
"           Protein S deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/16/20743\">",
"           Prothrombin gene mutation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/26/20903\">",
"           Screening for inherited thrombophilia in asymptomatic populations",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Thrombotic microangiopathy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/61/36826\">",
"           Causes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/20/25929\">",
"           Clinical features, diagnosis, and treatment of disseminated intravascular coagulation in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/25/7576\">",
"           Cryofibrinogenemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/1/29721\">",
"           Diagnosis of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/11/14522\">",
"           Hematologic manifestations of HIV infection: Thrombocytopenia and coagulation abnormalities",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/56/8073\">",
"           Pathogenesis and etiology of disseminated intravascular coagulation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/49/12053\">",
"           TTP-HUS: Recurrence after transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/31/42490\">",
"           Treatment and prognosis of thrombotic thrombocytopenic purpura-hemolytic uremic syndromes in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Venous thrombosis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/30/35305\">",
"           Approach to the diagnosis and therapy of lower extremity deep vein thrombosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/26/27050\">",
"           Catheter-induced upper extremity venous thrombosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/27/39353\">",
"           Deep vein thrombosis and pulmonary embolism in pregnancy: Epidemiology, pathogenesis, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/46/14055\">",
"           Deep vein thrombosis and pulmonary embolism in pregnancy: Prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/17/3351\">",
"           Deep vein thrombosis and pulmonary embolism in pregnancy: Treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/12/33994\">",
"           Diagnosis of suspected deep vein thrombosis of the lower extremity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/41/11930\">",
"           Evaluation of the patient with established venous thrombosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/37/19034\">",
"           Overview of homocysteine",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/48/43786\">",
"           Overview of the causes of venous thrombosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/21/36186\">",
"           Prevention of venous thromboembolic disease in medical patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/52/41802\">",
"           Prevention of venous thromboembolic disease in surgical patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/4/43082\">",
"           Treatment of lower extremity deep vein thrombosis",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-599899FBE4-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f3_44_3776=[""].join("\n");
var outline_f3_44_3776=null;
var title_f3_44_3777="Southern black widow";
var content_f3_44_3777=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F82471&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F82471&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Southern black widow",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 329px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In addition to the red hourglass mark on the ventral portion of the abdomen, the southern black widow also has a red dot just dorsal to the anal region.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Richard Vetter, MS.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_44_3777=[""].join("\n");
var outline_f3_44_3777=null;
var title_f3_44_3778="CDC weight for stature girls 2 to 5 years";
var content_f3_44_3778=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F65129&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F65129&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 563px\">",
"   <div class=\"ttl\">",
"    Weight-for-stature percentiles for girls 2 to 5 years, CDC growth charts: United States",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 543px; height: 673px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Developed by the National Center for Health Statistics in collaboration with the National Center for Chronic Disease Prevention and Health Promotion (2000).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_44_3778=[""].join("\n");
var outline_f3_44_3778=null;
var title_f3_44_3779="Patient information: Non-small cell lung cancer (The Basics)";
var content_f3_44_3779=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/15811\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?40/17/41237\">",
"         Normal lungs",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?34/34/35363\">",
"         Patient information: Lung cancer (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?17/46/18146\">",
"         Patient information: Quitting smoking (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?5/28/5570\">",
"         Patient information: Lung cancer prevention and screening (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?1/3/1076\">",
"         Patient information: Lung cancer risks, symptoms, and diagnosis (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?40/22/41314\">",
"         Patient information: Non-small cell lung cancer treatment; stage I to III cancer (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?16/63/17396\">",
"         Patient information: Non-small cell lung cancer treatment; stage IV cancer (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?19/13/19670\">",
"         Patient information: Quitting smoking (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Non-small cell lung cancer (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/non-small-cell-lung-cancer-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H1717527\">",
"      <span class=\"h1\">",
"       What is non-small cell lung cancer?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Non-small cell lung cancer is one type of lung cancer. Lung cancer happens when normal lung cells change into abnormal cells and grow out of control (",
"      <a class=\"graphic graphic_figure graphicRef67527 \" href=\"UTD.htm?40/17/41237\">",
"       figure 1",
"      </a>",
"      ). There are different types of lung cancer. Some types grow faster than others.",
"     </p>",
"     <p>",
"      Non-small cell lung cancer is the most common type of lung cancer. It does not usually grow as fast as another type of lung cancer called small cell lung cancer.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1717534\">",
"      <span class=\"h1\">",
"       What is lung cancer staging?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Cancer staging is a way in which doctors find out how far in your body a cancer has spread. To describe how far a person&rsquo;s non-small cell lung cancer has spread, doctors call it stage 1 (I), 2 (II), 3 (III), or 4 (IV).",
"     </p>",
"     <p>",
"      Sometimes, staging can be tricky. For example, your doctor might think that you have stage 1 or stage 2 cancer. But after you have surgery, your doctor might check the tissues you had removed and discover that you really have stage 3 cancer.",
"     </p>",
"     <p>",
"      Some of the main differences between the stages include the following:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        In stage 1, the lung cancer is in either the left or right lung. It has not spread outside the lung or to any lymph nodes. (Lymph nodes are bean-shaped organs that are part of the body&rsquo;s infection-fighting system.) Stage 1 cancers are usually small.",
"       </li>",
"       <li>",
"        In stage 2, the cancer has spread to other parts of the lung, such as lymph nodes in the lung or the lining around the lung. Stage 2 cancers can be different sizes.",
"       </li>",
"       <li>",
"        In stage 3, the cancer might be large. Or it might have spread to lymph nodes in the middle of the chest, between the left and right lungs.",
"       </li>",
"       <li>",
"        In stage 4, the cancer has spread to the other lung or to other parts of the body, such as the brain or bones. Also, lung cancer is described as stage 4 if it causes fluid to collect around the outside of the lungs.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Your treatment will depend a lot on the stage of your lung cancer.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1717541\">",
"      <span class=\"h1\">",
"       How are stage 1 and stage 2 non-small cell lung cancers treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;People with stage 1 or stage 2 non-small cell lung cancer are usually first treated with surgery to remove the cancer. To remove the cancer, a doctor might remove part of a lung. Or he or she might need to remove the whole lung. (People who have one lung removed can use their other lung to breathe.)",
"     </p>",
"     <p>",
"      People with stage 1 lung cancer might not need any other treatment after surgery. But people with stage 2 lung cancer usually need more treatment after surgery. This can include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Radiation therapy &ndash; Radiation kills cancer cells. Some people who do not want surgery or who cannot have surgery have radiation therapy instead.",
"       </li>",
"       <li>",
"        Chemotherapy &ndash; Chemotherapy is the term doctors use to describe a group of medicines that kill cancer cells.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1717548\">",
"      <span class=\"h1\">",
"       How is stage 3 non-small cell lung cancer treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Doctors can treat stage 3 non-small cell lung cancer in different ways. Treatment depends on where the cancer is, how big it is, and which treatments a person has already had.",
"     </p>",
"     <p>",
"      People with stage 3 lung cancer usually have 1 or more of the following treatments:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Chemotherapy",
"       </li>",
"       <li>",
"        Radiation",
"       </li>",
"       <li>",
"        Surgery",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Doctors also treat another type of lung cancer, called a &ldquo;Pancoast tumor,&rdquo; in these ways. A Pancoast tumor is a lung cancer that grows in the top part of the lung.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1717555\">",
"      <span class=\"h1\">",
"       How is stage 4 non-small cell lung cancer treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;There is no treatment that will cure stage 4 non-small cell lung cancer. But different treatments can reduce symptoms and help people live longer. People with stage 4 lung cancer can have 1 or more of the following treatments:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Chemotherapy",
"       </li>",
"       <li>",
"        Targeted therapy &ndash; These are medicines that work only for cancers with certain characteristics. Your doctor might test you to see if you have a kind of lung cancer that would respond to these medicines.",
"       </li>",
"       <li>",
"        Surgery to remove a cancer growth that is outside of the lungs",
"       </li>",
"       <li>",
"        Treatment for symptoms caused by the cancer &ndash; For example, if you have trouble breathing because fluid has collected around your lungs, your doctor can drain the fluid to help you breathe more easily.",
"       </li>",
"       <li>",
"        Radiation therapy",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1717562\">",
"      <span class=\"h1\">",
"       What happens after treatment?",
"      </span>",
"      &nbsp;&mdash;&nbsp;After treatment, your doctor will check every so often to see if your lung cancer has come back. Follow-up tests usually include exams and imaging tests such as chest x-rays or CT scans. Imaging tests can create pictures of the inside of the body.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1717569\">",
"      <span class=\"h1\">",
"       What happens if the lung cancer comes back?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If the lung cancer comes back, you might have chemotherapy, targeted therapy, radiation, or surgery.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1717576\">",
"      <span class=\"h1\">",
"       What else should I do?",
"      </span>",
"      &nbsp;&mdash;&nbsp;It is important to follow all your doctor&rsquo;s instructions about visits and tests. It&rsquo;s also important to talk to your doctor about any side effects or problems you have during treatment.",
"     </p>",
"     <p>",
"      Getting treated for lung cancer involves making many choices, such as what treatment to have and when.",
"     </p>",
"     <p>",
"      Always let your doctors and nurses know how you feel about a treatment. Anytime you are offered a treatment, ask:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        What are the benefits of this treatment? Is it likely to help me live longer? Will it reduce or prevent symptoms?",
"       </li>",
"       <li>",
"        What are the downsides to this treatment?",
"       </li>",
"       <li>",
"        Are there other options besides this treatment?",
"       </li>",
"       <li>",
"        What happens if I do not have this treatment?",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1717703\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?34/34/35363?source=see_link\">",
"       Patient information: Lung cancer (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?17/46/18146?source=see_link\">",
"       Patient information: Quitting smoking (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?16/63/17396?source=see_link\">",
"       Patient information: Non-small cell lung cancer treatment; stage IV cancer (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?40/22/41314?source=see_link\">",
"       Patient information: Non-small cell lung cancer treatment; stage I to III cancer (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?5/28/5570?source=see_link\">",
"       Patient information: Lung cancer prevention and screening (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?19/13/19670?source=see_link\">",
"       Patient information: Quitting smoking (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?1/3/1076?source=see_link\">",
"       Patient information: Lung cancer risks, symptoms, and diagnosis (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 14, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?3/44/3779?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15811 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-125.39.66.146-3A500C5829-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_44_3779=[""].join("\n");
var outline_f3_44_3779=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1717527\">",
"      What is non-small cell lung cancer?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1717534\">",
"      What is lung cancer staging?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1717541\">",
"      How are stage 1 and stage 2 non-small cell lung cancers treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1717548\">",
"      How is stage 3 non-small cell lung cancer treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1717555\">",
"      How is stage 4 non-small cell lung cancer treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1717562\">",
"      What happens after treatment?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1717569\">",
"      What happens if the lung cancer comes back?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1717576\">",
"      What else should I do?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1717703\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/15811\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?40/17/41237\">",
"      Normal lungs",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?34/34/35363?source=related_link\">",
"      Patient information: Lung cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?5/28/5570?source=related_link\">",
"      Patient information: Lung cancer prevention and screening (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?1/3/1076?source=related_link\">",
"      Patient information: Lung cancer risks, symptoms, and diagnosis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?40/22/41314?source=related_link\">",
"      Patient information: Non-small cell lung cancer treatment; stage I to III cancer (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?16/63/17396?source=related_link\">",
"      Patient information: Non-small cell lung cancer treatment; stage IV cancer (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?19/13/19670?source=related_link\">",
"      Patient information: Quitting smoking (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?17/46/18146?source=related_link\">",
"      Patient information: Quitting smoking (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_44_3780="Pseudomonal folliculitis";
var content_f3_44_3780=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F82321&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F82321&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pseudomonal folliculitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 313px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hot tub folliculitis (\"hot tub buns\"). Multiple pruritic follicular papules and pustules occurred on the buttocks and trunk of this woman 3 days after she had bathed in a hot tub. Bacterial culture grew Pseudomonas aeruginosa.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP. Goodheart's Photoguide of Common Skin Disorders, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy;2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_44_3780=[""].join("\n");
var outline_f3_44_3780=null;
var title_f3_44_3781="Causes of lactic acidosis";
var content_f3_44_3781=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Causes of lactic acidosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/44/3781/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/44/3781/contributors\">",
"     Burton D Rose, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/44/3781/contributors\">",
"     Theodore W Post, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/44/3781/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/44/3781/contributors\">",
"     Richard H Sterns, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/44/3781/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/44/3781/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?3/44/3781/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 4, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lactic acidosis is the most common cause of metabolic acidosis in hospitalized patients. It is associated with an elevated anion gap and a plasma lactate concentration above 4",
"    <span class=\"nowrap\">",
"     meq/L.",
"    </span>",
"    Impaired tissue oxygenation, leading to increased anaerobic metabolism, is usually responsible for the rise in lactate production. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/44/31432?source=see_link\">",
"     \"Approach to the adult with metabolic acidosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The pathophysiology and causes of lactic acidosis will be reviewed here. The possible role of bicarbonate therapy in such patients is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/44/40646?source=see_link\">",
"     \"Bicarbonate therapy in lactic acidosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;A review of the biochemistry of lactate generation and metabolism is important in understanding the pathogenesis of lactic acidosis. Both overproduction and underuse of lactate appear to be operative in most patients.",
"   </p>",
"   <p>",
"    Lactic acid is derived from the metabolism of pyruvic acid; this reaction is catalyzed by lactate dehydrogenase and involves the conversion of NADH into NAD+ (reduced and oxidized nicotine adenine dinucleotide, respectively). Normal subjects produce 15 to 20",
"    <span class=\"nowrap\">",
"     mmol/kg",
"    </span>",
"    of lactic acid per day, most of which is generated from glucose via the glycolytic pathway or from the deamination of alanine [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3781/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Lactic acid is rapidly buffered, in part by extracellular bicarbonate, resulting in the generation of lactate. In the liver and, to a lesser degree, in the kidney, lactate is metabolized back to pyruvate, which is then converted into either carbon dioxide and water (80 percent, catalyzed in part by pyruvate dehydrogenase) or glucose (20 percent, catalyzed in part by pyruvate carboxylase). Both of these processes result in the regeneration of the bicarbonate lost in the initial buffering of lactic acid.",
"   </p>",
"   <p>",
"    Excess lactate can accumulate when there is increased lactate production",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    diminished lactate utilization [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3781/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. Three mechanisms can underlie the accumulation [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3781/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Enhanced pyruvate production",
"     </li>",
"     <li>",
"      Reduced pyruvate conversion to carbon dioxide and water or to glucose",
"     </li>",
"     <li>",
"      An altered redox state within the cell in which pyruvate is preferentially converted into lactate",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In certain disorders, the primary role of lactate overproduction is clear. As an example, plasma lactate levels may transiently be as high as 15",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    during a grand mal seizure [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3781/abstract/5\">",
"     5",
"    </a>",
"    ], and 20 to 25",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    with maximal exercise, with the systemic pH falling to as low as 6.80 [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3781/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. Studies in these patients have demonstrated rapid recovery of acid-base balance with a maximum rate of lactate utilization that can reach 320",
"    <span class=\"nowrap\">",
"     meq/h",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3781/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The high metabolic capacity for lactate suggests that there must be some component of decreased utilization in those disorders in which lactate overproduction occurs more slowly. The importance of impaired metabolism is illustrated by the observation that infusion of lactic acid into normal animals at a rate similar to the rate of overproduction in shock is associated with increased hepatic utilization of lactate with little reduction in pH [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3781/abstract/4\">",
"     4",
"    </a>",
"    ]. In shock, for example, the reduction in perfusion to the liver and an associated intracellular acidosis may combine to substantially diminish hepatic lactate metabolism [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3781/abstract/3,4,8\">",
"     3,4,8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CAUSES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The causes of lactic acidosis can be divided into those associated with impaired tissue oxygenation (type A) and those in which a systemic impairment in oxygenation is not apparent (type B) (",
"    <a class=\"graphic graphic_table graphicRef78983 \" href=\"UTD.htm?5/24/5517\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Type A lactic acidosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most cases of lactic acidosis are due to marked tissue hypoperfusion in shock (due to hypovolemia, cardiac failure, or sepsis) or during a cardiopulmonary arrest [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3781/abstract/1,2,9,10\">",
"     1,2,9,10",
"    </a>",
"    ]. In some of these patients, concurrent respiratory acidosis contributes to the acidemia [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3781/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/62/6120?source=see_link\">",
"     \"Shock in adults: Types, presentation, and diagnostic approach\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/60/16329?source=see_link\">",
"     \"Clinical manifestations and diagnosis of cardiogenic shock in acute myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinical manifestations of shock include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A reduction in systemic blood pressure, the degree of which may be minimized by marked vasoconstriction",
"     </li>",
"     <li>",
"      Cool, clammy extremities, with the exception of the flushed, hyperemic skin of early septic shock",
"     </li>",
"     <li>",
"      Oligoanuria",
"     </li>",
"     <li>",
"      Impaired mental status",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The prognosis is generally poor unless tissue perfusion can be rapidly restored. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/20/13639?source=see_link\">",
"     \"Treatment of severe hypovolemia or hypovolemic shock in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/37/35418?source=see_link\">",
"     \"Prognosis and treatment of cardiogenic shock complicating acute myocardial infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/51/21306?source=see_link\">",
"     \"Evaluation and management of severe sepsis and septic shock in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Type B lactic acidosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The findings of systemic hypoperfusion are not apparent in type B lactic acidosis. Among the mechanisms that may be involved is a toxin-induced impairment of cellular metabolism or regional areas of ischemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Diabetes mellitus and metformin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Biguanide therapy in type 2 diabetes with phenformin in the past or currently with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    can lead to type B lactic acidosis, although the risk of lactic acidosis in the overall population of patients with type 2 diabetes treated with metformin is very low. This topic is reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/26/38312?source=see_link&amp;anchor=H7#H7\">",
"     \"Metformin in the treatment of diabetes mellitus\", section on 'Lactic acidosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    therapy, a moderate degree of lactic acidosis may be seen in some patients with diabetic ketoacidosis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3781/abstract/1,11\">",
"     1,11",
"    </a>",
"    ]. How this occurs in not clear although marked hypovolemia is likely to play an important role. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/16/44295?source=see_link\">",
"     \"Epidemiology and pathogenesis of diabetic ketoacidosis and hyperosmolar hyperglycemic state\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Malignancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of the lactic acidosis that rarely occurs in leukemia, lymphoma, and solid malignancies is unclear [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3781/abstract/12-16\">",
"     12-16",
"    </a>",
"    ]. Anaerobic metabolism due to dense clusters of tumor cells",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    metastatic replacement of the hepatic parenchyma have been proposed, but lactic acidosis has occurred in patients with relatively small tumor burdens [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3781/abstract/12,14\">",
"     12,14",
"    </a>",
"    ]. Direct lactate production by the neoplastic cells has also been suggested, but this would not explain the rarity of tumor-induced lactic acidosis. Thiamine or riboflavin deficiency has also been suggested in some of these cases [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3781/abstract/16\">",
"     16",
"    </a>",
"    ]. Regardless of the mechanism, removal of the tumor (by chemotherapy, irradiation, or surgery) leads to correction of the acidosis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3781/abstract/12,14-16\">",
"     12,14-16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/53/14168?source=see_link\">",
"     \"Overview of the complications of acute myeloid leukemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Alcoholism",
"    </span>",
"    &nbsp;&mdash;&nbsp;A mild degree of lactic acidosis may be seen with alcoholism. Lactate production is usually normal but lactate utilization is diminished because of impaired hepatic gluconeogenesis. Although lactate levels generally do not exceed 3",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    in this setting, alcohol ingestion can potentiate the severity of other disorders that are associated with the overproduction of lactate. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/29/6613?source=see_link\">",
"     \"Alcoholic and fasting ketoacidosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     HIV infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Given the increased propensity to serious infection, sepsis-induced lactic acidosis can occur in patients with AIDS. There are, in addition, cases in which lactic acidosis appears to result from drug-induced mitochondrial dysfunction in the absence of sepsis or hypoperfusion (type B lactic acidosis). These disorders are described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/40/30345?source=see_link&amp;anchor=H12#H12\">",
"     \"Mitochondrial toxicity of HIV nucleoside reverse transcriptase inhibitors\", section on 'Hyperlactatemia and lactic acidosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     D-lactic acidosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A unique form of lactic acidosis can occur in patients with short bowel syndrome or other forms of malabsorption. In these settings, glucose and starch are metabolized in the colon into D-lactic acid, which is then absorbed into the systemic circulation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/18/18723?source=see_link\">",
"     \"D-Lactic acidosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The normal plasma lactate concentration is 0.5 to 1.5",
"    <span class=\"nowrap\">",
"     meq/L.",
"    </span>",
"    Lactic acidosis is considered to be present if the plasma lactate concentration exceeds 4 to 5",
"    <span class=\"nowrap\">",
"     meq/L,",
"    </span>",
"    even among patients without a systemic acidosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16062069\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Lactic acidosis is the most common cause of metabolic acidosis in hospitalized patients. Impaired tissue oxygenation, leading to increased anaerobic metabolism, is usually responsible for the rise in lactate production. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mechanisms that underlie the accumulation of lactate include enhanced pyruvate production; reduced pyruvate conversion to carbon dioxide and water or to glucose; and an altered redox state within the cell in which pyruvate is preferentially converted into lactate. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pathophysiology'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Type A lactic acidosis is associated with impaired tissue oxygenation due to tissue hypoperfusion in shock (due to hypovolemia, cardiac failure, or sepsis) or during a cardiopulmonary arrest. In some of these patients, concurrent respiratory acidosis contributes to the acidemia. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Type A lactic acidosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Type B lactic acidosis includes those in which the findings of systemic hypoperfusion are not apparent. Type B lactic acidosis may be due to a toxin-induced impairment of cellular metabolism or regional areas of ischemia. Causes of type B lactic acidoses include",
"      <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"       metformin",
"      </a>",
"      therapy in patients with type 2 diabetes, tumor-induced lactic acidosis, alcoholism and drug-induced mitochondrial dysfunction in HIV-infected patients. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Type B lactic acidosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      D-lactic acidosis is a unique form of acidosis that occurs in patients with short bowel syndrome or other forms of malabsorption. Glucose and starch are metabolized in the colon into D-lactic acid, which is then absorbed into the systemic circulation. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'D-lactic acidosis'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/18/18723?source=see_link\">",
"       \"D-Lactic acidosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Lactic acidosis is considered to be present if the plasma lactate concentration exceeds 4 to 5",
"      <span class=\"nowrap\">",
"       meq/L,",
"      </span>",
"      even among patients without a systemic acidosis. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3781/abstract/1\">",
"      Kreisberg RA. Lactate homeostasis and lactic acidosis. Ann Intern Med 1980; 92:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3781/abstract/2\">",
"      Madias NE. Lactic acidosis. Kidney Int 1986; 29:752.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3781/abstract/3\">",
"      Arieff AI, Park R, Leach WJ, Lazarowitz VC. Pathophysiology of experimental lactic acidosis in dogs. Am J Physiol 1980; 239:F135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3781/abstract/4\">",
"      Arieff AI, Graf H. Pathophysiology of type A hypoxic lactic acidosis in dogs. Am J Physiol 1987; 253:E271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3781/abstract/5\">",
"      Orringer CE, Eustace JC, Wunsch CD, Gardner LB. Natural history of lactic acidosis after grand-mal seizures. A model for the study of an anion-gap acidosis not associated with hyperkalemia. N Engl J Med 1977; 297:796.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3781/abstract/6\">",
"      Osnes JB, Hermansen L. Acid-base balance after maximal exercise of short duration. J Appl Physiol 1972; 32:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3781/abstract/7\">",
"      Lindinger MI, Heigenhauser GJ, McKelvie RS, Jones NL. Blood ion regulation during repeated maximal exercise and recovery in humans. Am J Physiol 1992; 262:R126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3781/abstract/8\">",
"      Bersin RM, Arieff AI. Improved hemodynamic function during hypoxia with Carbicarb, a new agent for the management of acidosis. Circulation 1988; 77:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3781/abstract/9\">",
"      Fulop M, Horowitz M, Aberman A, Jaffe ER. Lactic acidosis in pulmonary edema due to left ventricular failure. Ann Intern Med 1973; 79:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3781/abstract/10\">",
"      Weil MH, Afifi AA. Experimental and clinical studies on lactate and pyruvate as indicators of the severity of acute circulatory failure (shock). Circulation 1970; 41:989.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3781/abstract/11\">",
"      Marliss EB, Ohman JL Jr, Aoki TT, Kozak GP. Altered redox state obscuring ketoacidosis in diabetic patients with lactic acidosis. N Engl J Med 1970; 283:978.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3781/abstract/12\">",
"      Sillos EM, Shenep JL, Burghen GA, et al. Lactic acidosis: a metabolic complication of hematologic malignancies: case report and review of the literature. Cancer 2001; 92:2237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3781/abstract/13\">",
"      Fraley DS, Adler S, Bruns FJ, Zett B. Stimulation of lactate production by administration of bicarbonate in a patient with a solid neoplasm and lactic acidosis. N Engl J Med 1980; 303:1100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3781/abstract/14\">",
"      Nadiminti Y, Wang JC, Chou SY, et al. Lactic acidosis associated with Hodgkin's disease: response to chemotherapy. N Engl J Med 1980; 303:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3781/abstract/15\">",
"      Rice K, Schwartz SH. Lactic acidosis with small cell carcinoma. Rapid response to chemotherapy. Am J Med 1985; 79:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3781/abstract/16\">",
"      Friedenberg AS, Brandoff DE, Schiffman FJ. Type B lactic acidosis as a severe metabolic complication in lymphoma and leukemia: a case series from a single institution and literature review. Medicine (Baltimore) 2007; 86:225.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2370 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-5A1610FE52-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_44_3781=[""].join("\n");
var outline_f3_44_3781=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16062069\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CAUSES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Type A lactic acidosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Type B lactic acidosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Diabetes mellitus and metformin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Malignancy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Alcoholism",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - HIV infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      D-lactic acidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16062069\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/2370\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/2370|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/24/5517\" title=\"table 1\">",
"      Etiology of lactic acidosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/29/6613?source=related_link\">",
"      Alcoholic and fasting ketoacidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/44/31432?source=related_link\">",
"      Approach to the adult with metabolic acidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/44/40646?source=related_link\">",
"      Bicarbonate therapy in lactic acidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/60/16329?source=related_link\">",
"      Clinical manifestations and diagnosis of cardiogenic shock in acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/18/18723?source=related_link\">",
"      D-Lactic acidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/16/44295?source=related_link\">",
"      Epidemiology and pathogenesis of diabetic ketoacidosis and hyperosmolar hyperglycemic state",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/51/21306?source=related_link\">",
"      Evaluation and management of severe sepsis and septic shock in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/26/38312?source=related_link\">",
"      Metformin in the treatment of diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/40/30345?source=related_link\">",
"      Mitochondrial toxicity of HIV nucleoside reverse transcriptase inhibitors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/53/14168?source=related_link\">",
"      Overview of the complications of acute myeloid leukemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/37/35418?source=related_link\">",
"      Prognosis and treatment of cardiogenic shock complicating acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/62/6120?source=related_link\">",
"      Shock in adults: Types, presentation, and diagnostic approach",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/20/13639?source=related_link\">",
"      Treatment of severe hypovolemia or hypovolemic shock in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_44_3782="Mefloquine-resistant malaria";
var content_f3_44_3782=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F75158&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F75158&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mefloquine-resistant malaria",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 394px; height: 586px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAJKAYoDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6J8ZeKIfC9tYSy2F9fyXt19khgs/L3l/LkkJJkdFA2xN39K5//hZT/wDQneJP++7H/wCSaPi5/rPB3/Yab/0hu6yKaQGv/wALKf8A6E7xJ/33Y/8AyTR/wsl/+hO8Sf8Afdj/APJNZFFFhXNf/hZT/wDQneJP++7H/wCSaP8AhZT/APQneJP++7H/AOSayKKLBc1/+FlP/wBCd4k/77sf/kmj/hZT/wDQneJP++7H/wCSayKKLBc1/wDhZT/9Cd4k/wC+7H/5Jo/4WS//AEJ3iT/vux/+SayKKLBc1/8AhZT/APQneJP++7H/AOSaP+FlP/0J3iT/AL7sf/kmsiiiwXNf/hZT/wDQneJP++7H/wCSaP8AhZT/APQneJf++7H/AOSayKKLBc1/+FlP/wBCd4k/77sf/kmj/hZT/wDQneJP++7H/wCSayKKLBc1/wDhZT/9Cd4k/wC+7H/5Jo/4WU//AEJ3iT/vux/+SayDRRYLmv8A8LKf/oTvEn/fdj/8k0f8LKf/AKE7xJ/33Y//ACTWRRRYLmv/AMLKf/oTvEn/AH3Y/wDyTR/wsp/+hO8Sf992P/yTWRRRYLmv/wALJf8A6E7xJ/33Y/8AyTR/wsp/+hO8Sf8Afdj/APJNZFFFgua//Cyn/wChO8Sf992P/wAk0f8ACyn/AOhO8Sf992P/AMk1kUUWC5r/APCyn/6E7xJ/33Y//JNH/CyX/wChO8Sf992P/wAk1kUUWC5r/wDCyn/6E7xJ/wB92P8A8k0f8LKf/oTvEn/fdj/8k1kUUWC5r/8ACyn/AOhO8Sf992P/AMk0f8LJf/oTvEn/AH3Y/wDyTWRRRYLmv/wsp/8AoTvEn/fdj/8AJNH/AAsp/wDoTvEn/fdj/wDJNZFFFgua/wDwsl/+hO8Sf992P/yTR/wsp/8AoTvEn/fdj/8AJNZFAosFzX/4WU//AEJ3iT/vux/+SaP+Fkv/ANCd4k/77sf/AJJrIoosFzX/AOFlP/0J3iX/AL7sf/kmj/hZT/8AQneJP++7H/5JrIoosFzX/wCFlP8A9Cd4k/77sf8A5Jo/4WS//QneJP8Avux/+SayKKLBc1/+FlP/ANCd4k/77sf/AJJo/wCFlP8A9Cd4k/77sf8A5JrIoosFzX/4WU//AEJ3iT/vux/+SaP+FlP/ANCd4k/77sf/AJJrIoosFzX/AOFkv/0J3iT/AL7sf/kmj/hZT/8AQneJP++7H/5JrIoosFzp/DXjqLW9fXSJNE1fTbl7WS7ja8+zlHSN41YAxSuQcyp1A712FeU+Ff8Akqemf9ga/wD/AEfZV6tSGef/ABc/1ng7/sNN/wCkN3WQBkgAEk8ADqa2/ipE8934LijUsz62QABn/lxu+apSTJZForGRml3EPcFcHjjC9cD3700IamnzZVZSkDucIkpwzH6dvqcVUcGNisilHHBVhgikxnOec9c96uRaleRjHns6nGVkAcEDtz2pgU+M471bhsZHjaafdBbqNxkZCc5OAAPX/Cl/tCZCv2ZYrbGc+SmM/XOarTSyTSNJNI0jt1ZjkmgC1GLLzFgJLBshrlsrtPYhfT1zz9KguLaa3WMzKAHztwwOcden1qTSzCt7GbgR+XzzJ0U44J9eccdKsjyLqZoGea4uSjCOVn2oX64C46Zzj1oAzKKBRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRR2oAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKDRRQAvhX/kqel/9gW//APR9lXq1eU+Ff+Sp6X/2Br//ANH2VerVLGef/FskS+DsEg/2yw4OP+XG7rIrX+Ln+t8Hf9hpv/SG7rIpoTCivP5tf1DSNY8Z3FxdXGoWmlpA9vZOIo1HmLuI3qm7joMk8dcnmr8vjC5sv7Rg1TSVh1C3FsYbeC680Tm4cxxruKrtO9SDwQOoJpgdjRXnja1f2+uXq61bFXN/p9vHBa6hIY4zISNwbau4dyhUA45z1rVbxh5Hi220W5TSm+0zvBH9l1LzZ0IVmUyQlFKghSDgnBIHvQB11W4I44YBc3ODuz5EQJBdgcZJHQD881Uq4uozpCipsR0UIJFX5to7en4jmgCvcSvNcSyyjEjsWYYxyfao6ti/dkC3Ucd0AcgzZLD1GQc0JLaSARPbeSp6Soxd1PvnqPbigCK2tprkyC3jLlF3MB6VHIjRyMkilXU4Kngg1bvdttGbONy7rJulkHALAYCjvgc9e5pY7mGcxx3kSgkCM3IJ3KB0OOnHf1FAFGipbiF4JNjlWyNyspyrDsQaioAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigBfCv/JU9L/7A1//AOj7KvVq8p8K/wDJU9M/7At//wCj7KvVqljPP/i5/rfB3/Yab/0hu6yK1/i5/rPB3/YZb/0hu6yKaEzl7jwZbXN1rktxqWoyLrCqs8Z8oKgX7mzEeRgcck5B5yeauaj4as9Qvby7lkuFnuY7ePcjL+6MEjSRuuQfmDNnnI4HHXO5RTA5hPB1sZXmu9R1G7uHure7aWZo8l4TlBhUAC+oAH4VFY+B7OzvbSaLUNRNvaXkl9DaFo/KWRw4YkhNzffONzEj1rrKKACiiigAqxDbZiE87mCH+FsZZz/sjv8AXoKNOjWW/t0dQys2CG6H6/jiqGoaxaxzFtS1C2ilHylZJVXbjtt7Y9KGxxi5OyVy/qEyz3byR5K4A3MMMxA5Y+5NV6yf+El0LOP7Ysf+/oqzBq2mTkeTqVlJ9Jl/xpcy7lujUWri/uZs3AV9OtZV+8haBxnp/EPzBNU6s2kiKkkVwWFvMv3lXdtYdGH6jj1qyJYL2aVDaqmFdo3j+VgACQCBw3SmZmbRQORRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAL4V/5Knpf/YFv/wD0fZV6tXlPhX/kqemf9gW//wDR9lXq1Sxnn/xc/wBZ4O/7DTf+kN3WQK1/i5/rPB3/AGGm/wDSG7rIpoTCiiimAUdferEFlPMVIjZYzyZXGEA9c+lSfaIbdWFiJDIylWnf5WAz/CB04HXrzQAeTHaqn2mNpLhxuEOdoQdi3fJ9K4HxX8TE06eWz0Oy0+e4Q7XuHi3RoR2UZ+Yj16fWqfxK8WSWjSaRp0jC7cZuZweUBH3Qf7xHU9hXlYGBgdK5a1az5Yn0OV5UqkVWrrR7L9WdjH4z1DWpbu18XapdTaddQsoZEybaYcxyoq4OAeoB5BxUHi2KyvNPg1calp11qjyCGc22Va7XGRO8ZAMcgxtcHhjgjvXLUVyuTe578cPGEk6enkrWEpCinqAfqKdSGoOg0tM1zVNKYHT7+4hUfwbtyH/gJ4r2/wCHGvDX7e3u3RYblHaF1B+XzNvyn6EkcV8/16v8Dztt75m4UXsP8q6cPJ83L0PEzrD03QdW3vK2v4HdYKkqwwwOCPQ0VJcgrczqeokYfqajruPkgooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAXwr/yVPS/+wLf/APo+yr1avKfCv/JU9M/7A1//AOj7KvVqTGef/Fz/AFng7/sNN/6Q3dZFa/xc/wBZ4O/7DTf+kN3WRQhMKs6dGst9CsozGCWb0wATz7cVWqxppdb+AxRmR933B3HcflmmBHcXE1y5ed2Ysd2CeAfYdqy9f1SLRdHub+bB8pfkU/xufur+dak0apcSRwuJUViquBgMPWvGfiP4iXWdSWzs3zYWjEbgeJZOhb6DoPxrOrU5I3O7L8I8VWUfsrf0/wCCcpcTS3NxLPcOXmlYu7HuT1qOiivNPuUraIKKKKQwooooAK9h+Cdvu0lm2gh73c2em1QMk+2M149XvHweiit/AqXLRyPL5krGNSNrRkkZYHquQM46cV0YZe+ePnkrYa3dr9WbkzmWeSTOd7Fs/U0ygdKK7z48KKKKACiiigAooooAKKKKACiiigAooooA5G21XXtbu9UbQ20u1srK5e0T7XC8r3EiHDnKuoRQ2QOGPGcdqpw+L7nT9d1+DVrW7ms7S5tovPt40MNsJIYickkMw3ux4DEA84GK0h4d1OxvtQk0HWIbS1vpTcSQXFn5/lyt95o2DrjPXDBhn8qbdeE2ubTXopNQJfVZYZWkMI+QxxxJ0B5z5We2N3tQAxvFtvaXM1usGq6jcSanJYRxJHFkSLEJCq8qNmO7HOc5OORdg8Std6Yl5YaNqd2RLJDNBH5CyQPGxVlYPIoJyD90tVa28JeTrUeofbd2zVJtS8vyuvmW5h2Z3ds7s49sd6zdQ8AG5mWT7dazILq6uTb3tl9ogbz3Dcx7wCy4wGORyeKAOu0bUoNY0q11Cz3+RcxiRN67WAPYjsR0NXayvCukf2D4esdLEwnFtH5fmBNgbk/w5OPzrVoAKKKKACiiigAooooAKKKKACiiigAooooAKKMUUAL4V/5Knpf/AGBb/wD9H2VerV5T4V/5Knpf/YGv/wD0fZV6tSYzz/4uf6zwd/2Gm/8ASG7rIrX+Ln+s8Hf9hpv/AEhu6yKEJhVyAeRZTSykj7QhjiQDluRlv90Yx70y3CRWslzIiSHcIolflS2Mkkd8D+dRyTPcT+ZM24nGfQD0A7D2pgef/EvxObC3OkWD4vJk/fuv/LKM9h/tH9BXlAAAwOgq5rF019q99dPktNM7cnPfj9MVUrzKk3OVz7zA4WOFpKC36+oUUUlZnYLRRRQAUlLWppXh/VdVg+0WVoTZhzG91IwSGMgZJdz0AHU9vqQKaV9iZSUVeTsMstB1bULe3nsrCeWC5nFrFMEJTzMgYJHQAkZJ4r6D0pLfRdMttP0+KFltoBAtzg7nOMO3pgknHHSvCNf1RVazstFvrg2tlZfYjcRMYhcEsXkYAYO0se/J2gmvX/Clwt14Y0qZW3A26An3Awf1FdWGtdo+dzx1JU4Se13/AMC/yNUccelFFFdh82FFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAC+Ff+Sp6Z/wBgW/8A/R9lXq1eU+Ff+Sp6Z/2Bb/8A9H2VerUmM8/+Ln+s8Hf9hpv/AEhu6yK1/i5/rPB3/Yab/wBIbusj8CaEJl3S3cSOrH/RVUySqyhlIA9+hzgZrPfK28p7iNj+ODV+5C2sJtRgzsQZ2ByFIPCD6d/fjtVGUZhlHqjD9DTGj5uQ5QE9TyadSKNqhfTil715B+jhRRRQAlLRRQA2RisbMOoBNdF40R7bULSxjjMenW1nF9jIBHnRuA7Sn1LuWJz0247UnhGZbP8Atm/MNvJPZ2DSWzTxiRY5jJGqOAeCwycZzWNeXl1f3Bnvrme6nbrJM5dj7ZPbnpVbIx1lU8l+f9fmQ16r8I9Q87R7uwc/NbS+Yg/2H/8Arg/nXlVdP8NtQ+weLLZXbEV2Dbt6ZPK/qB+dXRlyzRy5nR9thpJbrX7v+Ae1UUUV6R8OFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAC+Ff+Sp6Z/2Br//ANH2VerV5T4V/wCSp6Z/2Bb/AP8AR9lXq1Sxnn/xc/1ng7/sMt/6Q3dU9PxG0t0wDfZ1DKD0Lk4X/H8Kv/FcRm48GiZnWP8AtlslBkj/AEG77VRu/LhtY7eGVJt7ea7p0PZRz6DJ/GmgKZySSxJJ5JPelUAtg9DxSUUxHzpewPbX1zBKu2SKV0I9CCahr0j4keE5ZJ5NZ0uN5S/N1Coyc4++o/DkfjXmwOeleZUg4OzPvsHiY4mkpxfr5MWiiiszqCiiigC9o+r3mi3P2ixuZ4FLIZhEwUyKrbsZII7cHseav+OoreHxNdTWsfkW93HHfLEQAIRMgfYD3A3dePpUfhN9Mj1QnVhHu2/6K1wpe2SXPDTqOWQdcDv1BFW7zWbW1uprm2P9r6zMQ02p30QaNW7+TER9AGfsOFAq+mpzPSreK6ff8/L7+xz8NvPON0FvPKB1McbNj8hVqPTdWiuIGi03UFn3Boh9mkBJUjoMeuKnl8R65LK0kms6iXbAJW4ZM46cKQK0/B1zdanry2eoajqkltLFM7xpfvEZWWNmVS2ehKgepzSSTdipynGLk0rI9isLh7uxt7mW3ntnmTc0U6FGVuhBB981PXk+g+MtRsPEZi19GtbQ4t3s/LMa2IB+UKnUAZ5zyQckmvWPoQQehHQivRpVFNHxeOwcsLOz2e39eQUUUVocQUUUUAFFFFABRRRQAUUUUAFFFAoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAF8K/wDJU9L/AOwNf/8Ao+yr1avKfCv/ACVPS/8AsDX/AP6Psq9WpMZ5/wDFz/WeDv8AsMt/6Q3dZFa/xc/1ng7/ALDTf+kN3WRQhBRRRTAASDkHB9q4zxt4Li1dHvNLSOHUhyyj5Vn9j6N79+9dnRUyipqzNqGIqYeaqU3ZnzhNHJDM8M8bxzRna6OMFT6EU2vcfFvha08RQ72xBqCDEdyB19Fcdx+orxjVNOutKvpLO/hMU6dR2YdmB7g+tefUpOm/I+ywOYU8XHTSS3X+XkVaKKKyPQCiiigApsg3IwKhuPunvTqKAOk8aQxsukXltKLy2eyjtmvg4InljUBgy9UZQVUg8kAHvXbfC/Xzf6adLuXzd2a/uyerxdvxXp9MVw9m1rq3huy0b7dHZ3ttcT3KfaxtimLhQEWQcIfl/j4yeo6VJpOk6lpWrQXNrqGiLfQkSRwnUo8zKeCAc7cEZ6kVtCbjLmR5WLw8a9B0ZO0lt+nyfXovke10VXsb2G8EojOyeFtlxbsf3kD90Yeo9ehqxXop32PjZRcXZ7hRRRQIKKKKACiiigAooooAKKKKACiiigAo6VNaQfaJCpdY0RS7u3ZR1471Ms9tAwNvbmV15Ek57+uwcfnmgCnRV5ZP7QBjn2/agMpNgAyYH3WPQ+xqrPBLbuEnjaNsZww6j+tAEdFICD0INLQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAvhX/AJKnpf8A2Br/AP8AR9lXq1eU+Ff+SqaZ/wBgW/8A/R9lXq1JjPP/AIuf6zwd/wBhlv8A0hu6yK1/i5/rPB3/AGGm/wDSG7rIoQmFFFFMAooooAK5/wAbeHl8Q6SUjCi/gy9u57nuh9j/ADroKKUoqSszSlVlRmqkHqj5vdWR2SRSjqSrKwwVI6g0leifFTw95Uv9uWi/JIQl0o7N0D/j0PvivO68ycHB2Z93hMTHE0lUj/wzCiiioOkSlopKAA8itrwxZWTSXOo6vEkuk6eA88HObh3yI4gB6sOTkYAPsKxq3tPVdP8AC2p3N0wzqsf2S0hxyxSRGeU9gFwFHckn0NVHcyqt8tl10/z/AAuVr/Xry51+XWLbFhdvt/492PG1QvJPLZxk5613fhr4iwz7LfX0WCU8C6jH7s/7w/h+o4+leX0dqqFSUHdGGIwFHERUZrbZ9UfSPUA5BBGQR0xRXmXw38WeSYtG1OTEZO21mY/dP/PNj6eh/CvTuhwa9CnNTV0fG4vCzwtR05/J9xKKKdGjSSIiDLMwUD1JNWco2ir0lra5kCXm3ymKt5i8v7oB15zTlht7aIXfnLcKciGMoRlxj7/pjrjPNAEf9m3JGEVXkABaJGBdcjPK9fyqn/McGnSO0krSyMWkY7i3cn1q4LiC7VRqDSiVT/rkUEuv90+/ofzoAZZ2L3Me4Ose9/Li3A4kbGcZ+nf1NNWzla2Ey7SSC/lZ+fYDgtj0z+NMu7hriUPgxqoCogbIQDpj+f1p015PLdLcs+2ZcbWUYxj/AD+tADbeASI8jyCOFMbmxkknoAO561Yaw6SrKBZEBvPbsccrgdW9qjuLlJYAiW6ROz+Y5U8E4xwOw5JxVbJ27cnbndjPGfWgC2Zba3WT7J5skkilN0qhdqkc8A8k1ToooAOtWLe7eGMRlIpYw25UlXcFPqPSq9FAF06hJOrpfFp4254wrIc9Qcfhik+02n3Gsf3I7rIfN/766fhiqdXbFCsE9zHCJpYWUgEZCDkliO+MCgCG9gFtdyQq+8LjkjB6ZwR6ioKVmLOzMcsxLE+pNJQAUUUUAFFFFABRRRQAUUUUAFFFFAC+Ff8Akqel/wDYFv8A/wBH2VerV5T4V/5Knpf/AGBb/wD9H2VerVLGef8Axc/1ng7/ALDLf+kN3WRWv8XP9Z4O/wCw03/pDd1kU0JmX4p1CXSfDGr6jbLG09nZzXEayAlSyIWAOCDjI9a4/wAP+Opp7+ZLm+0nVbSLSm1GaTS0KtAykZiYGVwSRnHIPHIrtPEOnf2xoGp6b5vk/bbaW28zbu2b0K7sZGcZ6ZFc4PBt1eyWv9t6pBPHaWktpAtpaG3OJE2MXLSPu+XoBgZ5pgaOqeLbDTbR7ieG6ZE05tTIRVJ8tSoI5b73zDjp71DceLmgubK1bw/rRu70SvBCFg3MkezLHMoCj94OGIPBBAOM5lz4Hv76yu7fUdbhl83Sm0uMxWPlhFJU7yPMO4/LyMgemK6e70n7R4i03VfP2/Y4J4fK2Z3+aYznOeMeX6HOe2KAMrRfGlrq0tksWm6lDHfRySWkk6Rqs5QAsgG8kH/eABwcE1f0rXxe6pLp1zp19p14kInWO68o703bcq0buODwQSDyKyh4MI0fSbFdTkjNhDcRCaOPazebGybl5+Uruz36VH4Q8E/8I/rB1A3Fgzm0+ystpYfZ/MO4N5jsXYsxxySaQHU6tYpqel3djKPluImj+hPQ/nivnqSN4pHilXbLGxRx6EHBr6Prxn4nactj4qkmjGI71BOB6N0b9Rn8a5sTHRSPfyGvyzlRfXVeq/r8DlKKKK4j6kKKKKAEbJBwcHsa6bVL7QtUXTmc6pZJaWqW32SKKORV2gklHLD7zEsdw7muaopp2IlBSafY3Bp2h3OfsevNaMGChNStSu7Oed0ZYADgHOOuaqavpMmmR2sv2q0vLa5D+XcWrlkLI211yQDkHH4EHvWdXUWtkviTSdLtbTUbO2vNOtpw9pclkDgM0hlVsbeVODkjlR7U1qZybptNvTr93kjliMgg9K9q8CeJLfWNLt7WWcf2pDHtljfgyAcbl9eMZrxRXVsc8kZweuPpWlothd31xLNZzxWoslE8t3NJ5aW4zhSW65J4AGSemKulUcHoc+YYOGKp8snZrZn0DV3SGYXuxDh5UaNSDghiOMHtyBzVazEN3oVvfW9wLl2VDK6IVQhh95QecZ45xUf869Lc+HacXZhgg7WBDDggjBFT21x5KvG8aywSYLRtxyOhB7H3qXUC0sdrct8zSx4eTH3nBwc+4GOe9U6BFi7txEsUsTM9vMMozDkdip7ZH/16r1bsGyJ7d5EVJYzgSNhd4+6c9u/P4VJdwWzQ+ZZSBvJRVmGDgsTjcpPUE0AUKKKKAKVpqdnd3N9bwTZmsXEdwrKV8slQw6gZBBByOKbpOqRarClzZxTNYyxJNDcsAqTK2fugneMcHlQORjNcV46sNUh16Q6NbXMkfiC0Gm3MsCEi2cOAJmPYCOSXn1Vao+KdD1A6nrcOl280dj9k02L5YHdZIY5ZPMRQpUvhSMqrAkcdxQB6Te39tYm2F1JsNzMIIvlJ3OQSBwOOAevFWa8e/sCA2aTTaY17psWqwTvax6FLbxxp5bLIY7dy7kElS2AM4yAatS+HYjZ69qdjo0sd8ur2r6e4tWSSOALaj92pAKrjeCABwCD93AAPV6K8n1CK8ufG1tcw6FHZ3MOsIrTQaTL5ssGSple6GEKsp5XDY7kY4bZ+D7aW00Ka50QtdTa7dm9Z4Dua3LXJUScf6s4iOD8pyPXkA9aq3pOf7TtsDJ34xnHUEVyHgSyfTtNv7Q2729vFqFyLaJkKqsRcldg/u88Y49K6SgCeSyuYly0LFRxuT5l6eoqCrFhdPZziSMEr/Em4gNxjtUsdpDcqwspX80Lv8mVcYA6/P0OKAKVFW/7OugTmIBB/y1LDZ/31nFQywSRSiNkJcgFdvzBh6gjqKAIqK1NKsmN0FaTy22N5q7fmSM/LvHGOv5YqDTbvRNUmmnW7iW3iBjkDyLEQ46MvOCp9e5zWipzkrpGMq9OMlGUkr+fbcpUVK8E0YJkjIAOD0OPrjpUun2hvHdFcK6rlV4yx9B/WszW5VopWVkOHVlPowxSUDCiiigBfCv8AyVPTP+wNf/8Ao+yr1avKfCv/ACVPTP8AsDX/AP6Psq9WqWM8/wDi5/rPB3/Yab/0hu6yK1/i5/rPB3/YZb/0hu6yKaEwooopgFFFFABRRRQAV5z8ZI08nSJf+Wu6RP8AgOAf516NXmfxklBuNJhzyI5HI+pA/pWNf+Gz0soTeLhbz/JnnVFFFecfbBRRRQAUUUUAFXNIvzpt553kQ3MTxtBNBMPllicYZeOQcdCOQQDVOimJpNWZv/8ACSKsZtF0XTDpOMLZOjH5s5EhmyJC/vkDHGMVa8q61nSYd9xpGg6B5jusAkILsvDOEyZJ2BO0ZPU4GOTWJ4f046zrtlpiSiJ7mTZvxuKjBJIHc4BwO5wK3jBJqPjLRdIawurC1svLiitbsfvVTPmNJIP7zkljjjkDtVxuzkq8lPbSyu/Tv6+f3nuPh2OC20+30m2VxE1sIWlkADsQvBK9AOOg7nrUCW1xJEZFglKKNxbYcAetMDsJd6MVcHIIPINPNzOZvOM8vm5zv3HNemlY+Ebcndk96CbaydSGhWIRhlPAfJLD2PNU6muLqa42+c+QuSAAAMnqeOp96hoEFX7mN7fSrZGUK07NK2Dncoxtz+Z4qhVuyeN0+yXHETvuSTOPLfGM+4PAP50AVKKdLHJAxSeNo2BwQwxzTRzwOc+lABRVsWEqp5lwyWydAZjjJ9MDJ/Sori3lt2USgYYEqysGVh6gigCGiiigAooooAKKKltUjluY45WdUY4yi7jntxQBFTkQyNtXA9SxwAPc+lTa1HZaPKgvNQTY6mRfKiaRigOC2Bx+o6VQTxDp9lqSR2Eg1O6cbYUjISNmPA3OTgevTit6eGqzs4xdv66nJVx2HpXUpq/br925FrGsW2gD5xHdX2WCW4OUQgYJkyPfoOtctf8AjPWLuwgtVuDbBN294PkMm4nrjoADjAqLxtdz3OtGOe/ivhCgVWhGIkJGWVOTkA9+9YFfSYPA0qdOMnG73/r/AIY+FzTN8TWrShGTUVpZafk3+ZeutX1G5ZzNezkPGsLKrlVKDgLgcY9qoEA9hS0V6EYqOyPElOU3eTudF4a1+00e1uFl04z3MvBmWYqWXj5DwcDIzkc0upeLLu7tpbeC3t7SOUFHaPLOyntknj3xjNc5SHoaweEoup7SUbvzOyOZ4mNH2EZ2j2Vl+Wp6j4d1a91TSop9UNpJbqJI4lSNhKWAAJLA4AyQe9WkxvXfyuRnnHH1oEJtoLa2KhBDCibVGFztBJA9zk571Zin0+0sHn1JJJG8zbEkcTOWOMkHaOn1xXydZ+2qv2cfRI/R8KnhsNH20rtLVtl2+0uG1v5xNciKwjjM7TY3bEHYn19PWuMuvGunwStJpmnSynJCrdsNgGMAkDk+uOMVZ8T6s2t+DZzp1089vFOHuUnYK8K5+RAvcbjx14HWvOTXr4DLacouVZXaex81nGe1qc1DDOyavfR39PT87novw416fW/inZfaILaHydGvtogTaMGez6+vT9a9rr59+DH/ACVOH/sC3n/o+0r6Cry8xpxp4iUYKy0/JHvZLWnXwUKlR3bvr82ef/Fz/WeDv+wy3/pDd1kVr/Fz/WeDv+w03/pDd1kVxo9RhRRRTAKKKKACiilAyQBQA1mVEZnZVRQSzMcAAdSTXh/jvWo9d8QPPbHdaQoIYTj7wByW/Emt34k+KVvnbR9Okzaxti5lU8SsP4B/sjv6muCrixFXm91H1WT5e6S9vU3ey7IKKKK5T3gopKWgAopCQBknAqaN0s72BtQtnaNXV3t5d0RlTPI9RkZGRTERVd8P2C6xrVpY+d5ccz4klXBMaAFnYZ4yFUkV0fiGDw3ovii9t30nUZY4JVaOAXy+UVIDjcSm8ZBAKHkcjOak0fxMupveweILi1tPMt5IrW8ittr2yOw3wps42lN4UMDgkcjNUopOzOaVaUoc0I7r8/LW/n+pmP4w1GBvL8PTNo+mISYLeBV3AdmkYglpCACWPfpgV1/w10e7nup/EmrPJJcXAIhaU5eTP3pDn16CregeBLTWxFeXGk/2YYJCYtOEhZ7mDA2mXJ/1gPLYxuB6DFduVKkqRtK/LtxjGOMV1UaTvzSPBzHMKfI6NBavd/pfr5sSiiiuo+fCiisvRdctNW0X+1Yi8FoGlVjcYXb5bsjE8kAZQnOelAGpRWdYa7pOo288+n6pYXUEAzNJBcI6xjGcsQcDgHrTYtf0abTpdQh1bT5LCI7ZLlLlDEh9C2cDqO/egDcivrqEBUnfaOgb5gPTAPSpob6JJTctbAXa5MbR/Km492X29qyLC9tdQtUubC5gurd/uywyB0b6EcVYoAOrFiSzHqSck1asXlIaBbc3EJO5owOh6ZB/hPvVWporiSKJ4hsaJiGKOoYEjoaAFvYo4bqSKFzIinGTjOe4464PGagq+0C3cUUsJt4pmJV08wIC2cLhexPX0qi6sjsjgqykqQexFACUUUUAFJPdW2mWR1C+eRIkcLGIwC0r9doz0PfJ4xT40aSRUQbnY4AHeua8aajaf2UtjBcxzXLzLJIIiHVFUEAFumcnoO1dODoe3qqDWnU4MyxiwmHlUTSlbS/f9Sta+OL6zvpXtYk/s9mZ0spWLrGWOThhg43EnHTnFcmx3ElsZJyeMUlAr6+nRhTbcFa5+Z1sVWrpRqSult5X7f5BRRRWpzhRRRQMKKKKBHpXhe6a/wDDEDtJLLLZuYJDJk7VPKAH0Az9K1bObyLhHLSCPILBDjcPT3rgvAmrQ6Nr63F0UWBo3VmYM23jIwo6k4xz69utdGfEuiyL5pup4y7EmI25LL+Rxj05r5fH4Cp7ZunFtPU/Qcnzeg8LGNaajKOmr7dTl/GNndwazPdXUcQju5Gkjkg/1b+uO4+h5rCrd8Raw2uXNvBZQSrbR5EUR+Z3Y9WOO/AGB0ArCr6HDc/soqorM+Kx/sniJug2430b/H8Trvgx/wAlTh/7At5/6PtK+gq+ffgz/wAlTi/7At5/6PtK+gq+XzT/AHqfy/JH3/D/APyL6fz/APSmef8Axc/1ng7/ALDTf+kN3WRWz8WUZ5vB4QEkaw5wPQWF2T/KsauBHsMKKKKYBRRRQAVy3xH1l9I8PFLZ9t1eMYEbuq4+Yj3xx+NdTXkHxXv/ALT4lS1U5js4gn/Am+Y/0rKtLlgejleHVfExT2Wr+X/BscYAAAB0FLRRXmn24UKCzBQMsxAA9Segorf0OGz06wg8QalBPceXeiO0tUdY0ndF3lnbltqnaDtHOcZppXInLlVzJ1PT73Sro22qWk9ncAZ8udCpI9RnqPcVVU7mCoC7HoqjJP4Ctm28S6lBHLGTa3MLzNcLFeW63Cwu2cmMPnbnPQccCpn8W6v5BjtpLWxJPMlhapbyEf3d6AHbnnHuaehF6nVL7/8AgFvw7peoaRd3uo39hc2hstNlvIJZ4cIsjLtiPzDGSWyB1yPaqFv4q163iMcerXRBLHdKRI6564dgWGepwazJr27ng8me7uZYd5l8uSVmXeerYJ6n1rZ8LeE7/wAQMJIx9nsAfmuXHB9kH8R/Smrt2iZ1PZ04upiGrGEBLdXOAJZ7mZycDLu7E5J9SSa9X8B+DY9Mji1HVY92pEbkifkW/px3f+VdHoGg6doMATT4AshGHnfmR/qf6DitSuylQ5dZbnzmPzeVdOnRVo/i/wDJFrT0BuBPKMwwHzHJPf8AhHuSccVVJLEs33mOT9TVm0kUR3EErBUmAwx6K4OQT7dQaeIbRCzPdeaijlEUqzN6AnjHv+ldB4hT+tFX7WKyuZQm24hOCWO9SoUdWJIGMfrVD6UAFefeGx4i0fwnPpNvoN0mpK128FzJLbm33PLJJGTiXfj5lH3evtzXoNFAHk1z4a8R6v8A2vLdwXhmuLG3jH297VTM8c/mNEBBkBSMqNxP3uTWjqWjalqV9f6q+iX1qJXsxFbQXNutyrwlz5/LNESNyqFJ5C844FekUUWAwfBltqFto7DVkCXLzyyAFI1kKFjtMnlfJ5hHUrxW9RRQAGjjsav6btW3u3eCNwihlklXKhh0X6nP6elRi9LDbcQQSoeuECMffcO9ACWVsk6XEk24xwR7yq8F/bd0H8/So724a6uXmZQpbHAOegA6/hS3FyZYo4o1MUEY4jDE5Oclj6moKACnDYsU8024QwRNM+0c4UZwPTJwKbWH44unt9Dt4IcoLqVhMc/eVdpC/TJyfcCt8LR9vVjT7nHj8T9Uw063ZfjsvxMrVPFsl3YvbWVoLQyjbJJ5pdyvdV4GAe/c1jXGjana232i4029ht+P3kkDKvPTkjFX/BPGvIY9n2vyZTaeZjb5+xvLznj72PxxWHoujraaJr0s9xrVrqq6TdXOpXKxKZJlWE71kkaQOXYFsZUgHnjAr6RzjhG4UopJK73/AOD958LGnUzJKrXm5Sb5Ulbor9Wl12WrG1dh0u8muLGCKIPPeoZIIw67nUMVLYzwMqeTjpXQ6daCXx3YwfY4nsho0Fxs8hShYwSbnPHJ3qOT3FUPC97N5nhm6by3mfwpdSMZIlcFszNnBGOo9OmR0JFTWzHlXuLvv/29/kVhsl55NVJaXS083D9Jfec8JYHkkS3u7O68s4Z7S5jnQHGcbkJGfbNOo8Lx/a5dNXULgNHcPEJGWGKFY0O0EKsaqqgD0Fbd5cXEWmeLLvVbS1tl068VLKJbSOPyf9JESRk7d0hdDn5y2TyMCuiWKdJR51q1d/gv1OSnl6rym6UtE7K+70b7LojK1CA6fcx2t5PaR3jqHFr9pjadVIBBaINvUYIPIHWoa0vGUs8/j7xD5kqCKG5EaxR20MYOYYjuZ1QO7dgWY4HAqtp1hdajci3sYXmlxkhf4R6k9APc1eGrSqUVUqaXMsdhY0sS6FG7tp5t/cP0nTbnVb1LWzUNI3JLHCovdiewrqbPwSqXkhv76F7SNC2IiUkdhjC7WGRnnnnpWr4c0iLw/MLmG4ebUChQyKcRpnqFH8X1PpnFaDszuzuxZ2OST1JrxsZmsudxoPTufU5Zw7TVNTxcfeve1+nZ/qY58LaLJIWP22BWAG1JAyp/tcjJ9cVZstE0qxjVI7RbplcP51yMsSOmAOAv+yc+9XqK86WNxElyubPbhlWDhLnjSV/66bEtmbW0e7uILVIb6cKPPh+XBBznb0H4YzXN+JNDsH02+vLS28i6jAmIRzsIzhsKenXPFb4BJAAJJ4AArL8Wa1Y6bbSWFvG82oSwmK4Rz8kW4c9OpxjjsetaYKdeVdezbe1/RdzDNaWEhhZe2SS1tp1fbzMj4M/8lTi/7A15/wCj7SvoKvn34M/8lTi/7At5/wCj7SvoKjNP96n8vyQuH/8AkX0/n/6UziPiTJHDqfgd55lhiGttudumDY3Yx+PT8ax9QgNtfTQsyMVbqh455xTvjpcraWfhKd0Dqmt8r14+x3Q496iM0epWMOrWts1ta3JbEbuCQwPP4Hr+NcqpP2Xtel7fkeh9Yj9YdBvWyf4tP9CKiiiszoCg0UUAI7pFG8kp/dopdj7AZNfO+pXj6jqN1eynLXErSfQE8fpivbfHE72/hDVniOGMOzPoCQD/ADrwoe3SuPFS1SPpsgpLlnV+X6hRRRXIfRBW9qqyjwd4e+0w+W6y3XkM2N0sDFGDAddm7cAe5zisEHDKSquAQSrdGweh9j0rd8bSi714X8ayJBfWsFxDG4GIUKYES4AGxCCo9h65qlszKes4r1f6fqYVABLBVBZicAAZJPoBR6AAkngAck17B4E8IRaPBFfaggfVXXIVuRbg9h/tep/AVVOm6jsjDG42GEhzS1b2XcyPCPw++5eeIl/2ksgf/Rh/9lH416OqqiKiKqoo2qqjAA9AKWivQhTUFZHxmKxdXFS5qj+XRBRRRVnMFFFFAFrTHVb1FkKrFKDE5bgbSMfzxVd43ido5VKupwynqDU2nxrLfQo6b03ZK/3sAnH44qGSV55GlkOXc7ifegBtFFFABRRRQAUdqKKALz3MFzFDHcLLD5a7VMRyg9ynr6kGoLm2e3AYlXhY4SVDlW/H+hqCpra5ltmYxMMN95WAZW+oNAENFW2jtZ8vFMtsSeYpckD/AHWA6fXmmXFnPAu+RMx5wJFIZD+IoAgAJIAGSTgD1rkPH95G91a2MYVmtULSOGB+d8ErxxxgfiTXYwyGKVJFwSpyAe9ee+KtGXSL9fsxZ7GceZAzY3D+8re4PHuMGvVyeMHXvJ6pafqfO8TTqxwnLBe63q/y+99f8zFqO/SbUIGgvtQ1a5tWG020uoztARjGPKL7MY7YxU8c08BZra5ubaRlK+ZbzNE4B64ZSCPwNdDqhnvtftrfUdT1ybTbPw1DfSWkepzr9pZBcOwbD/OzeWoJbJ4r2sZUUGueCktd+lld9GfK5ZRlVjJU6koy00XW7SWvMur7bHOyzXboka6lqsMKAgRQX80UYzkH5EcLnk84zUNvakeVFbyXYItvsESx3EgKxHI2Jg8Z3HOOTmuo8NW1rqq+GLjUbG2t5L/UmsZ7e1eXy2HlGUYLOzcBSCc85BwM4qjoF7DqGj6Tqw023spJNXtoI1gkkc+VIjsN5c4LZQcqFHJGO9ZPE0Lv3Neui66a/f8AibxwOM5U1V93pq9UtdNOlvLb0Mk25s82zRtE0P7sxuCCmOMHPORio7yN76SBr66vrpYGDwwz3cskUTYwCsbMUUj1ArodcsG0vXjb2sVvePqGtXlzPqKzFordTdyH7OgVgTN8w37uE4wCeaj1uSDToNWli0+K8vG8ST6dE99dXEipGFlfLfPvc/J03Dk9QOKSxtKooOUL32230Wnze+hUsqxFCVSMKtrb6taavW3kr213MQJ+/uJ3eWSa4kMssksjSMzEAZyxJ6ADHQAV6foEf2fw1p0ap5QljMsi93JY4YnvkYwO1ef6+kFv4m1aytIzHBayRBQWJ4e3imxz6ebj8K77w86S+HdOaJy4RGibcOQ4Ykj6YYYrDNJKeFjKG1/8zs4fpyp4+pCq7ySf5r57F6iiivnT7cKKKVVLsFRSzHoAMk0AV9Xum0vQrjUY3Xzs/Z4l7q7A/Mfou4/WvLT6kkn1PNdr8Rnjjj0y0WY+eivLPAQQUZsbcj6fjXFV9VlNFU6Cl1lr/kfnfEeKdbGOnfSGnz6/5fI674M/8lTi/wCwNef+j7SvoKvn34M/8lUi/wCwLef+j7SvoKvDzT/ep/L8kfWcP/8AIvp/P/0pnlP7Q/8AyBPDH/YaH/pHdVyfgG8XzLnTXY7piJYATxvUHK+xI/PArrP2h/8AkCeGP+wyP/SO6rzDStSudKvUu7J1WZQR8yhgQeoINehl1H2+DnT7v9EeNnWKeEzSlW7RV/S8r/gendOvUUU+XJYMYmiZ1WQxN1jLAEqfpmmV4TVnZn2Cakk0FFFFIZgePUZ/BuqhRkiIMfoGBNeGV9Da1ALrRtQgIz5lvIuPX5TXzwmdoz1xXFil7yZ9TkEr0px7P81/wB1IwJUgHBx1paK5T3zstSXw/wCTpmqWWgXs5urUyPaRTk2qSxnZJuwPMCg4OAQDuHIya5zWNTk1WeB3gt7eO3gW2hhtwQiRqSQBkknljyTV3wv4n1Dw/dW/k3Uv9nLOJZ7XeQjjG1s45+6c/UDIOKo69pq6PrN3YRuZIIX/AHEv/PSIjMb575Uqfxq27o5qcOWfLL5at/1bQ1fh3brc+MrAOgZY90pBGRlV4P54r27r1614n8OLj7P4ysBnAmDwn3ypwPzAr2yuzDfCfN57f6xG+1v1YUUUV0HiBRRRQAUUUUAXoM29ibmEbpmJQuP+WA+nqfX+tUatWy4sL52wFIRFJ7tuzj8smqvSgAoq3FaDaklxPFFEV3kBsybe2F9T2/M0p+z3KkRrHaSBvkDMdrr6Enow9ehzQBToqae2ntyfPhkQA4yV4/PpUtpYTXDxlo5FtyfmkxjC9yM0ANitQ1us80yQxMxRSQWLEdeBThYzON1ttuVzgmLkg+4PIpl3dNctgZS3U/u4h0QYx+fvVf37igBzxugUyRuoboWUjNNq5bzm58y3upj+9IZZJDkLIOhJ7Ajg/hVWRHikeORSrqdrKexoAbV2yyLG9EGPOKgsO5iH3sfjjPtVKnxSSQyrJC5SRTkMKAGfyqvqukJrelyW7TRQ3EJ823aQ4yx4KfQ8fQgGtlWgvy8a26Q3T/Mjhjhn7rjoAe3vWeRgkMMEcEGrpVJUpqcN0ZV6EMRTdKorpnlE8MlvPJDOjRzRsVdG4KkdQact1eLqy6j9sm+0xwRW0RAVRFHHu2qMAZ++2c5zn0r1C/s7TVoxDqUafd2rcqn72PA4OR94exz+Feea/pT6RqBt2fzY2UPFLt2iRSOuO3ORj2r6jC4yljPdkveXT8ND8+zDK8Rll5wleD6r1ur/AHFCO71JdVstQk1OeS4sN/2MeTBHHbFsbmWOONUycDkgmq9ik1jp2n2VvdTLb2c8dyoKoS8kasqljt7BjwMCpaK61hqSVlFHmyx2Ik7ub/pW/IdDcX8NrPDHqNx/pF61/O5jiJklaRpCcFMLlnb7oBxxnFRTfabji6vZ5gb6XUnDLGN87qyljhRwA7YAwPrT6Kaw9JNNRWn/AAP8kJ43ESTTm9d/ne/5v7xJDLNf3t5czPNcXUivIzBRjbGkagBQOAsaj19TXXeFtesLTT0sL0SwnzWfz1G5PmA+8Oo6dRn6VyVFTVwtOrT9lJaeReGzCthq31iLvLz1PWogJohJbSR3ERx80Lhxz04HI/ECggqcMCD6EV5Xa3U9nI0lpPLA7KVLRsVJB7ZHatnSvFeo2LkTsL+BsAxXRLgY/unOQfevFq5LNXdOV/U+qw/FVOVlWhbzWv4HcyyW8Bj+1XlpbeZjb50mDgnAOOuODz7Vy/i/XpIro6fpN2v2eMAy3Fs5zM/XAYfwjpgd+a57W9Vn1i9F1dJCsgjWMCJNowowOKoV2YTK4UWqk9X+Fzy8y4gqYqMqNJcsb79WvMfLI80jSTO8kjHLM5JJPuTTKKK9Y+dbvqzrvgx/yVOH/sC3n/o+0r6Cr59+DP8AyVOL/sC3n/o+0r6Cr5DNP96n8vyR+lcP/wDIvp/P/wBKZ5T+0P8A8gTwx/2GR/6R3VeS161+0P8A8gTwx/2GR/6R3VeS16+S/wAB+v6I+a4q/wB7j/hX5s9P0a6F/odjcgszBPIlJ5O9AByfcYNWqzPCUc8Xhe3E42pJM8sQJ5ZCAN2PqD19K068LFxUa81Ha59hls5VMJTlPeyCiiiuc7RQcEHGfrXhnjbQJtB1ib5GNjMxkglA+UAnO0nsRXuVDAMpVgGU9VYZH5VnVpqorHdgMdLBzckrp7o+bQwI4INLX0kfCfhaa3B1OwsjdOhmWRY8Kibc/ORx2Oa+edXsLnTNQkt72ERSH94gU5VkPKsh6FSOhriqUZU1fofUYHM6eMk4RVmtbFRGKSI4CsVYMAwyDg5wfaui8Yx/2hP/AMJJaGWSx1F8y723G0uP4oGPYDAKE4ypAHQ1zlXtG1WfSLmSSBIp4Jl8u5tZhuiuY852OP1BHKnkVmn0Z3Ti7qUd0V7K6lsb2C7tiBPA4kQn1Br6A0nUIdV0y2v7Y/up03Af3T3X8DkV4f4i0uKxlt7rT/Nk0e+TzbSWTBI/vQsR/Gh4PcjB6Gum+FWu/Zb59HuWxBdHfAT/AAy91/4EP1Fb0J8kuV9TyM3wyxFFVobx/Lr93+Z6rRRRXcfJBRRRQAUHgE0UUAXdQ3edb2se4qkaBYwOdzDJyP7xJpyLFYFmmKTXYUhYsBkjb1Y9CR6UxdRnCkkI0+Nq3DD94o9M/wBeoqmOBgUAPllkmkLzMXfAGT6CmUUUAWrK8NssqPEs8bgYVycKRyDj69qrzSPPIZJnaRz1ZjTaKACiiigAI6giruPt6cBRergdcecoGO/8Qx+IqlRjIINACsCrMrAqynBBGCDSVcErXVnMs7F5YFDxuT823IBU+o5BqnQA6KRopUkTG9GDLuGRkVZvIVfddWwBt3ILLuyYmP8AC3fr0PeqlS207W8u9QGBG10bo6nqpoAirkfiBBOLuzuS5e0eERpjpG4+8v1J+b3zXdNYtKHlsAZrcAsR/HGOuGH9R1rPu7aC+sprO63eRKAdyjJjYdHHuPTuCRXXgcQsPWU3tszzc2wLxuGlSi9d16o8qorQ1nSLrSLgR3SgxtkxzJykg9VP9OorPr7CE4zSlF3R+ZVKc6UnCas0FFFFUQFFFFAgoFFAoGFFFAoAKKKKAOu+DH/JU4f+wLef+j7SvoKvn34M/wDJU4v+wLef+j7SvoKvkM0/3qfy/JH6Vw//AMi+n8//AEpnlP7Q/wDyBPDH/YaH/pHdV5OiPI6pErPIx2qqjJJPQAV6x+0P/wAgTwx/2Gh/6R3VcB4MtGuvENo21/KgbzpGXI2hQSMntkgCvUymap4Wc30b/JHz/EVJ1swp049Ul/5Mz0OdWi8qGQRhoYkjIjAChto3YA4+8TUVXdIto769MUxYAxs42DHzdfwFUuRwcE+3Ir55vmbbPtoxUIqK6BRRRSKCn+TKU3+VJsxu3bTjHrn0qfSyBqEGYo5gWAKSfdx1J9sYq3q6XklywMz3EeSEWIHaq9hgcdKAMqaKOTTtQ+0j/RFtnM5zjC44x77gMV5ldiG78HX5udNS7m0xfOilaV18lHZVbhT64bnI6+tdX4y1eGGxk0u2kWSeVlNw6EFUUciPPc5wTjpgD1rkrC4EDypKZPs9zE9vOI22sY2GDg/kfwr26OAnUwM4yWstUvTb7z5etndPC5xRqxfuw0k12b1Xov8AM88HQc0tddP4HvbjxS+l6Kl3LZ+YYlvLm1eONDgkBjgjsAGHByOlcvfWk1jdSWt2qpPGcOqurgH/AHlJB/Ovj3Frc/a4VoVPhfS5oaFqcNnFe2OpRTXGlXqfvYoSN8cg5SaPdwHHTnqCQabremHSri1ms7kz2N1GLmyugNrMoOPmX+F1YYI9R6Gsuug1gtf+FtEu4Jt9vp0f9nS25XBglZmk357rIOc9ipFC1QpLlmmuu/3f0v6R6l4L8Qp4h0oSvhb6HCXCe/Zx7H+ea368B8N6xLoOswX0WSinbMg/jjP3h/Ue4r3yORJYklibdHIodT6gjIrvo1Oda7nyOaYL6rVvH4ZbeXkOooorY8sKKKKACiiigAooooAKKKKACiiigAooooAtRYTTbhx96SRYifRcbv1wPyqrVpONKmJ6GdAPY7TVWgAooooAkgme3nSWLG9DkZ6H2NTXcEQT7RauDbO+1UOd0ZxnB/xqrVyAefp8sKEebHJ5+0nG5QuDj3HWgClIsU1u9vdRLPaucvE3Qn1Ho3oRXnPiHTH0nVJbcg+Qx3wOeQ8Z6HPf0PvmvSWjdER2RlSQbkYjhh7VFc21tf232TUI/Mticgj70RP8SHsfboe9ehgMc8LK0tYv+rnjZxlKx9O8NJrZ9/JnlNFdD4j8K32jl54x9s07ql3EMrjtvHVT9eK56vqadWFWPNB3R+d18PUw83TqxswNFFFaGQUUUUAFFFFAgooooGdd8Gf+Spxf9gW8/wDR9pX0FXz78Gf+Spxf9gW8/wDR9pX0FXyGaf71P5fkj9K4f/5F9P5/+lM8p/aH/wCQJ4Y/7DQ/9I7qub8AxbNM1CbBBkljiznggAsf1IrpP2h/+QJ4Y/7DQ/8ASO6rjvCviCDTraOxuLdWD3Qbzmb5UVsBiR3IwMduua6sLTnVwM4U1q5f5Hn4+vSoZvTqVnZKH4+8j03Q7aFILi4eRWmWPiJyUXaRzk9+COnTNVYNImkEzyqIEAyik7iTnAH07ZqPRPFGnX99dWVs0f2pZAkMkjALKPVc8kBhnHU8H2GtqDNbXsDt88UCLIzEbQdxATd/tegrzKlKdOXLJWZ9BRxNOrB1ISTSvt5f189zANtMFlZkKiI4fdxznGB60kNvLPHI0K7vLxkeme/09TWzrFwH0wGZ0N3cSBmiIO+MDoPy28e+a8/8bap9mtv7Lt5SLiRg11sb7ijpGcd+ckfQVWGw8sRUUImeOxsMFRlWn02Xd9jptc8R6Foez7J5d/dFCo+zTAgEjBLHkfTvya811fW7vUrppncwIVCCKJ2C7QMDPPJx3PWsyivqcLgKWG1jq+5+fZhnGIx2knaPZf1cO1FFFdp5J33g/XEh8OXds1/LFfKJhGNxDAMgAceu3BPtgYrx3WNQtNWjivhbtbarJj7WsagQTNj/AFq45Vz/ABDGCckY6V2ej3MVtcSicKEmieEu0fmBNwxkrkZGMggEHBOCDXA6pZyadqd1ZzhFlgkKEISV9sZ7YwR7Yr4rP6PsqyklpL8z9o8P8VHEYSUJS9+DWnW3d97/AKdCtW74QntRdahY6k90llqFo0Lm1hM0gdWV0Kr3IKnntn0zWFXR6Peyad4M1Way3QXst7DbreRDbIsZRmeMP1AO1ThcH14rwo7n3tbWFu9v6+QzxYtp9k0SS20+HTpJrd5TAhLOId22Iysesh2uSff6V6j4Aujd+DtNcnLRoYSfdSR/LFeKXl3c31y9zfXE1zcPjdLK5ZmwMDk1618KAR4SyehuZMfpXRh3755Gc07YWN90/wA7nY0UUV2nygVxk174nHi1NHj1HRQklm94sp02UkBZFTaR9o5+9nPHTpXZ1lNpG7xTFrPnfcsntPJ2ddzq+7dn/ZxjHfrQBzvhzxdM9zNbapa3zK+r3VhDe+XGIQVlkEcfDBvuqBu2kZ6nNazeIwuoCwvdN1LT5Jo5Wgmk8llk2DJ2lHbBxyAwGcexqGLwr5drFD9sz5eryarnyuu6V38vr2343e3SsXRvh22n6naXkl/aSvbrMpmWw23Fx5ilcyzFyXIz6Aew7AE+heJbu91ZDai91CxfQrW+igZIEnkeSSQFicqgYqq5GQvHFaMvjS1htZ5LjTdTjuoLuOzezMcbTB5AChG1ypBBHIY1kP8ADtm01LVNWZSml2mm7hAcN5EhfcwDglWztKgjjvVjSvAYsfMIurKLzL+3vvLsrAW8S+UANqoHOM465P40AaKeMbVoSP7P1Aah9rNkNPKx+eZQnmYyH2Y2Hdu3Yx3zxU/gvU7rVtPvZ75ZI5Evp4VilVQ0aq5AQ7cgkdMgnPqaqT+FJl1W51Oxv4or5743kRmtjIiA26wsjKHUtkLuyCuDjrznT8L6RNo1hPDdXgvJ5rmW5eUReUCXbcQFycY+tAGxRRRQAUUUUAT2lwbeQkrvicbZIz0cf49wa4T4ieL5fD2pLpulRrJK8CXAuJxkBWzgBehIwQe2a7SvH/F+t3ll4i1SwZbW9sVnLLb3kCyqhYAttP3lyfQjrmsa83GOh6mU4eFes1NXSV7D9P8AiPrEE2b6O2vIu6hPKYD2I7/WvT9F1W11rTo72xctE3ylW4ZGHVWHrXjPi6KxhOlT6fZLaw3dmlw0kbuYpHY4ZUDEldpBUjJ554yKufDjWJNL8RQ27Ofsl6wikU9A38LfXPH0NYUq0lLlk7nq47LaVWi6tGPLJdO9vLv/AEz2inwSvBKskZAdfUZH0I7imEc4ortPli6buO5hKX+8bCWjeID5eACu3pt4GMVDeW7Wtw0bZI4KttIDAjOR+dQVpac0kccbXLwfYt4IW4G/OOuxevt6UAVtPumtLlXGTGeJE7OvcEd653XPCVjdpLNoTMl4SpFoxCxnJ5CFuffB962mILMQNqkkhfQelCsVbKnBxj8DwRXRh8TUw8rwZx43AUcbDlqq/byPKZ4ZIJTHMjI46gio67n4h29xeiPVEk/0aFUha2AwLfsCv+ycfgfwrhq+tw1dYimqiPzXH4OWDryoy6bea7hRRRiug4wooooAKKKKAOu+DP8AyVOL/sC3n/o+0r6Cr59+DH/JU4f+wLef+j7SvoKvkM0/3qfy/JH6Vw//AMi+n8//AEpnlP7Q/wDyBPDH/YZH/pHdV5LXrX7Q/wDyBPDH/YaH/pHdV5KK9fJf4D9f0R81xV/vcf8ACvzYA4PFWpNQvZbNLSS7uHtlO5YmkJUH6VVor13FPc+bjOUbpPc1rPxDqtnBJFBeSKHYuXOGcEjBIY8joPyrKJJJJJJPJJ70lFTGnGLbirXLnWqVEozk2ltd7BRRRVmYUUUUABrE8cIR4kmnIIF3DFc/Qsgzj8Qa26yvHSE6jZ3Yl3Q3NsojixjyRH8hX6ZywP8AtHvXznEkb0ISts/0P0Tw3q8uOq077x272a/I5ytYZl8E7kMe2HVSHwfmJeAYJ9cbGAqfSbfTrTRv7X1ezm1BZLlrSG0WQxRkhVZndx8wODgKOvXoCKj17xFfawJIZCkOneeZoLSNFVYBjaqggAkKvAz7nvXyGy1P19tzlaK0XUxq9c+Ejs3hidCflS6YD8VBryKvV/hBIG0G+jH3kucn8VH+Fa4f4zz86V8K/VHd0UUV6B8cFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAKBkgfzr5+8S3S3viPU7iNt0clw5U+ozgfyr2DxzrMejeHrk+YBd3CGK3TPzEngtj0AzzXhoGAAOgrjxMton0uQ0GlKs+ui/U6jwHf6k2t2Gjw3jf2ZPMZLi0kAkhdApMhKEddqnkY5wetczBKqTRzQ7hGsgkjBPIUNkZ/DFdT4Vum0/wv4jupFaWzcR2skUJKS7nDbXaQcpEO/Zm2g1yZGEwfT6VzPZHuQSdSWnZfr+v9dPpMtvw394Bvzopsf8Aqov9xf5CnV6p+fBVyB1uLb7NMyo6ZaGRmwAe6H2PXPY1TooAklhkimMUikOOo6+4phVgM4OBXJfFDVbiHwyYDNLBiSNLWRHKvIxyZEyOsaptP+8w56ivJbTVNQs5hNaX91FKP4llP9etYTrqDtY9fCZRPE0vaKVj6HKxukkU6eZBKhjkTP3lP9e49wK878QaJPo9wAx861kyYZ16Oo9R/CRkZBp/g3x4b24isNcCLPIQsV0owrnsHHYn1HFejWzHf5DYaGYiOWJuVcHggivSy/MXQd46xe6Pms94fde0KvuzWz6Nf5fkeQUVPqEUcF/cxQmQxRysieYMNgEgZHrUFfYp3Vz8skuVtMKKKKYgooooA674M/8AJU4v+wLef+j7SvoKvn34Mf8AJU4f+wLef+j7SvoKvkM0/wB6n8vyR+lcP/8AIvp/P/0pnlP7Q/8AyBPDH/YZH/pHdV5LXrX7Q/8AyBPDH/YZH/pHdV5LXr5L/Afr+iPmuKv97j/hX5sKKKK9g+aCiiigAooooEFFFFABVPxv582m6FOcvbxJNbZxwj79+0/UHI/GrlWI7aPUNM1HT55DEskRuEfaW2yRAuOB6jcv415Wc4d18JK28dfuPquDcwjgc1pyntP3fv2/Gxzujq2oeF9Z0yJWe5gkj1OGNerhAUmwO5CMGx6KTWACCARgg9/WpLO5ntp4Lqzmkt7mJhJFLG2GRh0INbPiKKK8s7fX7OOOKG6fybyKMBVt7oDJwOyyAb199w7V8Fuj98+Cfk/zMKvSfg3LzrEHb91L/MV5vXb/AAim2eIrqHP+ttjgepVgf8aui7TRyZrHmwk1/WjR61RRRXpHw4UUUUAFFFFABRRRQAd6xdd8UaTob+XfXObnGfIiXe4+o7fjXLfEbxdLaTHSdInMc6/8fM6HlP8AYU9j6n8K8wYgbnduvLMx6+5Nc1XEcrtE93AZN7aKq1nZPZdT0XUvibMxK6Xp0cY/v3Lbj/3yOKyJviH4gkGFltI/9yAf1JrE07QNZ1IZsNJvp1zjeISq9M/eOFH4mrsfhLU5YrjyZNOnuoMbrKG8SSfHchQcHbkZ5z9a53UqPqezHBYKlpyr56/mWovH3iKM5N3DJ7PAv9MVai+JGuL/AKyKwk4/55Ff5GsMeGNfMnljRdRDc/et2A49yMfrUk3hLX4RufSpyvTMbLIAfQ7SeeOlJTqLqypYXBPeMfwM7VNRu9VvXu9QmaaduMngKPQDsPaqtbp8LXyEx3F3pFtckfLbzahGJS390gEhW9mIrPfSNSTUFsTYXLXrKJFgjTzGZSMhhtzkEc5FQ0+p1wnTS5YNWRqeC5/sFxq2p43i002YeXt3BzJiNQw6FAWBIPHHriuehj3vFGP4mVOfc4rfmtBoWjajb6k0f9qXoSFbNWDtbqrhzJKQcK2V2qvXqTjio/BFgdS8V6dBt3Isnmv/ALq8/wA8CnZtqJm6kYRnW6L8kv8Ahz3bbswn90BfyFFXFsJisslzm2VQCGmUgMSeAKeyWLp5MUnlyIB/pEmdsh7gj+EenH1r1D4AoUDqMdasrYztcvBs2umd7McKo9S3TH+NTwQwJJFbvGbq5kYAiKTGz0AboT69gKAPFfjBcfafFwY3E0rPbpKUZy0UW4cCLPQEAZHrnrXEV0/xLv01HxrfvE0bR24S0VoxhW8sYyoHbOQPpXMV5c3eTPv8JHloQj5IQjIPJHuO1e+eEtSOq+HNPvC2ZjGFkP8Atrwf5Z/GvBK9Q+D17v0/UbEnmKRZlHoGGD+orXDStK3c8/O6PPh+dbxf56f5FnxtYfZdWN1GP9Hvcyr/ALL5+dfwPP0Irnq7zxxCZdChmX/lhcfP9HXAP5r+tcHX3+X1XVw8ZPfb7j8DzvDLDY2cYrR6r5/8EKKKK7TygooooA674M/8lTi/7At5/wCj7SvoKvn34Mf8lTh/7At5/wCj7SvoKvkM0/3qfy/JH6Vw/wD8i+n8/wD0pnlP7Q//ACBPDH/YZH/pHdV5LXrX7Q//ACBPDH/YZH/pHdV5LXr5L/Afr+iPmuKv97j/AIV+bCgUUV7B8yFFFFAwooo7UAFFFFABUttPJbXEc0B2yIcrxn/9YqLvR2pNJqzHGTi1Jbo5zxbBa2vibUYLCJYLaOQBYlJKxnaNygnsG3AfSoNJ1W70mdpLR0KSALNBKgeKdQc7XU8EfqOxFdh4x8MyXKXet2spmedxLFAB80lskaq8vu+8HK+gJ7VwA5HHSvzKtTlSqNNW/wCHP6awGIpYvDRcZc2ivqnrZPXz6/ibl/YWN7p11quieZDFblDd2EpLNbByQGR/4492Bzhl3AHPWrfw1m8nxpYj/noskX5qf8KxtF1R9F1OG+Qbo0+WeIgETQn/AFkbA8EMuRz7HtW/plgumfE63s4SDDHeZix2jYbkH1CsB+FTD4k/MrEr9zUpv+V2+49looNFemfCBRRRQAUUUUAFYPjTXh4f0Vp48G8mJit1P97HLH2A5/Kt6vK/jDdh9VsLXd8sEJkYZ7sev5Cs60uWDaO7LcOsRiIwltu/kcGzMzM7sWdiWZmPJJ6k1v6fu0LRbfV/synUruZlsXnTKwxqo3TKh4ZizAKSCBgkZqnomlw31pLqV/crBo1tMkVxJGDJIzNyERR/EQDyxAHv0qHXdSk1jWLvUJl2Gd8pGDkRIOEQeyrgcV5y01PtJe++RbLf/L/P7upHf6jf6gSb+/vLrIwRNOzjHpgnFUyikY2rj0xTqKRqkloiR7id4vKe5uHiIA8tpWK47DBOKgCIOiKPwp9FALTYaFUDAAx9K6jS/GN3p0MEaWdq7LbrYzzZYS3FoCf3BIOFGDjcBnhfSuZooTa2JnTjUVpK5sra+G1eVhqmqGFiPKjWyUyR56mRiwVsf7PLdeK9D+Gnh1NPtJtct72O9t7n9zBOkTxbNpychuQSQMHocVxvgTwo3iC5a4u9yaZC2HI4Mzf3FPp6mvabJ2sVVLIiBFUIqIAFCjoMdK6sPTv77R89nGMUU8PCTb67fdtuW9RBlSK8yQLjJKMxOGHVhn+E/wCIqlUtxPLcyeZO5d8BckAcDtxUVdh82SNcTNCIWmkMQx8hY7eOnFWdJU+fKyDMscLtGg/iOMY/InjvVKnRsEkRjn5WDfL14PagDwDxXCbfxPq0RG0rcvwfc5/rWXXZfF21EHju8uIwfIvkS7jOMZ3DBH1BUg1xteXNWk0foGEnz0IS7pfkFdb8Lrz7N4tihJ+W6ieH6nG4fyrkqu6Jdmx1qwugceTOjH6Zwf0Jog+WSY8VS9rRnDumfQckH2u2ubTg/aIWiAPTcRlf1Arycgjhhgjg57V6/AD9qXY2Np3BgM9Ocgd+leVapNBcajdTWaGO2klZ41I5Ck5Ar7PJJO049ND8M4rpxvSqddV8irRRRXvHxwUUUUAdd8Gf+Spxf9gW8/8AR9pX0FXz78Gf+Spxf9gW8/8AR9pX0FXyGaf71P5fkj9L4f8A+RfT+f8A6Uzyn9of/kCeGP8AsND/ANI7qvJa9a/aH/5Anhj/ALDI/wDSO6ryWvXyX+A/X9EfNcVf73H/AAr82FFAq7rGl3mj3i2upQ+RcGMSiMsrHaSQDwT3Uj8DXrOSTSb1Z84oScXJLRb+RSooqxa2pnt7+cyRxxWNrJeTM+f9Wgy2AAcnHaiUlBc0noEISqSUIK7ZXoooFUSFGaKKACiiigRdTVLtZrGQy7msgBACB8oBJx7jJP51ynjDTYNL1x47LzTaTxrcwmRQPlfnavPIU5XPqpruNEltG0fW7a7jQyvCs1vJwGV0boCfUMcgdcVh+IoGuvB4m3xn7Ddrw7YYLIpGF9csucfU187nuHVSg6iVnB/enb9T9E4DzGeGxyw8pXVZfc43t+C/FdjiGAIIIyCOa7eAmTx/4Zndt0tzaWc8rZzucxYz+SrXHWkkUN5bS3KF4I5UeRBjLIGBYDPHIB612kpuG+LNm91Ok4kmjlgKKFCQOu+NNo+7tVgNvavkYbr1R+t4t+7Jf3ZHrFUdZ1a00eKM3KvNcyjfHBGdvy/3mbnAJHAHNXqx/GYgPhzNxjzVnVbY7ckHq4z2GMH64r3MHCFStGE1dM/NMzq1aOFnUotJpdf637GS/jSckmPTrNeeNxdsD355PvTrDxdezzxwy2FpcSyMETbmIkk4A4OP0rkq1fCsC3PiLT4pITOhlBZAwXIHOc+gxn3xX008FhoQb5FofB0c2x1SrGPtXq7ff5W/Q9IuFVZ3VQABxgHcAe4B7855qOnSEtI7FtxZiS3Tdz1ptfIH6XYPxA9z2ryJr+DWfizYXEJSa2N7FEnmqCrKvHTuDzj14rc+J3iX7NE2iWLkTyL/AKU6n7iH+Ae57+31rzGGR4JopoG2SxOskbY+6ynIP5gVx4iom+VdD6bJ8DKMHWlo5Ky9O5o6tr+qaqhivr2WSAOSItqxqSCcFlUAEj1OcVmVueK4YHmstWtdsa6vE129sDnyJN5VwD3UsCwHUA4PasOuZ3vqe9S5eX3VYKKKKk0CiiigArofCPhW88Qzq+Gg05WxJcEdfVU9T79BWl4E8HNrDJf6mjJpi/cQ8G4Pt6L7969ciRIokjiRY4kG1UQYCj0Arpo0Ob3pbHhZlmyot0qOsur7f8H8iKytILCzhtbOIRW8K7UQdh/U+9T0UV3HyrbbuwooooEFFFIThSfSgDzD4tHd9j8ziQXMwiBOcxbI9xHoN+R9c159Xa/GNiPHc0GSY7e2gjQdh8uSfqWJJriq8yr8bPu8ujy4an6ISkf7jfSnUjDIIrM7T6N8OzrLZaVPcM2Giid2Xg/dHP51wHitUXxNqgiiMKfaHwhOcc/y712HhV/N8L6S4Oc2qc/QY/pXP+ONPkh1JtQUs9teMW3H+CT+JD/Mex9q+tySolUab3R+K8XUJOlzRWkZO/l0OaxRRRX05+fBRRRQM674M/8AJU4v+wNef+j7SvoKvn34Mf8AJU4f+wLef+j7SvoKvkM0/wB6n8vyR+lcP/8AIvp/P/0pnlP7Q/8AyBPDH/YZH/pHdV5LXrX7Q/8AyBPDH/YaH/pHdV5LXr5L/Afr+iPmuKv97j/hX5s1/DP2WDUJNS1Pd/ZulwvqF1tGTsjG7AHck4GPerOjyjVNN0u+J1GS8sNT/wBKlvYI4WeO6mLghUml4WU4AJGPMrm7iCG5iMdxFHLGSCUkUMMg5HB9+aJ7eG4VBcRRyhGDqHUNtYdCM9x611V8I6tT2nNa236/eefhMxjh6DoOF027/pb0eutzc1HVL+60fxvNe31zcCLWI4oY5HykCDUxDiNPurlGYEgZOcknitXXrbWPsvxCuZpL0aANGuotOiEjC0EIhGwxoDtZj8xLYLZJBI6VxYs7UQxwi2hEUbiRE2DarA5DAdjnnPrU8PhP+2HkuodA+3ucK8qWXmn6FtprlqZdaFuZW89r2Sv66HoUc6vU5uRt3vpva7aXpr+B20NvqEEl7GRrd5po0OU/apbwR6ep+zllWGAKRI4bq5IYEH6VD4c1K/ufGnha0kvZxp/9gwStZq2IZHkFxuLr/H9wYDZA7DPNcJe6NYzXTvfadbPc42M00Cl8dMHIz+FSC0th5uLeEeaoST5B86gYAPqMEimstbbblo/Lyev4/gS88jGMVGDTVlv0Tjp3to/vNzw1eX2r+GvB02p6tNJdXmrgSXd23meWHt/MIAPyqoZVwowo9OTWyW1KLSLZ9Rtteif/AISG1EUmuXnn3EiuHDkJtAhQkDCqSvA6Yri1tbdTAVgiBgG2LCD92MYwvpxxxVeHSNNgmEsOn2ccobeHSFQ271yB15PNOWXSbXLK1n/kTDO4JS54Ntqz133tf0uvu9DpdS1TULrRfHE15fXFwYtXjihjkfMcCjUxDiNPurlGYEgZOcknisioBZ2ohSEW0AijcSIgQbVYHIYDsc859a1tDGnnVIRrAnNkchxAQGJxxye2cZrrw9D6tF9dtvJa/eefjMV9eqR6O71fZu6+7Yl8OaQdb1E2guEt8RtJvdSw4xxx9asT6c+l2Hiuz1e1iJt7Alt7EhHyvlkAdSWK4z0rV1IWvhfxu7vZsll5RMcUMmTtZCuct6nOe3pWB40ubjUPCd1qEYdHnuwbsRY2CMfLGjHcCAM/dwd3BJGK83M8RP6vOdrwlFW9X/wD6PhrAUnmFGk3arCbvv8ACl6dXovn5Hmg6Cu/8Am21zXdCV5PJ1jT0MKq4yt5AisVwf4ZEBxg8MoGMEVwFdn8HiF+IWnM33VSXP0K7T/OvjKfxI/asev9nm+yf5Hr4OR7VyPxAlf7VYQZPlLAZAOxZmOT+gFdhLG0ErxPwyMUP4cVynxBQ+VpUmw42yrvzx94Hb+ufxr6TKmvrKv5n5PxEm8BK3dfmcfWt4WuLS0161nvyyxRncrjOEf+EnHJAPX2rJor6mcOeLi+p+eUqjpTjUSvZ3PRZvEWjxXLQm7lcKcGWODKH6c5I98VPLrWkW6RyvqMUiuNyrEjO2P9ocbT7GvM6K8x5PQ01Z9AuKMXrdR18np+JW13w8L97vUNDlvLycyGSa1mQGZlJ++m37wGQCvUDnkZrj+td3G7xurxuyOvIZTgj8abrWlf8JBFNd2cJ/tqMb5Y41GLxcgFgOMSDOT/AHh7jnxc0yX2Kdah8PVdvM+94V42+tyjgsfpN7S2T8munkzKhtxrPhWws9PkWTUtMN1PLZlCJJYmZW3RHo+0Lkp16kZrmwQRkHIPStzw7o+qy6vYy21veW4hv4YXuFUo1u5YYznlTjoSMVR1y7jv9b1C7ggit4p7h3SGL7iDPAH8/qa+de1z9Eg7ScU7rf0uUqKKKk2Cus+HfhuPXdRluL1d1haEb0/56uein27muTr1D4Q31v8AYLzTi6Leed5yoeDIpAHHrjHT3rWjFSmkzz8zqzpYaUqe/wCRY0+1fxLr3iJb+/1C2h064WxtrSyunthEgiRhIfLILElzjdkYXpUXijxPceHGMNnqEN8LGOFZ7aSwnmmIOAWkuEbZGxB3DcoBrpNU8L6VqV+95cwTR3Tx+VJLbXUtu0idlfy2XcPY5qrdeCNAutwls5RG6RxvFHdTRxuIwFTciuFYgKACRngV6R8OYWo+JfESTX01p/ZP2WHV49KiilhkLsXKKHZw+BgyA4CnIB6VV1rUtWvZrewnax/tTTtfggWdIXWFw1uZFYpvLDAfBG7nHUZ47h9B010kVrbKyXiX7De3M6lWV+vYovHTjpUGoeGNJv3uHubeTzJ7hLt3juJI281ECK4KsCpCgDjHr15oA5uLxRrU2qroKjTl1UX0ts94YXMHlpCku4R787iJFG3fxgnJ6VLpvibWdXvItLs10+21GL7SLu4lieWH9zKI/kQOp+YnPLfLgjmt2Twro8llFbNby4imNwkwuZROJCMF/ODeZkjgnd046UknhTR2s7a2W2lhit1dYzBcyxPtc5cMyMGYMQCQxOTyeaAOK8KauNP0/SUl/s60K6DJOb+aAu0ZEyqF4YEpls7QQScc10vgvxFdaxqWrWN4Ul+xpBKk62M1n5iyb/8AlnKS3BjPIJBB+tX18HaI9vFZrp++JbU2McYkcnyiwbaOc53KCD1GOtSxaf4U8IXl29xq6WuoXKok73FxLcsdm7aGZ2ZuNzDIHt2FJu25UISm+WKuzhvjRGP+Ei025x889god+7MjsvP4YGa8/rpfiBr8HiLX0uLJZFs7eBbaIyLtdwCSXI7ZLHA9K5uvNqNOTaPvMDCVPDwhPdIKSlorM6jtvhdrdzba1FpTky2Nxvbys/MrBS37vPc4xjoa63xjqEOp6VpF1a3fyMrJLYqTthkXndz1JDAZ74OPQcB8PBDJ4pihuYI5oXhl3bsho9qFw8ZHIcFRg1u6lcpd301xHF5SyHdtznnueg6nJ4GOa+o4ehztya26/p+p+UeIdSNGUIRes1qvn8X4Wafr3K1FFFfWH5YFFFFAjrvgx/yVOH/sC3n/AKPtK+gq+ffgz/yVOL/sC3n/AKPtK+gq+QzT/ep/L8kfpfD/APyL6fz/APSmeU/tD/8AIE8Mf9hof+kd1XktetftD/8AIE8Mf9hof+kd1Xktevkv8B+v6I+a4q/3uP8AhX5sKKKK9g+aCtm+hsdUTw/Frej6jP8AZl8uzks5Y3TLOW3+U+B5gOBkNu9hisal824WNkt77ULRX+/9jvJbff8A7xjZc/jXNiaLrRSW6/rz/I7cBilhqjctmrPr+q/Nfobd1a22j6NrH2Ke8u7231lrG5uoLKK/kQBWZji4lCJuYEbjuwRtABOaiupzb2F/fw2l5o1nJeW9tbxTaXBfXsrGEuQiM7RRqxDHczHgDvWJYRf2dbCHTJrqxUZ+a0uJIX5OT86ENyeTzzToPtFutx5GpatFJcvvnmTUZ1llOMfPIH3NxxgmuJ4Kvr729vJdOlv67HqxzTCXX7vZvpd631vzK+6urdN9rafikRxeLtXtoIPs8ULQFY9oUrvt4pGBAJA+Z24BIHSs6oooQks0rSXE00xDSSTzvK7EKFGWck8KoH4VLXoUIShTUZu7R4uMq06taU6StF9Ap0UbzSLHErPI5CqqjJJPQCm1LaTva3UNxFjzInWRc9Mg5H8q1d7aGEbXV9hrCaXIPmOUAXuSo6Ae3pXaa9H4cj8NajqLTNbQ3FlHFeWNvEWZScBWXIG3EgXJ5H51YsL8x6Pr3iUQRxSXl1GqwFvlOHVmA75Jzz2wadqPiSHVNZ0yKxczxzORKk8Z+VmfKgeuPxHQ44rxca6uIg4Qja10+2ybT0+7zR9Zkyw+BrQrVp31i0rWfxNJp3Vu7v0eqPBEJKgkgnHauy+E6k+Lg44MdtIcjtnArnddupb3Wr64uLeK2neU+ZDEMKjDggfiOfcmvQfgrpJnkvL0qcyMtsh9FHzO34cflXxlFXqKx+2ZlU5MJNy6q33nqV0jXkllNk4mURs2c4ZeCM+uMHn1ryrxFqz6vf8AmFBHBEDHDGP4UyTz6k9Sa7nxdrY0zS4o7EbJZt6RFsMwXo8h7ZPCj05rzIDAr7LJ8NaLrSW+36n4nxPjuaSwsHtq/wBPu/UKKKK9w+SCiiigAra8Kaymi6jJNcRNNbSxNFJGuPmz068Vi0VFSnGpFwlszShWlQqKpDdG/L4kuILoDTXf7LFOZYBcDfIF4/dse68Dj2yMVxnxE02PTvFVzJaKo06/AvbQouF8t+So91bcCO1dV9vsj4W+wNbt9vW685ZgBjYVAIJ69unTvVe4sR4h8PRaWLpYb6zne4tFdSwn3qAYQRwhLKCCeCTXz+cYH2tH2lOOsX967/r9599wdnv1PHexr1FyVF8ovov0+484paCCCQQQwJBB7HuKK+OP2gKVSVZWUlWU5DKcEH60lFAj0H4f+LdSm1i20vUZvtUE2VSST/WIQMj5u44xg16hXj/ws02S88SC8wfIslLs3q7DCr/M/hXsFehh23DU+OzmFOGItTVtNbd/+GsFBoq9YrAtrNO0QmmidTtZioC54Ix156g9q3PJKGR2IzVfxRreheGYIG1Ke8eeaISrbwqvmNkdACeB7muK8R/FW7W9nttNgtrqBGKtNdJuDn1QDBAB96898R6vNr+tXGqXUUMVxOEDrDnaSqhcjJOM4ziuapiEtI7nuYLJqlRqVfSP4/8AAOn1z4l6zqAuYdPitNKtZcopt0/fqnp5uc5I6kAVw2PmJPLHqTyT+NLR3rjlJy1Z9NRoU6C5acbIKKKKk2CiiigDrPhnpTaj4ha5Nzb29tYRtLO0p5KsCmAPxPPar8qqksiI29FYhW/vAHg1X8NaZb6ZBZ61LdeZeyQO1vbrGdsZYtHuZu+AG+XGORUvavs+HqE6dGU5Kylt/mfiniFjqOJxsKVKSbgmn5O+zfXv5XCiiivoT4AKKKKAOu+DH/JU4f8AsC3n/o+0r6Cr59+DH/JU4f8AsC3n/o+0r6Cr5DNP96n8vyR+lcP/APIvp/P/ANKZ5T+0P/yBPDH/AGGR/wCkd1XktetftD/8gTwx/wBhof8ApHdV5LXr5L/Afr+iPmuKv97j/hX5sKKKK9g+aCiiigAooooAKKKKACigUUCCtPQI5BqcErLtgUNJKzHaPKAPmHP+7npzWm9pp+oeEZrnTrOSC60wxm5ld93niQkE+2GAwPSp9c1Kz0PwjoGp3gaS48ia3s7NIQqGQ53ySs3VcMp465rzcbjI0qMnJW3Wvppt30PocmymrisbThTd9pK2ml9dXtaz6brtqeNSGJTIYAwgBPlg9dueM++MV9DeD9NOheDtNslUC9uohJJ6qr84/wCBE/kK8x8DeHYbbU7J9eht3uLhBJZ6fLuL4DK3nOo+4u3JUMRnI4Ir16S5/ey3t47FYgZ5W74XnA/QD6ivisLTbd+ux+xZ9i42VO+i1b/r5nn/AI1u4rrXXFvKJYYI1gUhSuCv3hz1+bdzWDVjUJ1ur+6uEUqssryAN1AJJwfzqvX6FRpqnTjBdEfgmKrOvWnVfVthRRRWpgFFHaigAooo7UAFdB4M1SPTtQnimjZ0vIxbjaQNrFgVJ9sjmufqazm+zXcE+3d5Uiybc4zg5x+lZ1qaqQcH1N8LWdCrGpHozjbqKS81uaG1slhmmuTHHaQsXCuWxsUnkjPrVrUfDuqWF2ttJatOzKWR7XMqOBwcMB1B4I7V2MWg2Gj3NrrLR6m5kkkubWSREWKRiThSB02kg5zyR0xXV+BIb2LTr2SeN0spSjxO2QXkyRlfUYzk/Svh45RUVCVWt7rVrba9/mftuI4xofW6eGwa9pFp3eqt236P9U7njUWkanK4SPTrxnPAAgb/AArrND+HN/dFZNXlWxh/55ph5T/QfrXrO9iPvHH1pK5o4aK31OmtnteatBKP4lLR9Ls9HsEs9Pi8uFTk5OWdj1Zj3NXaKuolsthDJLDKxkdlMiPgqR2wRg8EGt0ktEeNKTm3KTu2UqtWMsQW4hmbYsygeZjIQg5GQOx70rTWsRCwW6zADl585J+gOMU8XMNzHtviYzGcxtBEMgd1xwMdCM+9Mk8X8W/DzWNM1aUadZyXljIxaJ4yCRnnB9evB9CKxB4R8Q/9Ae7/ACH+NfQVz5cenRQxzxSYmZyEzkggYJB6dxiqVc7w0W7ntQz2vCKi0nbrr/meHL4L8RN/zC5R9WUf1qVfAviNv+XBV92mUf1r2yil9Wj3G8+xH8q/H/M8MvvB+v2Sb5dNlkTu0JEmPrjmobPwvrl24EGlXWP70i7FH1Jr3kHBGOtQ61d/2Rpz3l3BI53iOKJiU3scnk+gAJ49qqGC9pNQjuyavElShSdSpFJLrr+R5lpnwx1G4dRfXttbg8lY8yMB1JJ4A4qefw/4Y0mHdb3Da1dl9u2XcsSL3bAA3eg5xWprPim51C0S2t4xZQkETLE5Pm59SecY7fWuer6LBZFTh79dXfb/ADPgs345xda9PCSsu+z+XVfMmuJUdYY4IEgt4U8uKJSTtXJPU8k5JOTUNFFe/CEacVCCskfC161TEVJVarvKTu2+rCiiirMwooooA674M/8AJU4v+wLef+j7SvoKvn34M/8AJVIv+wLef+j7SvoKvkM0/wB6n8vyR+lcP/8AIvp/P/0pnlP7Q/8AyBPDH/YaH/pHdV5LXrX7Q/8AyBPDH/YaH/pHdV5LXr5L/Afr+iPmuKv97j/hX5sKKKK9g+aCiiigAooooAKKKKBBRRRQA9ZZFieJZHWKQgugbhsdMjvisnxxFc3Or6fJAHle8t4vJj6gzA+WwA6csq5HuK6CHS72bTZtQjt3NlCQHlOAAc449eSOlTzW62lvB4onOy20qx2WiHpLetJIEH4Z3key189xBGM8Omt1L9GfoHAFWpQzCSltKDsn195Wt8/1NLwxZw3Hj3xPqyMrhJBAXU5UzFR5u0/3QwIHtWl8QJbq3sbC3UGO2uN0khzgyODgKR6AYI7Zb2pnw90/+zvCFksgPnTg3EhPUlumfwxWP44k3+J71fK8vy2CHn75AGX9i3XiuPJKPNVUn0V/vO/jPFtUpRi9G1H5L/O3luYVFHaivrT8wCrNhY3N/IyWsW8opd2LBVRR1ZmOAo9yQKrVrQ2Q1rwlqOjW5jN3NeWsxgZgDdRIxJjGfvENtbb3x3rDEVHSpuUTrwVCOIrKnN2Wu2+ivZeb2RTlspEsIr6OS1ubGRzGtzaXMdxEX5+XfGxGeDxnPFVlXcwUdScV0Udja6Lf+FrvUtOudNuTrsEccVzdcmNYZWafy/LQgDDKBlgN55zUdzY6rpfhDX31KO5t5JtYtQrSEgyp9sbkf3lKkc9CK41j7XUtWvl1S8+992enLJ+a0oXSavZ69JPfT+W2qRQutOSzbV2vb+2gt9LuFtZ5ysrgys21URUQuxJz0XsazYpFljWRN21hkbkZDj3VgCPxArovEV5eW9j41jtL68tFfxPGjG1uHhbaxk3DchBGcDODzgVT8NrLHFqSaawXVV06ZdOZ2DEXG3CEFurYzjPfFGHxdSVOVWa0SW3omPG5bQp1qdCk2nJvV9uZpfl/XStpdhNqeoQ2dtt82U4Bc4UcZJJ9AATVCK5tLks2n3Yu4AAROkMsaPn+75iKWHuBj3rudHurzTdf8Kafe3N62tNbX7zm4mZrgQCMeW0rMd33923PvjoMeeaLJPcaXbXV3dXd3c3EUcss11cPO7MUX+JyTjjp0rShiZ1qzitElr11v0MMXgKeGwym23KT06aWT1V9HqajXVw9mto08ptkYusRY7VY8EgetdvbeMdPeyja8srhr4BY/KgYLGcYAI/ugjjaB9K4KgHBravhKWISU1sc2DzHEYOTlSlurd/zPRJ9Z1S10/8AtDVtDjKmTacSGJlGcLvTHA7A8ZxV3QtQs9ecJZyLb3ATfJbyk/IB1Kt/GB1x19qwr/Vpb/wEZrhhNdvcLaTOzfNtX51YjuTgDPt61yFtPLa3EVxbOY54mDo4/hI6GvNjl0K8JXioyTe2x7087q4SrT5ZucHFN3tfXfVdfvPXh9gDZxduoPA+Ubx/TNRXE8lxJukwAOERRhUHoBXPxeLtOudQSN7d7W3kTLTsc7JMZ+6ONmePXv7Vswyw3Fuk9rMk8D5CyJnqOoIPIPsa8WthatDWpGx9Vhcww2LuqM0326/d2HUUUVznYFFFPhUNICyqY1+Z97bFCjk5bsPegL23Hzwx28yRTXMPmSTLbxCM7y8jDIGByB6kjjIqvqUtvpRb+0rqCAq2zCt5jFh1AVeePfFed+JJ0l8RX9xb3P2hWmLJOo259MfTp+FZh5JJ5J5J7mvoKeTQkouUn5nxlfiipCU4QgtHpr/lv951mq+L5RI0ejKIYhwLiRAZW9x2X8OfeuXlmmlAEsskgBJG9y2Cep5qOivXo4enQXLTVj5rFY6vi5c1aV/y+SCiiitjkCiiigYUUUUAFFFFAHXfBj/kqcP/AGBbz/0faV9BV8+/Bn/kqcX/AGBrz/0faV9BV8hmn+9T+X5I/SuH/wDkX0/n/wClM8p/aH/5Anhj/sND/wBI7qvJa9a/aH/5Anhj/sND/wBI7qvJa9fJf4D9f0R81xV/vcf8K/NhRRRXsHzIUUUUDCiiigAooFFABRRRQI0r/Wbm802x09iI7S0TasadHbJO9vU81o3GgXWr+FdEsYVWGxurp7rUJS/zsqfLGAvpy3489qwbW3ku7mG3gGZZnEaD3JwK9buZFKw28SotvbIIYgq44HGfXnrXhZy4xpKiurv/AF6s+y4TlV+tSxj1cVZX6X0VvRIrhURFRQVjUBQB2AGP5V554rDjxNqfmKFY3DHA6YPQ/iMGvRK5L4gpbieyl8zF60QEkeODGPuMT64yMegFcuT1OWs423R3cT0faYVTv8L++5ydaf2GzPh/7cuox/bRLsazIw2PUevr6VJaeG9Yu4jJDp823oN+ELf7oYgn8KvanrtrJ4ZttKtrTy7hVRZ5GjVcFCeAcZJJ5OfSvenV5pKNN311tbReZ8dRw6hCU66to+W6er8tv8jDsdPvNQdksLS4unUZZYY2cgepwKuHwvrEzLBNpF2omOwCeEojHHQlgB2PWsS7tbe8hMN3BFPESCUlQMufoa6zT7CyPx01G6azt2uY7yJUlMY3KPsUPAbqByfzrPE16lKVopWs39xtgcJRrw5ptppxWlvtM4rTtN0y323Gm2dlFvUFZIIlXcD0IIHI5p8ej6ebrzY9OtftLOH3rAu8v2OcZzzWz4de41Twh4XcwaeLu91aCzjEdssEccT2skgj+UZKgxLyxZuW56Y0/tEVzpN/Oxa8a31u2tVuDpMNjDh3ZXjiCHe6rgcyDOccnJxh9dpxSTh/wNv8zr/sqvNylGpdW0euqV9PwfcwJ9DFrbma4sYYEhu/LxIioy3DBm4U87iA5Jx2NNZQylWAKkYIPINb15YrK1xp1hb2kKf8JsYIYljEcSjy7kAEKBx696bd3Mdx4f1W4y13Jbavb2yXB0mGxhAd3V44th3uq4HMgznGCcnCp5jHTmjvbbzS/wAyq+STV+Weye/Vpy2+UbnM2+mWFtFLFb2VrFHMMSJHEqhx0+YAc1oWVk8scqWscaxW0DTP8yoscSLljzgAACtrXL13u/HyG20+O100v9kihtEjMZSeNclwNxJDkEZx6AVNf/aob7xxYwxRQ6RZ6HcxQIlqm6QGzD+c8pXeSzMcAMFxgYJpPMEoXhDW1/lv/SCOTSlVUatS8b2e973t1/M5ocgEUUyH/VJ/uin16x88wooooEaGgWC6nrFraSMyRSMfMZeoUAkkfgK9IiSKC2jt7WFYLaP7sa+vqT1Zj3JrivAQzrsh7Layn9Mf1rtq+bzmrJ1VTvpa/wCZ93wvh4LDyrW95u1/LQKKKfHE8pPloWA6kdB9T0FeMfUDP0ql4g1AaboUrm3S4S5Y20iSOQvIypwBz0J6g5Aqp4i18aXZqmlXkBv5HKyNEQ5ijwOAemSeD14rj9X1q91YRrdyL5cZJSONAignqcDv717GAy6pKUas9u2tz5nOM8o04Tw9J3lbdWa13/DyM6iiivpT4MKKKKBBRRRQMKKKKACiiigAooooA674Mf8AJU4f+wLef+j7SvoKvn34Mf8AJU4f+wLef+j7SvoKvkM0/wB6n8vyR+lcP/8AIvp/P/0pnlP7Q/8AyBPDH/YZH/pHdV5LXrX7Q/8AyBPDH/YZH/pHdV5LXr5L/Afr+iPmuKv97j/hX5sKKKK9g+aCiiigAooooEFFFFABRRRQB3Xwnt7aTU9QuLmPc1tB5iScZjySCQTxnHFb/GOM47Zrmfh/HttdTuPnBby4Ac/KQSWI+vyj8K6avk81lfEtdrfkfo/DsOXAxdt7/mFPLloljkWOWMchZY1cA+oyKZRXnptao9txUlZoc8jvIZHZmfOdxOTmvPvGUax+Jb7ZnEjCU5OcFlDH9TXf1xvj62ZNTguthEU8CDzMcF14Iz68CvVyaXLXce6PneKKbnhFJdJL8n/wDmKImkiuri6juLoXVw5kkn+0OZC20LkPnI+UADBGAOKKK+lcVLdHwUZyj8LsQw26Q29lbxNKkFk4kgjErbUYIUDYzgkKzAE5PJqS4NxdOGu9S1a5xIkoWfUZ5FDISVO1nI4JJAxinUVDo03q4r7jSOKrRVlNr5v+ur+8iEPKlprpyLlr357iRt0zBgZGy3zN87cnOM8U+5E922b3UdWulEiS7LjUZ5U3KSV+VnI4JJAxinUUewpae6tPIf1uvr77183/AF1ZFJCJIryOSW5YXrl7km4fdKSwc7mzkgsAcZxxT7w3F3btbzajqv2VomhNumoTpFsYEMvlq4XBBIPHOadRih0KclZxX3BHFV4O8ZtP1YigAADoKWiitTAKKKKBHT/D8A6reHcAwtHwD3+Zc4rsq5b4bQv/AGjdT/uGgWLY6MQZG5BAVcjgkcnpit7V9WstMjllneKWbd8tpDKN2T6kZ2qPzr5nMqU6uK5YK7sj77Ia9PD5fz1Xyq73/TuVvEGtR6NDGiRLNfTLvVJM7I0z95h3JxwPTmuK1PWb/U/lvLhmiH3Yl+WNfoo4qLVb+bU7+a7udokkP3VGFUAYCgegGBVSvYweChh4LT3urPmMzzWtjakrSah0Xl5+YUUVo2MWm/2XeTXs8v2wfJbW8a8En+Nm/uj06muyUuVXPLhDndr29TOxRRRVEhRRRQAUUUUCCiig0DCiiigAooooA674Mf8AJU4f+wLef+j7SvoKvn34Mf8AJU4f+wLef+j7SvoKvkM0/wB6n8vyR+lcP/8AIvp/P/0pnlP7Q/8AyBPDH/YaH/pHdV5L2r1r9of/AJAnhj/sND/0juq8l7V6+S/wH6/oj5rir/e4/wCFfmwooor2D5oKKKKBBRRRQAUUUUAFFFFAHY/D2ZpP7Rs1Usdi3CgDJ+U4b9G/Suj+3WCa0+kTzSQ3o2qGdfkaRsYT179TgVznwvYprd08RK3Cwfuyoy3LqDgd+O1R61qFnBPdMsNt/alrq5miaPLb4uSQX6EBgPfk14WIwsK+Kmmnsvv7n2GDzCphMupuLW737LW3rqdZgg4IwRwR6UVQ0DXbfX7qaFolsroAyr87OrqAS3PY9MVeByBXiVqM6EuSorM+rw2KpYqn7Wi7oWnxuilPOhWZEcSqjHgOAQD+RII7imUVmm07o3lFSVpK6POfEtkun65d28QxDu3xY6bG5X9Dj8KzK6r4gQ4vLC4A/wBbBsP1RiP5EVytfaYSp7WjGb6o/K8yoLD4qpTWybt6dAoooroOEKKKq6rd/YNLvLzZ5n2eF5dmcbtqk4z26Um1FXZUYuTUVuy1Qa67/hVvjf8A54+Gv/BnP/8AI1H/AAq3xv8A88vDX/gzn/8AkauD+1ML/P8Ag/8AI9f/AFfzD/n3+Mf8zkaK67/hVvjf/nj4a/8ABnP/API1H/CrfHH/ADy8N/8Agzn/APkaj+1ML/P+D/yD/V/MP+ff4x/zORorrv8AhVvjj/nl4b/8Gc//AMjUf8Kt8cf88vDX/gzn/wDkaj+1ML/P+D/yD/V/MP8An3+Mf8zkcZ7UCuu/4Vb43/54+Gv/AAZz/wDyNR/wq3xx/wA8vDf/AIM5/wD5Go/tTC/z/g/8g/1fzD/n3+Mf8zkaK67/AIVb44/55eG//BnP/wDI1H/CrfG//PHw1/4M5/8A5Go/tTC/z/g/8g/1fzD/AJ9/jH/M5Giuu/4Vb43/AOePhr/wZz//ACNR/wAKt8b/APPHw1/4M5//AJGo/tTC/wA/4P8AyD/V/MP+ff4x/wAzkaK67/hVvjj/AJ5eG/8AwZz/APyNR/wq3xv/AM8fDX/gzn/+RqP7Uwv8/wCD/wAg/wBX8w/59/jH/M5Giuu/4Vb43/54+Gv/AAZz/wDyNR/wq3xv/wA8fDX/AIM5/wD5Go/tTC/z/g/8g/1fzD/n3+Mf8zkaK67/AIVb44/55eG//BnP/wDI1H/CrfHH/PLw3/4M5/8A5Go/tTC/z/g/8g/1fzD/AJ9/jH/M5Giuu/4Vb44/55eG/wDwZz//ACNR/wAKt8b/APPHw1/4M5//AJGo/tTC/wA/4P8AyD/V/MP+ff4x/wAzkaK67/hVvjf/AJ4+Gv8AwZz/APyNR/wq3xv/AM8fDX/gzn/+RqP7Uwv8/wCD/wAg/wBX8w/59/jH/M5Giuu/4Vb43/54+Gv/AAZz/wDyNWT4o8G+KvDGjtquqwaI1lHNBDJ9mv5XkHmypECFaBQcFweo4BprM8LJ2Uvwf+QpZDj4pydPRecf8zW+DH/JU4f+wLef+j7SvoKvn34M/wDJU4v+wLef+j7SvoKvn80/3qfy/JH2fD//ACL6fz/9KZ5T+0P/AMgTwx/2Gh/6R3VeS161+0P/AMgTwx/2Gh/6R3VeS16+S/wH6/oj5rir/e4/4V+bCiiivYPmgooooAKKKKAD60UUUCCiiigZPaXdxZu72k8kLuhjZkOCVPUfjUFFFKyvcfM2rN6HT/DeWKLxZbi4cLHJG6YJA3kjIXJ6ZIFdPo+qprVrPceX5dxFMVlUdGByVfHYnBBxxnp1rzGtXw7rL6NdSyCBLiOVNrxMxXOCCDke4rzsdgVXUpx+Kyt8v87nuZRm7wcoU56Qu7/NL8rHolFPW7t9Vt0vrBYVjaMPJEjgtGx4bcucgbuB26UyvlpwcJOMlZo/QqdSNWKnB3TMXxpb+foAlC/NazBs/wCy42n9Qv51wFesPHFNDNBcgtbzIY5AOuD3HuDg/hXmutaZNpN+9rOQ/AeORR8siHow/wA8HIr6HJ8QpU3Rb1X5f8OfE8T4OUKyxMV7stH6r/gFGiiivaPlgrK8V/8AIr6x/wBec3/oBrVrL8V/8ivrH/XnN/6Aazq/w5ejNsN/Gh6r8z3X9oDxHrPhnwvpE/h7UH0+5udTW3klSKOQmPyJnxiRWHVF5xnivEv+Fm+Pf+htu/8AwCs//jNe9fGzwbqvjXw7plnob2KXNrqC3bfbJXjRkEMsZAKoxzmQHp2NeRf8KO8cf89PDf8A4Hz/APyPX57VVRv3D92y6eCjSaxPxX7PbTsdD8DPG/ijX/H0um69rc2oWX9mT3Ajkt4I9siywKCDHGp6SNwTjmvTfiV43XwPaaTcy6e97BeXn2eYpJtMEQjeSSXGDu2rGx28Z9a4b4PfDHxH4S8aS6vrkukG2Ony2irZ3Mkrl3khYEhokAGIz3PUV6Z4m8Ox69faFPNMFi027e5eJo94nDQSwlDyMf63OeemMc5GlPm5fe3ODGulKtJ0Ph0t93+Zgaf8S9NufEviKwmiEGm6RHC66iJPMW6Z3aMqiKMkiRGjABJZgQB0zT8W/EqCG10uPw48pvLzUfsMv2nR7yZ7XbC0rbrZQkpYqFwvGQ27kKaZrHwi0i8trizsZI7LTjYWdnbWpg85Imt7iSdWfex8xWMmGVuozk88W9E+HQ0650q48/R7ZrHUjqHk6Vo6WULg28kOzaHY5/ebtzM3TGAOlnKLovxJ05PDlre+I5vJvJnvGMVnaTT7IYJ3jMjKgcooCrlmwuc9Ola+qePvDemXXkXN9KxCws8lvaTTxRiU4i3yRoyJuyMbiM5Fc9B8N9Q062QaJ4hitbp7e6s7iWfT/OV4priSYbV8xdroZGAJLA91rP8AEHw21PT9EvbPwnfRvYXJ0/zbCeANK32YQxArMZFCjy4VJBViSpwRmgDv08U6M/lbbzPm6g+lJ+6fm5Tduj6dtjfN93jr0rn4fiX4ds9MspNU1f7TNLZC/eez0u5EfkFmXzioDmNMqc724xyeRUCfD+/TXredddhGkQa1LraWf2E+aZZA+5TL5mNuZGIwgxnBz1qHTPhj9h0W60/+19/n+Hv7B8z7Njb80p83G/n/AFv3c/w9eeADprzxpoNnqS2M16/mmSOJpI7eWSCN5MbFeZVMaFty4DMCdy+orR13W9O0G0jutXuVtreSZLdXZWI3u21RwDjJPU8etcB/wqa3j199Rgl0WXzpLeaZ77RY7q4RokRD5MzN+7DCMHBV8EkjBNdHqfgPR5Vg/sey0/SJRqVrqNxJa2aIbkwybwr7duSctyc43E4NAEsvj3w/FLFHNcXkTOYw5k065RYC5wgmJjxCWJGBJtJyD0IqlqPxC0M2OpGx1X7NLawyyi7uNNuJLfEbhHZSAomCsQCI361m678MLfUfGN/rsTaKz37wyT/2ho0d5NE0aqgMErMPLyqLkFWGRkYJrPn+E1zcprMcmvQQR6jbTQOtnp5gWRpHVvNmQSmN2XBwVWPl2JySaAOp1n4g6Jp39pRRvdXN3ZRzEpHZzmN5Ioy7RCYRlC4A5UEkc8cU20+IGlP4csdYu7bWbeC5i8xgNIvJBFhVZixEXCjdw5AVsEgnBxkzfDee48VX+qS6zFFa3f2gSw2lmYJZlljZAkziTZIF3AgmMMSq5Y45oaz8LdQ1rTNMtdU1vSbz7DZPYItxoxlhCkKFlWJpyFnAU/OcjnhRigDqrv4heGbS++yzahIXAhLSR2k0kUYmx5TPKqFFDbhgswHNP8IeMbfxJf6xZx2d7by6deS2xaS2mWOQIQNwkZFTJJ+4CSBz05rFj+G+zQdV03+1c/braxt/M+zfc+zIq7sb+d23pkYz3rf8NaBeaJq2syC/gn0zULp7xLc2pWWKV9u7Mu8hl+U4GwHnqcUAUtR+JPhbT9RuLG6v7lbi3uPskuywuHRZiu4R71jKlyOig5PbNWD470L+yV1KN9SmtPMlicwaVdSvC8Zw6yosZaMg/wB8Cqb+Bt0l039o/wCv1+LXP9R93YsY8r73OfL+979OKwdf+FB1S9mnOqWUsctzd3DW2oab9qgXz9nzCPzFHmJs4dsj5vu0Ab9v41ik8Q6nGAbnRbfS7HUIJbK1luJpftEky5CRhmZcRoRheMknjpa/4T7w59mt5vtlxm4llgjh+xT+eZIwC8flbN4cZHylcnPANctJ8KGOkQ2Sa0p8vTNM00iS0LRTCzMhPmoJAWSTzMFNwxj7xq94O+Gw8O31jci/tCLa9u7zyLSwFtCPPjRNiIHOxV2ZHXOfxIBrxeNdOt9OuLy8ubq8gS7uIN9jo12/k+W2CkiqrkFehc7QxBIA6DF+NV3b6h8JJryylWa1uLjTZopUOQ6NeQFWHsQQap618Jm1GVmOqWU0bXV/cNb6hpv2qAfaZA+5Y/MUeYmMB23Dn7opnxN0j/hH/gRaaN5/2j+zv7Js/O2bPM8u6t03bcnGcZxk49a0o/xI+qMcT/Bn6P8AI5P4M/8AJU4v+wLef+j7SvoKvn34Mf8AJU4f+wLef+j7SvoKuzNP96n8vyR5nD//ACL6fz/9KZ5R+0R/yBPDH/YaH/pJdV5NXrX7Q/8AyBPDH/YaH/pHdV5LXr5L/Afr+iPmuKv97j/hX5sKKKK9g+aCiiigQUUUUDCiiigQUUUUDCiiigAooooA6vwHeQwS3VpcPHEbraIndSNzg/dLdAMHv3x0rr2Vlco6kODgqRyD6VyWnWk+s+DIbGzssGG9LPcu6rGNy8kknOcbeg6AV0XhXVXXUotK1lJE1KwVtsmQwlVBuAJ/vY6EdRj0r5zMaHtZSqw3W602XU+5yTFuhThQqfDL4ZWdrveJa7nPWq+oWNpqVukGoRsyoSY5I22vHnrg9CO+DWqZYbtIzdzSpcqu0ybd6uM5BPfPOO/ao3tMRO8c8E2wbmVCchfXkV48KkqclKDsz6WrShWg4VFdPocjb+DYFula41HzLYMCVSEq7r3HPAP503VfB8W2aTR7qSXYC6wTR4dgBkhWHBPsQM109KjMjqyMVZTkEdjXcs0xKkpOX4I8mXD+BcHBQt53d0eS9aq6rafb9LvLPf5f2iF4t+M7dykZx3612ni/Q2jml1KwiBs3+eZE/wCWDk88f3SeQe2cVytfTUqsMRT5o7M+BxOGq4Gu4TVmtvPzR13/AAtLxv8A89vDX/gsn/8Akmj/AIWl43/57eGv/BZP/wDJNcjRXN/ZeF/k/F/5nd/rBmH/AD8/CP8Akdd/wtLxv/z28Nf+Cyf/AOSaP+FpeOP+evhv/wAFk/8A8k1yNFH9l4X+T8X/AJh/rBmH/Pz8I/5HXf8AC0vG/wDz28Nf+Cyf/wCSaP8AhaXjf/nt4a/8Fk//AMk1yNFH9l4X+T8X/mH+sGYf8/Pwj/kdd/wtLxv/AM9fDf8A4LJ//kmj/haXjj/nr4b/APBZP/8AJNcjRR/ZeF/k/F/5h/rBmH/Pz8I/5HXf8LS8b/8APbw1/wCCyf8A+SaP+FpeN/8Ant4a/wDBZP8A/JNcjRR/ZeF/k/F/5h/rBmH/AD8/CP8Akdd/wtLxv/z28Nf+Cyf/AOSaP+FpeN/+e3hr/wAFk/8A8k1yNFH9l4X+T8X/AJh/rBmH/Pz8I/5HXf8AC0vG/wDz28Nf+Cyf/wCSaP8AhaXjf/nt4a/8Fk//AMk1yNFH9l4X+T8X/mH+sGYf8/Pwj/kdd/wtLxx/z18N/wDgsn/+SaP+FpeOP+evhv8A8Fk//wAk1yNFH9l4X+T8X/mH+sGYf8/Pwj/kdd/wtLxx/wA9fDf/AILJ/wD5Jo/4Wl43/wCevhv/AMFk/wD8k1yNFH9l4X+T8X/mH+sGYf8APz8I/wCR13/C0vG//Pbw1/4LJ/8A5Jo/4Wl43/57eGv/AAWT/wDyTXI0Uf2Xhf5Pxf8AmH+sGYf8/Pwj/kdd/wALS8b/APPXw3/4LJ//AJJo/wCFpeN/+e3hr/wWT/8AyTXI0Uf2Xhf5Pxf+Yf6wZh/z8/CP+R13/C0vHH/PXw3/AOCyf/5JrJ8UeMvFXifR20rVZ9EWykmgmk+zWEqSHypUlADNOwGSgHQ8GseimsswsXdR/F/5iln2PknF1NH5R/yOu+DP/JU4v+wLef8Ao+0r6Cr59+DP/JU4v+wLef8Ao+0r6Cr5/NP96n8vyR9nw/8A8i+n8/8A0pnlP7Q//IE8Mf8AYZH/AKR3VeS161+0P/yBPDH/AGGh/wCkd1Xktevkv8B+v6I+a4q/3uP+Ffmwoo71o6JpNxrNxLBaPAsyRGULLIE3gdQCeM/XFetKSiuaWx85CEqklCCu2Z1FbpfSrvQY7e1065/t1CN7xEsjKucsRk9uvHUZrCPGMjGRke9KE+a+li6tL2dtU7rp+XqFFFFWYhRR2ooGFFFFABRRRQIKKKKAL2lateaTJK9jL5bSJsbKg98ggHuOxoj1W9TVl1PzmkvVff5knzbj059scY9Ko0VDpwbba3NlXqJKKk7LVa7PuerwzRXVtBdW2PJnQOoBztP8S/gcj8qsW05t3c7FkV0KMrZwQfp9KwvBwf8A4RiIyDCfaZPLPqMLn9a1+cGvjMTSVKrKC2TP1LA15YjDQqy3aLtwYpdPSdYo45RMUYRgqMbcjiqVan2c3S2ywkCwX/WOq8xttG4v7+nb0qv9qt0KiGzRoxjc03zO47+yn6VgdZXtxK0yrbqWlb5QuM5z1BB4xjrnisvVPC2h3F5L9n8613YXdC4aJWxywBGcZzxnp0redrW2WY2k0kzyq0YDJs8tT1Pue351RrWlXqUXenKxz4jCUMUkq0VKx5bfWsllez2s4xLC5jb6g1BXoXiPQl1lTcWvy6mqBQufluAOAPZ8cD1x615/IjRyNHIrI6naysMEH0Ir63CYqGJhzLfqj82zPLqmAquEl7r2fdf59xtFFFdZ5oUUUUDCjtRRQIKKKKBhRRRQIKKKKACiiigANFFFABRRRQMKKKKBBRRRQM674M/8lTi/7At5/wCj7SvoKvn34M/8lTi/7At5/wCj7SvoKvkM0/3qfy/JH6Vw/wD8i+n8/wD0pnlP7Q//ACBPDH/YZH/pHdV5LXrX7Q//ACBPDH/YZH/pHdV5LXr5L/Afr+iPmuKv97j/AIV+bCj1oor2D5k9Q0H/AEfQ9PaGBLSSWBWkMS7WkwThiepzgGrV3svU2X8EV3H2WVen0IwV/A1g+Cb4XWkSWTkmazbzEz3iYgYH0Y5/4FW7XxuLU6WIlrrf/hj9Ry2VLEYKnZJq1mrLdb/icN4i8OT2Ezz2SPPpzt8jICzRf7Ljsffoa59htYqwKsOCDwRXraMyNuR2RumVODRIwmP7+OGY4xmWJXOPqRmvQo5zKMUqkb+Z4uK4WhObnQnyp9Gv1PJ44ZZELxxSOo4JVSQKawKsVYEMOoPBFeui4mUBUlZFHRUO0D8BxUF3DbXwT+0LaK6MZ3I0mcg+5GCw9jWsc7jf3oaepz1OE5KN4VbvzVl993+R5RRXq88FtdWTWN1Agsnx8kKBDGR0ZcDqP16V5zrekXOkXQjuAHifmKdB8kq+oPr6jqK7sHmEMU3FaPseTmeS1cAlNvmi+q6P+tjOooorvPGCiiigYVa0m2S81S0tpWKRzSrGzDGQCcZGaq0Umm1ZDi0pJtXR6vbWNvplo1hbzSyNbuHaOZQHiDjIBx1Bxn2zinVz/gNlmstSffJLel083cSx8oDg/n1PbAqbxlrb+HfDd3qkNob2SHYFtxJsMhZ1QDdg4+96V8bjYOnWlGTu9NfkfqOVVo1sLGcVZa2V72V3ZfcbeTtKgnaeozwaSuL/AOE+tJ/Efh3TNPtzcx6vD55uPM2iBSjOgK4OWPluMZGMVeu/F9i1lqQsTOuoWtlLeJBeWc1uXVB1AkVSwzgHHrXKegdNRXOReLLGCy0+TVDcQSXMMLtILOYwK0gGB5oUoOTjlquyeIdLjgnme6ASC6Fk48ttwmLBQm3GSSWXGBjBz05oA1qralplnrA23sYFwRsS6T/WKe27++PrzjvWHc+MNJa2vvs18YnggmmFxLZTNDiIHeynCiULjkI2eKsz+J9NtJLeG8luEM3lqs5sp1gZnxt/ebSgySBgt1ODzV06kqUuaDszKtQp14OnVjdPucZqdlNpuoXFndACaByjYOQfcex61Vrt/G+nfabOPUol/eW4EU+O6ZwjfgflP4VxFfY4TELEUlNb9fU/MMywTwWIlSe3T06f13Ciiiuk4QooooAKKKKACiiigAooooAKKKKBBRRRQMKKKKBBRRRQMKM0UUAdd8Gf+Spxf9gW8/8AR9pX0FXz78Gf+Spxf9gW8/8AR9pX0FXyGaf71P5fkj9K4f8A+RfT+f8A6Uzyn9of/kCeGP8AsMj/ANI7qvJa9a/aH/5Anhj/ALDI/wDSO6ryWvXyX+A/X9EfNcVf73H/AAr82FFFFewfNGhoWpvpOopcogkTBSSMnG9D1HsfQ+uKZNqsmm6n461XSbue9itI7Z7RLq5mkhQyLuYFC2FOewxjBA4qlUel2lnY3d/I0Etxb6iAl9bvcy7J1BBAxu+UjHykYx06Eg+XmOAeJSlD4kfQZJnCwLdOrfkf4PudHdeJtZ0ufU7C+j0+61CMWX2VoI3jjLXMrRAOCzHCsucgjI7A1QbU9X0jxDqUDyWFxql/d2dnHOIHjhj3RyNuaPeScBGGN4ycciu1m0fSNWSfUI4/tMN9HHC8u9lYCNiyKcH5HVmJyMHOCD0xTXwfogtrmE20zi4dJZJJLqV5S6fccSFi4YdiCDXy8ouLs9z9AhOM4qUXdMwp/E+tq8WnRjTf7UXWRpks7ROYWQ27Th1QPkNjaCpY85GeciC48Z6pD9msHjg/tFry5t5LmGwnuYwkO35hDGS+TvUYLYHPJrrbXw3pVrFaxw2zYtrk3kbPK7uZirKXZiSXJDMPmJ/QUlx4b0udHVoJY2ad7rzIbiSKQSMMMQ6MGXI4IBA9qRRyV14v15NMs7qayXTYzFM09xc6bcyx70k2qCi4eFGUb9zg4BxjikvtcE8XiizWXS7KR7m2SGSOxkuWvJWtklACowZ36hWA+6MEGukl8GaJJDHEbe5CJG0PyXs6mRGYsyyEPmQFmYndnOTU1x4V0eeaSb7K8U7zJcebb3EkLpIkflqyMjAphBt+XAxVQk4SUl0Iq041YOEtmrHl3hzUJdSsHkuVCzRzPC2I2jztbGdrfMvHY9K1K7TWNE0vSvCtz5FsUYXAeKVnZ3MkjZfLMSWBAJ5PWuLr6/A4j6xRUnvsfmeb4JYLEumndPVfMKMUUV2HmBRRRQIt6VfXGm6hBd2cjRzRsMFTjI7j6HpXe+PtHk1TTrrT7Hy4maeCVRISFCrKkhHQnopH19ua85QK0iK7bUJAZvQdzXrt4gjuXjAKomEUH+6Bhf0ArwM7SvB9df0Ps+E5Saqx6afqefy+A0stV0+60KRYBHfz3s7TMWKmSF0URjGNqlgQpwMZrMtfBXiCWbzdSubeSf8Asu6snlfUZ7gyyyhAHCugWJflOVQen3u3ptFeCfYHmWt+DPEV/aSWYu4Jbb7NbwwhtQnhSAoihwYkXbLuKkgueM9OK1ZNAe5+KJvlWdNOht47qZWQiKW7AeNGB/iIjJzjphO9dxRQB5u3g3WpbPVbaNrOwhurG7tzDBfTywTSSqQreU64hAJJOwtnNJrHg7xDfySQtdwzWpa2MO7UJ4lgWMJvXyEXZJkqTuYnqOBXpNFFgJbZElm8qVQ8cqtEynowYEY/lXkRUqSrAhlOCD1Br160z9rg2ruO9cD15ryjUAg1C6EUxmj819sp6uMn5vxr3skk/fj6fqfHcWQVqUvX9CvRRRXvnxwUUUUAFFFFAgooooAKKKKBhRRSgFiAoJJOAB3NAhKKkuIJbaeSC4jaOaNirowwVI7Go8Uk76jaadmFFFFMQUUUUDCiiigDrvgx/wAlTh/7At5/6PtK+gq+ffgx/wAlTh/7At5/6PtK+gq+QzT/AHqfy/JH6Vw//wAi+n8//SmcJ8XvCuq+K9H0mHQzY/abLUBdst5M8SMnkTRkBlRznMoPTsa84/4Vb43/AOePhr/wZz//ACNX0FRWNDG1qEeWnKy9EdOKyvC4yaqV4XaVt2tPkz59/wCFW+N/+ePhr/wZz/8AyNR/wq3xx/zy8N/+DOf/AORq+gqK2/tTFfz/AIL/ACOb/V/L/wDn3+Mv8z59/wCFW+OP+eXhv/wZz/8AyNR/wq3xx/zy8N/+DOf/AORq+gqKP7UxX8/4L/IP9X8v/wCff4y/zPCtK8A/EPSrgy2X/CNoW4dDqU5Rx6MPs2DXQyeH/GpkYppPhtFJ4X+2Zzj/AMlK9UormrYipXd6ju/Rfod+FwVHCRcKKsvVv82zyn/hHfHH/QM8N/8Ag4n/APkSj/hHvHH/AEC/Df8A4OJ//kSvVqKxudR5T/wj3jf/AKBfhv8A8HE//wAiUf8ACPeN/wDoF+G//BzP/wDIlerUUXA8quPD3jS6tFtbvRfCtxbKSRHJq05wT3yLXIP0Nc1ffDHxdJOWsrLw/bxH/lm+sTyYPsfso4+ufrXvVFb0cXWofw5WOLFZdhsXrWgm/uf3rU+ff+FW+OP+eXhr/wAGc/8A8jUf8Kt8cf8APLw3/wCDOf8A+Rq+gqK6P7UxX8/4L/I4/wDV/L/+ff4y/wAz59/4Vb43/wCePhr/AMGc/wD8jUf8Kt8b/wDPHw1/4M5//kavoKij+1MV/P8Agv8AIP8AV/L/APn3+Mv8z59/4Vb43/54+Gv/AAZz/wDyNXR6X4X8fWlgbe5t/D92wk3I8msT5RcYKj/RScdD17dK9forKtjq9aPLUldei/yOjDZVhcLP2lGNn6v9WeU/8I743/6Bfhr/AMHE/wD8iUf8I943/wCgX4b/APBxP/8AIlerUVy3PRPKf+Ee8b/9Avw3/wCDif8A+RKP+Ee8cf8AQL8Nf+Dif/5Er1aii4HlP/CPeN/+gX4b/wDBzP8A/IlH/CO+OP8AoGeG/wDwcT//ACJXq1FFwPKH8PeOTDMi6d4cRpInjDjWZ8ruBGR/ovXmuUHwt8cY/wBV4b/8Gc//AMjV9BUV0UMXWw6apu1/Q4cXluGxjUq8btebX5M+ff8AhVvjf/nl4b/8Gc//AMjUf8Kt8cf88vDf/gzn/wDkavoKit/7UxX8/wCC/wAjk/1fy/8A59/jL/M+ff8AhVvjj/nl4b/8Gc//AMjUf8Kt8b/88fDX/gzn/wDkavoKij+1MV/P+C/yD/V/L/8An3+Mv8z59/4Vb43/AOeXhv8A8Gc//wAjUf8ACrfG/wDzy8N/+DOf/wCRq+gqKP7UxX8/4L/IP9X8v/59/jL/ADPn3/hVvjj/AJ5eG/8AwZz/APyNR/wq3xx/zy8N/wDgzn/+Rq+gqKP7UxX8/wCC/wAg/wBX8v8A+ff4y/zPn3/hVvjj/nl4a/8ABnP/API1H/CrfG//ADx8Nf8Agzn/APkavoKij+1MV/P+C/yD/V/L/wDn3+Mv8z59/wCFW+OP+eXhv/wZz/8AyNWtoPgLxfpLtO2l+Gri7B/dyNq84EQ9Qv2U/N7np2HevbKKipmOJqRcZS0foa0clwNCaqQp6rzb/NniPiDwF4y1e4juRp/huC4xtlcatO3m+hI+yjnHBPesv/hVvjj/AJ5eG/8AwZz/APyNX0FRRTzHE04qEZaLyX+Qq2S4GtN1J09Xvq1+TPn3/hVvjf8A54+Gv/BnP/8AI1H/AAq3xv8A88fDX/gzn/8AkavoKir/ALUxX8/4L/Iz/wBX8v8A+ff4y/zPn3/hVvjf/nj4a/8ABnP/API1H/CrfHH/ADy8Nf8Agzn/APkavoKij+1MV/P+C/yD/V/L/wDn3+Mv8z59/wCFW+OP+eXhv/wZz/8AyNR/wq3xv/zx8Nf+DOf/AORq+gqKP7UxX8/4L/IP9X8v/wCff4y/zPI/hj4B8R6B40/tfXP7IS2XT5rRVs7qSZy8kkLAkNEgAAiPc9RXrlFFcdWrOtNzm7tnp4fD08NTVKkrRX/D9T//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Arguin PM, Mali S. Infectious diseases related to travel. Yellow Book 2012. Centers for Disease Control and Prevention. Available at:",
"     <a href=\"file://wwwnc.cdc.gov/travel/yellowbook/2012/chapter-3-infectious-diseases-related-to-travel/malaria.htm#2534\" target=\"_blank\">",
"      file://wwwnc.cdc.gov/travel/yellowbook/2012/chapter-3-infectious-diseases-related-to-travel/malaria.htm#2534",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_44_3782=[""].join("\n");
var outline_f3_44_3782=null;
var title_f3_44_3783="Histopathology of ARPKD kidney";
var content_f3_44_3783=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F73986&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F73986&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Histopathology of autosomal recessive kidney disease (ARPKD)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 289px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Histologic examination of a renal sample from a patient with ARPKD reveals cystic dilatations of the collecting tubules with flattening of the epithelium that runs perpendicular to the renal capsule.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_44_3783=[""].join("\n");
var outline_f3_44_3783=null;
var title_f3_44_3784="Opioid abuse and dependence: Overview and patient evaluation";
var content_f3_44_3784=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Opioid abuse and dependence: Overview and patient evaluation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/44/3784/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/44/3784/contributors\">",
"     Michael F Weaver, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/44/3784/contributors\">",
"     John A Hopper, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/44/3784/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/44/3784/contributors\">",
"     Andrew J Saxon, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/44/3784/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/44/3784/contributors\">",
"     Richard Hermann, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?3/44/3784/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 17, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Opiate medications are very effective for the treatment of acute and chronic pain, but also have the potential to be abused. Heroin abuse in the United States (US) has remained at high levels since the mid 1990s, with over 100,000 new users annually [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will provide an overview of opioid abuse and patient evaluation. Long-term treatment for opiate dependence is discussed separately. Other substance abuse, and the management of acute intoxication and withdrawal, are also discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/52/29514?source=see_link\">",
"     \"Treatment of opioid abuse and dependence\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/51/3897?source=see_link\">",
"     \"Opioid intoxication in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/5/28758?source=see_link\">",
"     \"Opioid withdrawal in the emergency setting\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/12/32970?source=see_link\">",
"     \"Cocaine abuse and dependence in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/28/4554?source=see_link\">",
"     \"Cannabis use disorders: Treatment, prognosis, and long-term medical effects\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/17/21783?source=see_link\">",
"     \"Cannabis use disorders: Clinical features and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/34/44584?source=see_link\">",
"     \"Intoxication from LSD and other common hallucinogens\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term opioid refers to natural and synthetic substances with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/31/19962?source=see_link\">",
"     morphine",
"    </a>",
"    -like activity. Opiate refers to a subclass of opioids consisting of alkaloid compounds extracted from opium, including morphine,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/0/35848?source=see_link\">",
"     codeine",
"    </a>",
"    , and semisynthetic derivatives of the poppy plant. The term endorphin refers to another subclass of opioids consisting of endogenous peptides that produce pain relief, including enkephalins, dynorphins, and beta-endorphins.",
"   </p>",
"   <p>",
"    Opioids have analgesic and central nervous system (CNS) depressant effects, as well as the potential to cause euphoria.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/31/19962?source=see_link\">",
"     Morphine",
"    </a>",
"    is the prototypical opioid. Heroin is a derivative of morphine and is the opioid most commonly abused by injection.",
"   </p>",
"   <p>",
"    Opioid dependence or addiction is defined as continued use of opioids despite significant opioid-induced problems; these problems may be cognitive, behavioral, or physiological [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/2\">",
"     2",
"    </a>",
"    ]. Repeated drug use results in opioid tolerance (requiring escalating doses to achieve the same effect), withdrawal symptoms, and compulsive drug taking.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     MECHANISM OF ACTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Opioids activate specific transmembrane neurotransmitter receptors (mu, kappa, delta) that couple G proteins. G-proteins are molecular intermediaries that initiate the intracellular communication process. Stimulation of G proteins begins the intracellular process of signal transduction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/49/22293?source=see_link\">",
"     \"Peptide hormone signal transduction and regulation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Activation of endogenous mu opioid receptors results in the prototypic opioid effects of reward, withdrawal, and analgesia. Mu receptor activation can mediate a variety of G proteins that lead to secondary effects on messenger-generating enzymes (adenyl cyclase and phospholipase-C) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/3\">",
"     3",
"    </a>",
"    ]. Secondary messengers such as cyclic adenosine monophosphate (cAMP) are acutely decreased by opioid receptor activation. Chronic opioid receptor activation results in molecular effects opposite to those of acute opioid administration. Long-term opioid use causes up regulation of cAMP, along with changes in gene transcription.",
"   </p>",
"   <p>",
"    Opioid receptors are located in the central and peripheral nervous system. The effects of activation of neuronal mu receptors will depend on the location of the receptor, the types of G proteins present in the activated neural tissues, and the frequency and duration of activation. Activation of mu receptors in the central nervous system results in responses such as respiratory depression, analgesia, euphoria, and miosis. Stimulation of peripheral mu opioid receptors, in smooth muscle of the bronchi and intestines, results in cough suppression and opioid-induced constipation",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     OPIOID ABUSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Opium is the crude substance derived from the opium poppy; it has been used by people since as early as 4000 BC.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/31/19962?source=see_link\">",
"     Morphine",
"    </a>",
"    was purified from opium early in the nineteenth century and widely used for analgesia during the US Civil War. Heroin and morphine were key ingredients in many patent medicines in North America during the late 1800s.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Heroin",
"    </span>",
"    &nbsp;&mdash;&nbsp;The popularity of heroin as a drug of abuse reached a peak in the 1960s, but declined somewhat during the 1970s and 1980s due to greater awareness of the risks of overdose and the increased popularity of cocaine. Throughout the 1990s, heroin abuse again became a growing epidemic. The supply available on the street has become purer and is being tried by more adolescents and middle class people [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/4\">",
"     4",
"    </a>",
"    ]. According to the 1998 National Household Survey on Drug Abuse, an estimated 2.4 million people in the US had used heroin at some point in their lives, and 130,000 reported use in the last month. Data from the 2005 National Survey on Drug Use and Health (NSDUH) are similar, with an estimated 136,000 reporting use of heroin in the past month.",
"   </p>",
"   <p>",
"    Heroin has a half-life of 30 minutes, but a duration of action of four to five hours due to active metabolites, including",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/31/19962?source=see_link\">",
"     morphine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/5\">",
"     5",
"    </a>",
"    ]. Heroin is metabolized to 6-monoacetylmorphine (6-MAM) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/6\">",
"     6",
"    </a>",
"    ], a metabolite specific to heroin, detectable on urine testing, and can differentiate heroin from other opioids.",
"   </p>",
"   <p>",
"    Like all opioids, heroin binds to receptors that are part of endogenous opioid systems [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/7\">",
"     7",
"    </a>",
"    ]. Opioids also act on several other CNS neurotransmitter systems, including dopamine, gamma-amino-butyric acid (GABA), and glutamate. Heroin is more lipid soluble than other opioids, allowing it to rapidly cross the blood-brain barrier (within 15 to 20 seconds) and to reach high brain levels [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Names and routes of administration",
"    </span>",
"    &nbsp;&mdash;&nbsp;The chemical name for heroin is diacetylmorphine. Street names include dope, horse, smack, and tar.",
"   </p>",
"   <p>",
"    Heroin is used by multiple routes of administration.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intranasal insufflation (snorting, sniffing) requires minimal equipment and the onset of action is rapid enough to produce euphoria (the \"rush\"). Increased purity of heroin in the US and concerns over injection risks have resulted in a rising prevalence of heroin snorting in many areas [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The intravenous (IV) route is rapid and potent, but also most dangerous to the user. Injection is the most efficient means of producing euphoria when relatively low purity heroin is being used. Most overdoses occur when heroin is taken intravenously.",
"     </li>",
"     <li>",
"      Heroin can be smoked; this is more common in Asian countries where it is known as \"chasing the dragon,\" but has become more popular worldwide, including some cities in the US. Smoking heroin is the fastest route for delivering drug to the brain.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Other opioids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other opioids besides heroin are subject to abuse. Opium extracted from poppies is more commonly abused outside the US.",
"   </p>",
"   <p>",
"    Opium is most commonly smoked, and concern has been raised about the second hand exposure of children to the effects of smoke in countries in the Middle East and Asia.",
"   </p>",
"   <p>",
"    The prevalence of prescription opioid abuse in the US has increased in the past decade, and has become one of the fastest growing drug problems [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/10\">",
"     10",
"    </a>",
"    ]. 2005 NSDUH data indicate 2.2 million new non-medical users of prescription analgesics [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/11\">",
"     11",
"    </a>",
"    ]. Most prescription pain medications are illegally diverted from legitimate sources, especially controlled-release",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/34/10792?source=see_link\">",
"     oxycodone",
"    </a>",
"    (OxyContin) and hydrocodone (eg, Vicodin, Lortab) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/12\">",
"     12",
"    </a>",
"    ]. Health care professionals with access to opioids may personally abuse them, especially",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/44/11976?source=see_link\">",
"     meperidine",
"    </a>",
"    and injectable",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/52/38730?source=see_link\">",
"     fentanyl",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/43/36535?source=see_link\">",
"     \"Prescription drug abuse and addiction: Clinical features, epidemiology, and contributing factors\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Studies have shown differences between those who primarily abuse prescription opioids compared to heroin. Those who abuse prescription opioids:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Are more likely to have complaints of pain [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/13,14\">",
"       13,14",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Are more likely to be in psychiatric treatment [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/13\">",
"       13",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Have greater social stability [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/15\">",
"       15",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Are less likely to use other illicit drugs [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/13\">",
"       13",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, up to",
"    <span class=\"nowrap\">",
"     2/3",
"    </span>",
"    of those who primarily use heroin will also use prescription opioids [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/12\">",
"     12",
"    </a>",
"    ]. Prescription opioids are most commonly obtained from a relative, friend, or dealer, and not directly from a physician.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Overdose",
"    </span>",
"    &nbsp;&mdash;&nbsp;Overdose can occur at any time with any opioid. Studies in the UK and Australia show that changes in the drug market (such as prescription opioid availability and illicit use) and the addiction treatment system are better predictors of mortality in opioid-dependent patients than age or length of heroin use [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/16,17\">",
"     16,17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Recent epidemiologic studies have shown that overdose is more common with nonmedical use of prescription opioids than with heroin [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/16,18-20\">",
"     16,18-20",
"    </a>",
"    ]. A study of age-adjusted unintentional drug poisoning mortality rates from 1999-2004 in urban and rural areas of the US showed that prescription opioids have replaced heroin as a leading drug for fatal overdose [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/18\">",
"     18",
"    </a>",
"    ]. Overdose with heroin remains a concern, however, because the amount of actual heroin in drugs bought on the street varies from dealer to dealer and day to day, and because of the high lipid solubility of heroin. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/51/3897?source=see_link\">",
"     \"Opioid intoxication in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Data regarding specific drugs as cause of overdose mortality are skewed because death certificates do not list individual drugs as a cause of death. This is due to lack of toxicological data at the time the death certificate is completed. One of the only individual drugs listed in ICD codes is",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/57/36761?source=see_link\">",
"     methadone",
"    </a>",
"    , which may result in overrepresentation of this specific opioid in studies using death certificates as the data source [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Tolerance and physical dependence occur after one to two weeks of daily use, resulting in a withdrawal syndrome after abrupt cessation. Tolerance develops much more slowly to the miotic effects, constipation, and respiratory depression.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Detection in drug screens",
"    </span>",
"    &nbsp;&mdash;&nbsp;Metabolites of opioids can be detected on a urine drug screen up to three to four days after the last use and occasionally longer in chronic users (",
"    <a class=\"graphic graphic_table graphicRef58181 \" href=\"UTD.htm?24/57/25499\">",
"     table 1",
"    </a>",
"    ). Not all opioids are detected on all drug screens because some opioids are broken down to different metabolites for which there are no commonly used screening assays. When evaluating a suspected opioid overdose or withdrawal syndrome, a good history of drugs taken is important in addition to urine drug testing.",
"   </p>",
"   <p>",
"    False-positive opiate drug screens have been reported in patients taking",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    and quinolones [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/22,23\">",
"     22,23",
"    </a>",
"    ] and in those eating poppy seeds (",
"    <a class=\"graphic graphic_table graphicRef58181 \" href=\"UTD.htm?24/57/25499\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/24\">",
"     24",
"    </a>",
"    ]. Confirmatory testing (eg, with gas chromatography, mass spectrometry, or high-performance liquid chromatography) is warranted in patients who have a positive screen after ingesting substances which might cause a false positive result, although these techniques may not resolve the issue in the setting of poppy seed consumption. As noted earlier, the presence of 6-MAM on confirmatory testing verifies the use of heroin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H116843663\">",
"    <span class=\"h2\">",
"     Medical consequences",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Heroin addiction is associated with increased mortality. In one study, the mortality rate of 115 untreated subjects with heroin addiction was 63 times that expected for a non-using group of the same age and sex distribution, and higher than a group of former heroin users in",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/57/36761?source=see_link\">",
"       methadone",
"      </a>",
"      maintenance programs [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The two leading causes of death in a study of 42,676 people who entered opioid pharmacotherapy were overdose and trauma [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/26\">",
"       26",
"      </a>",
"      ]. Medication treatment was associated with a 29 percent reduction in mortality compared with time out of treatment, although the first two weeks of treatment had the highest mortality risk.",
"     </li>",
"     <li>",
"      Contaminated drugs and inadequate sterile technique with injection drug use leads to localized and systemic infections (eg, cellulitis, localized abscess at the injection site, endocarditis, osteomyelitis). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/51/43831?source=see_link\">",
"       \"Skin abscesses, furuncles, and carbuncles\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14840?source=see_link\">",
"       \"Epidemiology, risk factors and microbiology of infective endocarditis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/46/42726?source=see_link\">",
"       \"Hematogenous osteomyelitis in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Intravenous drug use with shared needles or syringes is associated with an increased risk of infection with a blood-borne pathogen, such as HIV, hepatitis B, and hepatitis C. Substance abusers are also at increased risk for systemic bacterial infections such as pneumonia and tuberculosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/58/5033?source=see_link\">",
"       \"Substance use disorders: Principles for recognition and assessment in general medical care\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hepatitis C virus (HCV) infection may also occur in those who abuse heroin but do not inject it. Transmission has been associated with tattooing [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/27\">",
"       27",
"      </a>",
"      ] and sharing of straws for intranasal insufflation [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/28,29\">",
"       28,29",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/7/2169?source=see_link\">",
"       \"Epidemiology and transmission of hepatitis C virus infection\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Chronic use of opioid agonists can result in hyperalgesia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/52/29514?source=see_link\">",
"       \"Treatment of opioid abuse and dependence\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Narcotic bowel syndrome is characterized by an increase in abdominal pain associated with continued or escalating dosages of opioids. Two case series have found that the pain is [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/30,31\">",
"       30,31",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Often severe",
"     </li>",
"     <li>",
"      Chronic or recurring",
"     </li>",
"     <li>",
"      Significantly reduced following medically supervised withdrawal from the opioids.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Between one and seven percent of Caucasians of European descent have a genetic defect placing them at risk of respiratory depression from small doses of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/0/35848?source=see_link\">",
"       codeine",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/32\">",
"       32",
"      </a>",
"      ]. This group has multiple functional alleles for cytochrome P-450 enzyme CYP3A4, making them \"ultrarapid metabolizers\" of codeine into",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/31/19962?source=see_link\">",
"       morphine",
"      </a>",
"      . Their increased metabolism can result in potentially lethal morphine levels. A patient history of adverse reactions to codeine consistent with intoxication should prompt selection of a different drug or markedly lower dose.",
"     </li>",
"     <li>",
"      Substance abusers, especially heroin users, engage in drugged driving and have higher rates of motor vehicle collisions [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/33\">",
"       33",
"      </a>",
"      ]; those arrested for drugged driving have significantly increased rates of all-cause mortality [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/34\">",
"       34",
"      </a>",
"      ]. However, patients maintained on either",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/57/36761?source=see_link\">",
"       methadone",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/53/41816?source=see_link\">",
"       buprenorphine",
"      </a>",
"      do not have significant alterations in tasks related to driving performance when not using illicit drugs [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Other consequences",
"    </span>",
"    &nbsp;&mdash;&nbsp;Consequences of",
"    <span class=\"nowrap\">",
"     opioid/heroin",
"    </span>",
"    addiction and abuse, both to the abuser and to society, are multiple [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Most impoverished street-level heroin users need to engage in some illegal behavior (ie, shoplifting, burglary, prostitution) to obtain money with which to purchase heroin.",
"     </li>",
"     <li>",
"      Health care costs of opioid dependence are over one billion dollars in the US annually [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/2\">",
"       2",
"      </a>",
"      ]. Costs to society include lost work productivity due to intoxication or complications of use, health care costs for uninsured users with medical complications, prosecution and incarceration expenses for criminal offenses, and economic and psychological costs to the victims of crimes. Additional costs arise from transmission of diseases such as HIV and hepatitis to sexual contacts who are not themselves drug users.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Taking a history in a patient who has admitted to use of opioids, most commonly heroin, should focus on the amount of drug used recently, route of administration, last use, previous attempts at drug treatment, and problems that have resulted from drug use. A direct approach is most beneficial; asking these questions as part of a routine health history can improve the comfort of the patient and the clinician. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/58/5033?source=see_link\">",
"     \"Substance use disorders: Principles for recognition and assessment in general medical care\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Begin by asking how long the patient has been using opioids and the preferred route of administration: intranasal, intravenous, or subcutaneous. Familiarity with street terminology is helpful; intranasal use is often referred to as \"snorting\" or \"sniffing,\" intravenous use is called \"shooting up\" or \"mainlining,\" and subcutaneous use is known as \"skin-popping.\"",
"   </p>",
"   <p>",
"    It is difficult to know exactly how much active drug a patient is using because street drugs are diluted (or \"cut\") by dealers with other white powders prior to sale. A given amount of heroin powder bought on the street will contain 10 to 40 percent active drug; the rest is an adulterant such as sugar, powdered milk, over-the-counter medications such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/47/19190?source=see_link\">",
"     pseudoephedrine",
"    </a>",
"    (to counteract some of the drowsiness associated with the high), or even a prescription medication that the dealer has been able to obtain. Heroin becomes progressively more diluted and adulterated as it moves down the distribution chain [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Consumer and dealers generally do not know precise measurements of the quantity or potency of the heroin being used or sold [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/37\">",
"     37",
"    </a>",
"    ]. Nevertheless, it is useful to try to estimate the amount of drug being consumed since this will impact the likelihood and severity of withdrawal symptoms when the drug is stopped. It may be helpful to ask the usual amount of drug powder that the addict consumes each time he or she uses and the number of uses per day. Dependent persons typically use heroin two to six times a day.",
"   </p>",
"   <p>",
"    Another way to estimate quantity is to ask the patient how much he or she has been spending on average each day or week to purchase heroin. Drug prices vary widely based upon geography (even between neighborhoods) and demand [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/38\">",
"     38",
"    </a>",
"    ]. A typical \"quarter bag\" ($25 worth) has enough adulterated heroin powder to snort several lines or inject several times, depending upon the tolerance of the buyer. Amounts used can range from $20 to $200 per day. Although typical street-level drug transactions are for standard dollar amounts (ie, $10, $20, or $50), the actual amount of pure heroin sold for a given price changes with time and location of sale.",
"   </p>",
"   <p>",
"    Addicts do not always engage in a cash transaction to obtain drugs. Acquiring drugs often involves trading stolen goods for drugs, engaging in prostitution, trading favors (such as the use of a car or house) with the dealer, or getting heroin from friends at no charge. Many drug users share illicit drugs without taking money, with an expectation of reciprocity: that they will get drugs from others when they need them in the future [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is important to determine if the patient is dependent on or abusing other drugs",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    alcohol in addition to opioids. Obtaining an accurate history can be complicated, as patients may accelerate use of one substance (eg, alcohol) during times when heroin is less available. The clinician must accurately identify patients who need concomitant treatment of alcohol or",
"    <span class=\"nowrap\">",
"     sedative/hypnotic",
"    </span>",
"    dependence because withdrawal from these drugs can be life threatening.",
"   </p>",
"   <p>",
"    It is also important to specifically inquire about nonmedical use of prescription opioids, Many heroin users obtain prescription opioids illegally. In addition to inquiring about the drug, dose, and average number of tablets consumed daily, users should be asked about the route of administration. Over 10 percent of nonmedical user of prescription opioids involves \"snorting\" the tablet contents [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3784/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinician should determine whether the patient has been using larger and larger amounts of heroin to get the same effect. This demonstrates tolerance to opioids and indicates that the patient is likely to experience withdrawal symptoms if he or she stops using abruptly. Many addicts start out using heroin to get high, then reach a point where they must use simply to avoid withdrawal symptoms.",
"   </p>",
"   <p>",
"    Another important element of the history involves asking about previous substance abuse treatment. Ask when the patient has been in treatment and what type (detoxification, opioid maintenance, inpatient, residential, outpatient counseling, or self-help groups such as Narcotics Anonymous). Asking the length of the longest period of abstinence helps predict the patient's ability to maintain abstinence in the future. Abstaining from heroin for at least one year suggests a favorable prognosis for remaining abstinent again for a significant period of time.",
"   </p>",
"   <p>",
"    Asking about problems that have resulted from drug use helps the patient to begin thinking about reasons to stop using drugs. Patients should be asked about past and present physical and psychiatric conditions as well as legal and social problems, especially if the patient has lost jobs, relationships, or freedom as a consequence of heroin use.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     PHYSICAL EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A routine physical examination can elucidate common complications of heroin use or assist in diagnosing opioid dependence. Chronic intravenous use can be confirmed by the presence of \"track\" marks, which are callouses that follow the course of a subcutaneous vein. These are caused by repeated injections into adjacent sites over an accessible vein. Tracks are often found in easily accessible body areas, such as the backs of the hands, antecubital fossae, on the legs, or in the neck. Signs of recent injection may be found in unusual places in patients attempting to hide their sites of injection. A thorough examination for tracks or recent injection sites should include looking between the fingers and toes, under the fingernails and toenails, in the axillae, breast veins, and the dorsal vein of the penis.",
"   </p>",
"   <p>",
"    The nasal septum should be examined for perforation from repeated intranasal insufflation (especially when cocaine is mixed with heroin and snorted). A heart murmur may indicate subacute bacterial endocarditis. Posterior cervical lymphadenopathy may suggest early viral infection, especially with HIV. Hepatic enlargement may indicate acute hepatitis; a small, hard liver is consistent with chronic viral hepatitis due to hepatitis B or C virus, which is common among injection drug users who share needles.",
"   </p>",
"   <p>",
"    Signs of opioid intoxication may include pinpoint pupils, drowsiness, slurred speech, and impaired cognition. Signs of acute opioid withdrawal syndrome include watering eyes, runny nose, yawning, muscle twitching, hyperactive bowel sounds, and piloerection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     LABORATORY EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who use heroin are at risk for infections related to shared needle use, including HIV and hepatitis. When a patient has been identified as abusing heroin, counseling regarding HIV testing should be provided, and testing encouraged. Patients should also be tested for hepatitis A, B, and C. Hepatitis A and hepatitis B vaccination should be given to patients whose hepatitis serology is negative. A complete blood count and liver function studies are appropriate and may suggest need for further investigations. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/58/5033?source=see_link&amp;anchor=H16#H16\">",
"     \"Substance use disorders: Principles for recognition and assessment in general medical care\", section on 'Laboratory findings'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Illicitly purchased heroin can vary in potency, increasing the risk of morbidity and mortality.",
"     </li>",
"     <li>",
"      Prescription opioid analgesics are the most commonly abused opioids in the US. Prescription opioids are the leading cause of opioid related overdose in the US. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Overdose'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7\">",
"       'Other opioids'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Urine drug screens can detect opioid metabolites within four days of last use, and possibly longer in chronic users. False negative tests may occur because not all opioids are detected in drug screens, and false positive tests can be seen in patients taking",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"       rifampin",
"      </a>",
"      , quinolones, or eating poppy seeds. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Detection in drug screens'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Consequences of heroin addiction are increased mortality, increased crime, and infections related to shared needles, endocarditis, and localized infections from non-sterile technique. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Other consequences'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H116843663\">",
"       'Medical consequences'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Ask patients about amount, frequency, and duration of heroin or other opioid abuse, and look for signs of use on physical examination. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'History'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H12\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Identified heroin users should be screened for HIV and hepatitis A, B, and C. Vaccination for hepatitis A and hepatitis B should be given to those with negative serologies. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Laboratory evaluation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Substance Abuse and Mental Health Services Administration. (2003). Results from the 2002 National Survey on Drug Use and Health: National Findings (Office of Applied Studies, NHSDA Series H-22, DHHS Publication No. SMA 03-3836). Rockville, MD.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3784/abstract/2\">",
"      Effective medical treatment of opiate addiction. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. JAMA 1998; 280:1936.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3784/abstract/3\">",
"      Cam&iacute; J, Farr&eacute; M. Drug addiction. N Engl J Med 2003; 349:975.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3784/abstract/4\">",
"      Bruner AB, Fishman M. Adolescents and illicit drug use. JAMA 1998; 280:597.",
"     </a>",
"    </li>",
"    <li>",
"     Reisine, T, Pasternak, G. Opioid analgesics and antagonists. In: Hardman, JG, Gilman, A, Limbird, LE (Eds), Pharmacological Basis of Therapeutics, 9th Ed, McGraw-Hill, New York, 1996. p.521.",
"    </li>",
"    <li>",
"     Way, WL, Way, EL. Opioid analgesics and antagonists. In: Katzung, BG (Ed), Basic and Clinical pharmacology, Appleton &amp; Lange, Norwalk, CT, 1989. p.368.",
"    </li>",
"    <li>",
"     Watson, SJ, Akil, H, Khachaturian, H, et al. Opioid systems: Anatomical, physiological and clinical perspectives. In: Hughes, J, Collier, HO, Rance, MJ, Tyers, MB (Eds), Opioids Past, Present and Future, Taylor &amp; Francis, London, 1984. p.145.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3784/abstract/8\">",
"      Sporer KA. Acute heroin overdose. Ann Intern Med 1999; 130:584.",
"     </a>",
"    </li>",
"    <li>",
"     Community Epidemiology Work Group. Epidemiologic Trends in Drug Abuse, Vol. II. Proceedings of the Community Epidemiology Work Group, December 2003. NIH Pub No. 04-5365. Bethesda, MS: NIDA, NIH, DHHS, 2004.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3784/abstract/10\">",
"      Cicero TJ, Inciardi JA, Mu&ntilde;oz A. Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004. J Pain 2005; 6:662.",
"     </a>",
"    </li>",
"    <li>",
"     Substance Abuse and Mental Health Services Administration. (2006). Results from the 2005 National Survey on Drug Use and Health: National Findings (Office of Applied Studies, NSDUH Series H-30, DHHS Publication No. SMA 06-4194). Rockville, MD.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3784/abstract/12\">",
"      Rosenblum A, Parrino M, Schnoll SH, et al. Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug Alcohol Depend 2007; 90:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3784/abstract/13\">",
"      Brands B, Blake J, Sproule B, et al. Prescription opioid abuse in patients presenting for methadone maintenance treatment. Drug Alcohol Depend 2004; 73:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3784/abstract/14\">",
"      Trafton JA, Oliva EM, Horst DA, et al. Treatment needs associated with pain in substance use disorder patients: implications for concurrent treatment. Drug Alcohol Depend 2004; 73:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3784/abstract/15\">",
"      Sigmon SC. Characterizing the emerging population of prescription opioid abusers. Am J Addict 2006; 15:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3784/abstract/16\">",
"      Oppenheimer E, Tobutt C, Taylor C, Andrew T. Death and survival in a cohort of heroin addicts from London clinics: a 22-year follow-up study. Addiction 1994; 89:1299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3784/abstract/17\">",
"      Gibson A, Degenhardt L, Mattick RP, et al. Exposure to opioid maintenance treatment reduces long-term mortality. Addiction 2008; 103:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3784/abstract/18\">",
"      Paulozzi LJ, Xi Y. Recent changes in drug poisoning mortality in the United States by urban-rural status and by drug type. Pharmacoepidemiol Drug Saf 2008; 17:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3784/abstract/19\">",
"      Wysowski DK. Surveillance of prescription drug-related mortality using death certificate data. Drug Saf 2007; 30:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3784/abstract/20\">",
"      McCabe SE, Cranford JA, West BT. Trends in prescription drug abuse and dependence, co-occurrence with other substance use disorders, and treatment utilization: results from two national surveys. Addict Behav 2008; 33:1297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3784/abstract/21\">",
"      Wysowski DK, Nourjah P. Analyzing prescription drugs as causes of death on death certificates.. Public Health Rep 2004; 119:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3784/abstract/22\">",
"      de Paula M, Saiz LC, Gonz&aacute;lez-Revalder&iacute;a J, et al. Rifampicin causes false-positive immunoassay results for urine opiates. Clin Chem Lab Med 1998; 36:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3784/abstract/23\">",
"      Baden LR, Horowitz G, Jacoby H, Eliopoulos GM. Quinolones and false-positive urine screening for opiates by immunoassay technology. JAMA 2001; 286:3115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3784/abstract/24\">",
"      Pettitt BC Jr, Dyszel SM, Hood LV. Opiates in poppy seed: effect on urinalysis results after consumption of poppy seed cake-filling. Clin Chem 1987; 33:1251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3784/abstract/25\">",
"      Gr&ouml;nbladh L, Ohlund LS, Gunne LM. Mortality in heroin addiction: impact of methadone treatment. Acta Psychiatr Scand 1990; 82:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3784/abstract/26\">",
"      Degenhardt, L, Randall, D, Hall, W, et al. Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: Risk factors and lives saved. Drug Alcohol Depend 2009; :.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3784/abstract/27\">",
"      Howe CJ, Fuller CM, Ompad DC, et al. Association of sex, hygiene and drug equipment sharing with hepatitis C virus infection among non-injecting drug users in New York City. Drug Alcohol Depend 2005; 79:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3784/abstract/28\">",
"      Tortu S, McMahon JM, Pouget ER, Hamid R. Sharing of noninjection drug-use implements as a risk factor for hepatitis C. Subst Use Misuse 2004; 39:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3784/abstract/29\">",
"      McMahon JM, Tortu S. A potential hidden source of hepatitis C infection among noninjecting drug users. J Psychoactive Drugs 2003; 35:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3784/abstract/30\">",
"      Grunkemeier DM, Cassara JE, Dalton CB, Drossman DA. The narcotic bowel syndrome: clinical features, pathophysiology, and management. Clin Gastroenterol Hepatol 2007; 5:1126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3784/abstract/31\">",
"      Drossman DA, Morris CB, Edwards H, et al. Diagnosis, characterization, and 3-month outcome after detoxification of 39 patients with narcotic bowel syndrome. Am J Gastroenterol 2012; 107:1426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3784/abstract/32\">",
"      Gasche, Y. N Engl J Med 2004;351:2827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3784/abstract/33\">",
"      Reece AS. Experience of road and other trauma by the opiate dependent patient: a survey report. Subst Abuse Treat Prev Policy 2008; 3:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3784/abstract/34\">",
"      Skurtveit S, Christophersen AS, Grung M, M&oslash;rland J. Increased mortality among previously apprehended drunken and drugged drivers. Drug Alcohol Depend 2002; 68:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3784/abstract/35\">",
"      Baewert A, Gombas W, Schindler SD, et al. Influence of peak and trough levels of opioid maintenance therapy on driving aptitude. Eur Addict Res 2007; 13:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3784/abstract/36\">",
"      Moore MH. Policies to achieve discrimination on the effective price of heroin. Am Econ Rev 1973; 63:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3784/abstract/37\">",
"      Johnson BD, Golub A. The potential for accurately measuring behavioral and economic dimensions of consumption, prices, and markets for illegal drugs. Drug Alcohol Depend 2007; 90S:S16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3784/abstract/38\">",
"      Weatherburn D, Lind B. The impact of law enforcement activity on a heroin market. Addiction 1997; 92:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3784/abstract/39\">",
"      McCabe SE, Cranford JA, Boyd CJ, Teter CJ. Motives, diversion and routes of administration associated with nonmedical use of prescription opioids. Addict Behav 2007; 32:562.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7804 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-183.1.191.153-22FFA76FCA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_44_3784=[""].join("\n");
var outline_f3_44_3784=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      MECHANISM OF ACTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      OPIOID ABUSE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Heroin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Names and routes of administration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Other opioids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Overdose",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Detection in drug screens",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H116843663\">",
"      Medical consequences",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Other consequences",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      HISTORY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      PHYSICAL EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      LABORATORY EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PSYCH/7804\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PSYCH/7804|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/57/25499\" title=\"table 1\">",
"      Urine test drugs of abuse",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/17/21783?source=related_link\">",
"      Cannabis use disorders: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/28/4554?source=related_link\">",
"      Cannabis use disorders: Treatment, prognosis, and long-term medical effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/12/32970?source=related_link\">",
"      Cocaine abuse and dependence in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/7/2169?source=related_link\">",
"      Epidemiology and transmission of hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14840?source=related_link\">",
"      Epidemiology, risk factors and microbiology of infective endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/46/42726?source=related_link\">",
"      Hematogenous osteomyelitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/34/44584?source=related_link\">",
"      Intoxication from LSD and other common hallucinogens",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/51/3897?source=related_link\">",
"      Opioid intoxication in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/5/28758?source=related_link\">",
"      Opioid withdrawal in the emergency setting",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/49/22293?source=related_link\">",
"      Peptide hormone signal transduction and regulation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/43/36535?source=related_link\">",
"      Prescription drug abuse and addiction: Clinical features, epidemiology, and contributing factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/51/43831?source=related_link\">",
"      Skin abscesses, furuncles, and carbuncles",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/58/5033?source=related_link\">",
"      Substance use disorders: Principles for recognition and assessment in general medical care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/52/29514?source=related_link\">",
"      Treatment of opioid abuse and dependence",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_44_3785="ECG atrial flutter tutorial";
var content_f3_44_3785=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F82303&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F82303&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1049px;\">",
"  <div class=\"figure\" style=\"width: 479px\">",
"   <div class=\"ttl\">",
"    Single lead electrocardiogram (ECG) showing atrial flutter",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 459px; height: 178px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The atrial rate in this tracing of atrial waves is 300 beats per minute and the flutter waves, which are \"saw toothed,\" are uniform in morphology, amplitude, and cycle length. Impulse conduction to the ventricles is dependent upon the electrophysiologic characteristics of the atrioventricular node. Most commonly, every other atrial impulse is conducted and there is 2:1 block. However, when conduction through the atrioventricular node is impaired as a result of underlying disease, drugs, or increased vagal tone, there may be higher degrees of block which may be variable, resulting in a regularly irregular ventricular rate.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal rhythm strip",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 165px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal rhythm strip in lead II. The PR interval is 0.15 sec and the QRS duration is 0.08 sec. Both the P and T waves are upright.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Morton F Arnsdorf, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_44_3785=[""].join("\n");
var outline_f3_44_3785=null;
var title_f3_44_3786="Moyamoya disease: Etiology, clinical features, and diagnosis";
var content_f3_44_3786=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Moyamoya disease: Etiology, clinical features, and diagnosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/44/3786/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/44/3786/contributors\">",
"     Nijasri Charnnarong Suwanwela, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/44/3786/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/44/3786/contributors\">",
"     Jose Biller, MD, FACP, FAAN, FAHA",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/44/3786/contributors\">",
"     Douglas R Nordli, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/44/3786/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/44/3786/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?3/44/3786/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 6, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Moyamoya disease is a unique chronic progressive cerebrovascular disease characterized by bilateral stenosis or occlusion of the arteries around the circle of Willis with prominent arterial collateral circulation. \"Moyamoya\" is a Japanese word meaning puffy, obscure, or hazy like a puff of smoke in the air. Thus, the term was used to describe the smoky angiographic appearance of the vascular collateral network [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Moyamoya disease was first described in Japan in 1957. Many similar cases have subsequently been reported, mainly in Japan and other Asian countries. The disease is found less frequently in North America and Europe.",
"   </p>",
"   <p>",
"    This topic will review the etiology and clinical aspects of moyamoya disease. Prognosis and treatment are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/36/7751?source=see_link\">",
"     \"Moyamoya disease: Prognosis and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The etiology of moyamoya disease is unknown. The high incidence among the Japanese and Asian population, together with a familial occurrence of approximately 10 percent of cases, strongly suggests a genetic etiology.",
"   </p>",
"   <p>",
"    Accumulating evidence suggests that the RNF213 gene on chromosome 17q25.3 is an important susceptibility factor for MMD in East Asian populations [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/3-8\">",
"     3-8",
"    </a>",
"    ]. As an example, a report from Japan found that the c.14576G&gt;A variant of RNF213 was present in 95 percent of 41 patients with familial MMD, 79 percent of 163 patients with sporadic MMD, and 2 percent of 283 normal control subjects [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/5\">",
"     5",
"    </a>",
"    ]. Other studies have linked familial moyamoya disease to chromosomes 3p24.2-p26, 6q25, 8q23, and 12p12 [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/9-11\">",
"     9-11",
"    </a>",
"    ]. Although the mode of inheritance is not established, one study suggested that familial moyamoya is an autosomal dominant disease with incomplete penetrance [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/12\">",
"     12",
"    </a>",
"    ]. The authors proposed that genomic imprinting and epigenetic modification may account for the predominantly maternal transmission and elevated female to male incidence ratio. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Epidemiology'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/38/21097?source=see_link&amp;anchor=H1497302#H1497302\">",
"     \"Basic principles of genetic disease\", section on 'Imprinting'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several alleles of class II genes of the human leukocyte antigen (HLA) have been associated with moyamoya disease [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/13\">",
"     13",
"    </a>",
"    ]. High levels of fibroblast growth factor, which may stimulate arterial growth, have been found in the vascular intima, media, and smooth muscle, as well as cerebrospinal fluid among patients with moyamoya [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. Transforming growth factor beta-1, which mediates neovascularization, may also contribute to the pathogenesis of the disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. High levels of hepatocyte growth factor, a strong inducer of angiogenesis, have been detected in the carotid fork and cerebrospinal fluid in patients with moyamoya disease [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An association between upper respiratory tract infection, especially tonsillitis, and moyamoya disease has been observed, suggesting the possibility of autoimmune disease. However, the absence of immune complexes on blood vessel walls argues against this hypothesis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Associated conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Classic angiographic findings of moyamoya vessels have been demonstrated in patients with other medical conditions. This has led some investigators to propose the term \"moyamoya phenomenon\" or \"moyamoya syndrome\" as an entity separate from true idiopathic moyamoya disease.",
"   </p>",
"   <p>",
"    Traditionally, patients with the angiographic appearance of moyamoya and no known risk factors are considered to have moyamoya disease, while those with one of the well-recognized associated conditions (neurofibromatosis type 1, cranial irradiation, Down syndrome, and sickle cell disease) are classified as having moyamoya syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some of the conditions associated with moyamoya include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Atherosclerosis [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/20\">",
"       20",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Infectious diseases",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Meningitis [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/21\">",
"       21",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Other viral or bacterial infection (eg, Propionibacterium acnes, leptospirosis, HIV) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/22,23\">",
"       22,23",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hematologic conditions",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Sickle cell disease [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/24-26\">",
"       24-26",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Beta thalassemia [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/27\">",
"       27",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Fanconi anemia [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/28\">",
"       28",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Hereditary spherocytosis [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/29\">",
"       29",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Homocystinuria and hyperhomocysteinemia [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/30\">",
"       30",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Factor XII deficiency [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/31\">",
"       31",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Essential thrombocythemia [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/32\">",
"       32",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Vasculitis and autoimmune diseases",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Systemic lupus erythematosus [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/33\">",
"       33",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Polyarteritis nodosa and postinfectious vasculopathy [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/34\">",
"       34",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Graves' disease [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/35-37\">",
"       35-37",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Sneddon syndrome and the antiphospholipid antibody syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/38,39\">",
"       38,39",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Anti-Ro and anti-La antibodies [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/40\">",
"       40",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Connective tissue disorders and neurocutaneous syndromes",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Neurofibromatosis type 1 (NF1) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/41-43\">",
"       41-43",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Tuberous sclerosis [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/44\">",
"       44",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Sturge-Weber syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/45\">",
"       45",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Phakomatosis pigmentovascularis type IIIb [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/46\">",
"       46",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Hypomelanosis of Ito [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/47\">",
"       47",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Pseudoxanthoma elasticum [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/48\">",
"       48",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Marfan syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/49\">",
"       49",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Cavernous malformation [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/50\">",
"       50",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Chromosomal disorders",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Down syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/51,52\">",
"       51,52",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Turner syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/53\">",
"       53",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Alagille syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/54,55\">",
"       54,55",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Other vasculopathies",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Vasospasm after subarachnoid hemorrhage [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/56\">",
"       56",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Radiation therapy to the base of the brain (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/22/37226?source=see_link&amp;anchor=H29#H29\">",
"       \"Complications of cranial irradiation\", section on 'Cerebrovascular effects'",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/57\">",
"       57",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Fibromuscular dysplasia [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/58\">",
"       58",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Other extracranial cardiovascular diseases",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Congenital heart disease [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/59\">",
"       59",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Williams syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/60\">",
"       60",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Coarctation of the aorta [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/61\">",
"       61",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Renal artery stenosis [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/62\">",
"       62",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Metabolic diseases",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Type I glycogenosis [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/63,64\">",
"       63,64",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Hyperphosphatasia [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/65\">",
"       65",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Primary oxalosis [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/66\">",
"       66",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cranial trauma [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/67\">",
"       67",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Brain tumors [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/68-70\">",
"       68-70",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Pulmonary sarcoidosis [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/71,72\">",
"       71,72",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Hereditary multisystem disorder with short stature, hypergonadotropic hypogonadism, and dysmorphism [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/73\">",
"       73",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Polycystic kidney disease [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/74-76\">",
"       74-76",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In epidemiologic surveys conducted in Japan, the following observations have been made [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/77-79\">",
"     77-79",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The annual incidence of moyamoya is 0.35 to 0.94 per 100,000 population",
"     </li>",
"     <li>",
"      The prevalence of moyamoya is 3.2 to 10.5 per 100,000 population",
"     </li>",
"     <li>",
"      There is a female predominance, with a male-to-female ratio of 1:1.8 to 1:2.2",
"     </li>",
"     <li>",
"      A family history of moyamoya disease is present in 10.0 to 15.4 percent of patients",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A study that analyzed hospital discharge data from Washington and California in the western United States found an estimated overall moyamoya incidence (combined idiopathic moyamoya disease and moyamoya syndrome) of 0.086 per 100,000, lower than in Japan [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/80\">",
"     80",
"    </a>",
"    ]. Among ethnic groups in California, the moyamoya incidence rate for Asians was 0.28 per 100,000, similar to the incidence in Japan. The incidence rates were lower for blacks, whites, and Hispanics (0.13, 0.06, and 0.03 per 100,000, respectively).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Age distribution",
"    </span>",
"    &nbsp;&mdash;&nbsp;Moyamoya disease and moyamoya syndrome occur in children and adults of all ages, although presentation in infancy is rare [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/81\">",
"     81",
"    </a>",
"    ]. Data from Japan regarding the peak age of moyamoya disease onset are conflicting. A study published in 1995 found a major peak in the 10 to 14 year old age group and a lesser peak in the 40 to 49 year old group [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/77\">",
"     77",
"    </a>",
"    ]. In contrast, a report published in 2008 found a major peak in the 45 to 49 year old group and a lesser peak in the 5 to 9 year old group [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/79\">",
"     79",
"    </a>",
"    ]. Methodologic differences between studies and improved clinical detection over time may, at least in part, account for the apparent change in age distribution of moyamoya in Japan. A cohort study of 802 patients with moyamoya disease from China also demonstrated a bimodal age distribution, with a major peak in the 5 to 9 year old group and another peak in the 35 to 39 year old group [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical manifestations of moyamoya are variable and include transient ischemic attack (TIA), ischemic stroke, hemorrhagic stroke, and epilepsy. The expression of disease may differ by age at the time of diagnosis.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Ischemic cerebrovascular events, either TIA or infarction, are more prevalent than hemorrhagic events in children",
"     </li>",
"     <li>",
"      Hemorrhagic stroke (mainly intraparenchymal and intraventricular hemorrhage) is more common in adults",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These points are illustrated by the results of a study from Japan that found that children (ages 0 to 9 years old) with moyamoya disease presented with ischemic events in 77 percent of cases, while intracerebral hemorrhage was observed in only 5 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/83\">",
"     83",
"    </a>",
"    ]. In contrast, adult patients with moyamoya presented with intracerebral hemorrhage in 69 percent of cases, while ischemic stroke and TIA were found in 27 percent. The rate of epilepsy was also more frequent in children than in adults (25 and 5 percent, respectively). A report from Korea noted that hemorrhagic stroke in moyamoya disease often presents as intraventricular hemorrhage with or without intraparenchymal hemorrhage [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/84\">",
"     84",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Unlike the data from Asia, a retrospective study from Germany of 21 white patients with idiopathic moyamoya disease found that all presented with ischemic events, including 16 who were adults at symptom onset [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/85\">",
"     85",
"    </a>",
"    ]. Only one hemorrhagic stroke (a subarachnoid hemorrhage) occurred during a mean follow-up of 3.7 years. While small patient numbers prevent definitive conclusions, the study suggests that the clinical expression of idiopathic moyamoya disease differs between Asians and Caucasians.",
"   </p>",
"   <p>",
"    Among symptomatic patients with moyamoya disease, some have only one or a few events, while others have multiple recurrences. In a study from Korea with 88 patients (36 of whom had revascularization surgery) from 1 to 75 years of age at presentation who were followed for 6 to 216 months, the following outcomes were reported [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/86\">",
"     86",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A single ischemic or hemorrhagic cerebrovascular episode was noted in 40 patients (45 percent).",
"     </li>",
"     <li>",
"      Recurrent ischemic and hemorrhagic cerebrovascular events occurred in 48 patients (55 percent). Recurrences included ischemic events (TIA",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      infarction) in 37 patients, ischemic and hemorrhagic events in 9, and multiple hemorrhages in 2.",
"     </li>",
"     <li>",
"      The most frequent neurologic deficit was hemiparesis in 64 percent of cases. Additional common sequelae were aphasia, seizure, altered mentation, and visual disturbance.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In children, symptomatic episodes of ischemia may be triggered by exercise, crying, coughing, straining, fever, or hyperventilation [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/87,88\">",
"     87,88",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are case reports of patients with moyamoya who develop dystonia, chorea, or dyskinesia, but these appear to be uncommon manifestations of moyamoya [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/89-91\">",
"     89-91",
"    </a>",
"    ]. Rare patients with moyamoya disease have morning glory optic disc anomaly (",
"    <a class=\"graphic graphic_picture graphicRef55325 \" href=\"UTD.htm?39/31/40433\">",
"     picture 1",
"    </a>",
"    ), usually in conjunction with other craniofacial abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/92-94\">",
"     92-94",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/47/6906?source=see_link&amp;anchor=H9#H9\">",
"     \"Congenital anomalies and acquired abnormalities of the optic nerve\", section on 'Morning glory disc'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The prognosis of moyamoya disease is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/36/7751?source=see_link&amp;anchor=H2#H2\">",
"     \"Moyamoya disease: Prognosis and treatment\", section on 'Natural history and prognosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Suzuki stages",
"    </span>",
"    &nbsp;&mdash;&nbsp;Suzuki and colleagues followed patients with moyamoya disease and classified the angiographic progression into six stages [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Stage 1 - Narrowing of carotid fork only",
"     </li>",
"     <li>",
"      Stage 2 - Initiation of basal moyamoya with dilatation of all main cerebral arteries",
"     </li>",
"     <li>",
"      Stage 3 - Intensification of moyamoya together with reduction of flow in the middle and anterior cerebral arteries",
"     </li>",
"     <li>",
"      Stage 4 - Minimization of moyamoya vessels; the proximal portions of the posterior cerebral arteries become involved",
"     </li>",
"     <li>",
"      Stage 5 - Reduction of moyamoya and absence of all main cerebral arteries",
"     </li>",
"     <li>",
"      Stage 6 - Disappearance of moyamoya vessels; the cerebral circulation is supplied only by the external carotid system",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     NEUROIMAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Head CT",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    brain MRI are important studies for the detection of brain infarction and hemorrhage in patients with moyamoya. Noninvasive and conventional angiographic studies can demonstrate stenosis or occlusion of the Circle of Willis vessels. Transcranial Doppler ultrasonography is a noninvasive way to evaluate intracranial hemodynamics and large artery stenosis. A number of methods may be useful to estimate resting brain perfusion and blood flow reserve.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Head CT",
"    </span>",
"    &nbsp;&mdash;&nbsp;On CT scan, infarction may involve cortical and subcortical regions (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef74421 \" href=\"UTD.htm?28/52/29506\">",
"     image 1",
"    </a>",
"    ). Dilatation of the sulci, accompanied by focal ventricular enlargement indicating volume loss, is usually found in the chronic phase of disease. In a retrospective series of 32 adults with MMD and first-ever ischemic stroke, patients with early stage MMD (ie, Suzuki stage 1 or 2) had ischemic lesions on brain MRI involving only deep subcortical structures, while those with advanced stage MMD (ie, Suzuki stage 3 or higher) had predominantly cortical lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/95\">",
"     95",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Suzuki stages'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In patients with parenchymal hemorrhage, cranial CT usually shows a high density area indicating blood in the basal ganglia, thalamus,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    ventricular system (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef66683 \" href=\"UTD.htm?8/51/9010\">",
"     image 2",
"    </a>",
"    ). Bleeding in the cortical and subcortical regions has been reported with lower frequency [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/96,97\">",
"     96,97",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Brain MRI",
"    </span>",
"    &nbsp;&mdash;&nbsp;Brain MRI, particularly diffusion and perfusion MR techniques, is superior to CT scan for detection of small",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    acute ischemic brain lesions. In some cases, dilated collateral vessels in the basal ganglia and thalamus can be demonstrated as multiple punctate flow voids, a finding which is considered virtually diagnostic of moyamoya syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/19\">",
"     19",
"    </a>",
"    ]. Gradient echo (T2*) MRI sequences may detect asymptomatic cerebral microbleeds [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/98\">",
"     98",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In patients with moyamoya, both fluid-attenuated inversion recovery (FLAIR) images and post contrast T1 images may show a linear pattern of increased signal in the leptomeninges and perivascular spaces [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/99,100\">",
"     99,100",
"    </a>",
"    ]. This pattern has been termed the \"ivy sign\", since it resembles the appearance of ivy creeping on stones [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/99\">",
"     99",
"    </a>",
"    ]. The probable cause is slow retrograde collateral flow through engorged pial vessels via leptomeningeal anastomosis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/100,101\">",
"     100,101",
"    </a>",
"    ]. Observational data suggest the ivy sign is correlated with decreased cerebrovascular reserve [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/102\">",
"     102",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Angiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;MR angiography (MRA) can demonstrate stenotic or occlusive lesions in the distal internal carotid arteries (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef51947 \" href=\"UTD.htm?11/62/12256\">",
"     image 3",
"    </a>",
"    ) and the arteries around the circle of Willis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/103,104\">",
"     103,104",
"    </a>",
"    ]. In addition, MRA can visualize the collateral \"moyamoya vessels\" in the basal region (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef80530 \" href=\"UTD.htm?23/34/24105\">",
"     image 4",
"    </a>",
"    ), although it is less sensitive to smaller vessel occlusion than conventional cerebral angiography. Nevertheless, due to its high diagnostic yield and noninvasive nature, MRA has supplanted conventional angiography in most centers as the primary imaging modality to evaluate moyamoya syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/19,104\">",
"     19,104",
"    </a>",
"    ]. CT angiography (CTA) can also noninvasively demonstrate the abnormal vessels of moyamoya disease, including the collateral moyamoya vessels in the basal ganglia [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/105\">",
"     105",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although now used less frequently than MRA and CTA, conventional cerebral angiography is the gold standard for the diagnosis of moyamoya disease. Characteristic angiographic findings include stenosis or occlusion at the distal internal carotid artery and the origin of the anterior cerebral and middle cerebral arteries on both sides, and abnormal vascular networks at the basal ganglia or moyamoya vessels (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef74421 \" href=\"UTD.htm?28/52/29506\">",
"     image 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef66683 \" href=\"UTD.htm?8/51/9010\">",
"     image 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The Suzuki angiographic stages of moyamoya disease are discussed above. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Suzuki stages'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In adults who presented with intracerebral or intraventricular hemorrhage, small aneurysms in the periventricular area have been reported (",
"    <a class=\"graphic graphic_picture graphicRef64850 \" href=\"UTD.htm?13/34/13857\">",
"     picture 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Hemodynamic studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transcranial Doppler ultrasonography (TCD) provides a noninvasive way to evaluate intracranial hemodynamics by measuring blood flow velocity in large intracranial vessels at the circle of Willis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/19\">",
"     19",
"    </a>",
"    ]. Since the mean velocity of blood flow is inversely related to arterial diameter, TCD can also detect arterial occlusive disease; a focal increase in velocity usually suggests large artery stenosis.",
"   </p>",
"   <p>",
"    In patients with suspected moyamoya disease, TCD has been used in the initial evaluation of moyamoya disease, and serial TCD studies have been used to follow changes in blood flow over time [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/19,106,107\">",
"     19,106,107",
"    </a>",
"    ]. One of the most widespread applications of this method is in patients with sickle cell disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/11/31930?source=see_link&amp;anchor=H5#H5\">",
"     \"Cerebrovascular complications of sickle cell disease\", section on 'Predicting risk'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although supporting evidence is limited, additional methods that may be useful to determine the extent of inadequate resting brain perfusion and blood flow reserve in patients with moyamoya disease prior to and after treatment include the following [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/19,108-113\">",
"     19,108-113",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Perfusion CT",
"     </li>",
"     <li>",
"      Xenon-enhanced CT",
"     </li>",
"     <li>",
"      Perfusion-weighted MRI",
"     </li>",
"     <li>",
"      Positron emission tomography (PET)",
"     </li>",
"     <li>",
"      Single-photon emission CT (SPECT) with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5752?source=see_link\">",
"       acetazolamide",
"      </a>",
"      challenge",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     PATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Brain tissue of patients with moyamoya disease usually reveals evidence of prior stroke. However, the cause of death in most autopsy cases is intracerebral hemorrhage [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/114\">",
"     114",
"    </a>",
"    ]. The hemorrhage is commonly found in the basal ganglia, thalamus, hypothalamus, midbrain,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    periventricular region. Bleeding into the intraventricular space is frequently observed. Multiple areas of cerebral infarction and focal cortical atrophy are commonly found.",
"   </p>",
"   <p>",
"    Although large vessel stenosis and occlusion are the hallmark of this disease, extensive territorial infarction is uncommon. The brain infarcts are generally small and located in the basal ganglia, internal capsule, thalamus, and subcortical regions [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/115\">",
"     115",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Vascular stenosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pathologic vascular lesions appear in the large vessels of the circle of Willis and in the small collateral vessels [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/116\">",
"     116",
"    </a>",
"    ]. Bilateral concentric stenosis or occlusion is consistently found in the distal internal carotid arteries and the proximal anterior and middle cerebral arteries. Less frequently, the posterior circulation is affected, especially the posterior cerebral artery.",
"   </p>",
"   <p>",
"    In the large arteries, variable stenosis or occlusion is associated with the following microscopic features [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/117-119\">",
"     117-119",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Fibrocellular thickening of the intima",
"     </li>",
"     <li>",
"      Tortuosity",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      duplication or triplication of the internal elastic lamina",
"     </li>",
"     <li>",
"      Attenuation of the media",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As an example, one study found that specimens of the middle cerebral artery from patients with moyamoya (n = 25) had significantly thinner media and thicker intima than those from control subjects (n = 6) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/120\">",
"     120",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The pathology of the smaller perforating vessels in moyamoya is variable. Morphometric analysis suggests that some are dilated with relatively thin walls, while others are stenotic with thick walls [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/117\">",
"     117",
"    </a>",
"    ]. Dilated vessels, more common in younger patients than in adults, tend to show fibrosis with attenuation of the media, and microaneurysm formation. Stenotic vessels tend to have intimal thickening and duplication of the elastic lamina.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Collateral vessels",
"    </span>",
"    &nbsp;&mdash;&nbsp;One of the hallmarks of moyamoya disease is the presence of a collateral meshwork of overgrown and dilated small arteries, the moyamoya vessels, that branch from the circle of Willis.",
"   </p>",
"   <p>",
"    Leptomeningeal vessels are another source of collaterals in moyamoya (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef59381 \" href=\"UTD.htm?33/55/34678\">",
"     image 5",
"    </a>",
"    ). As a result of intracranial internal carotid artery stenosis, leptomeningeal anastomoses may develop among the three main cerebral arteries (middle, anterior, and posterior). These collaterals result from dilatation of preexisting arteries and veins. In addition, transdural anastomoses, termed vault moyamoya, may develop from extracranial arteries such as the middle meningeal and superficial temporal arteries [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/121\">",
"     121",
"    </a>",
"    ]. Ethmoidal moyamoya is the term applied when the collateral network involves primarily the frontobasal region, derived from the ophthalmic artery and the posterior and anterior ethmoidal arteries.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Aneurysms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cerebral aneurysms have been associated with moyamoya disease in a number of reports [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/122-126\">",
"     122-126",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Large artery aneurysms can develop at vessel branching points in the circle of Willis and cause subarachnoid hemorrhage when they rupture. In patients with unilateral moyamoya, these aneurysms are found most commonly in the anterior communicating",
"      <span class=\"nowrap\">",
"       artery/anterior",
"      </span>",
"      cerebral artery complex [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/127\">",
"       127",
"      </a>",
"      ]. In patients with bilateral moyamoya, aneurysms are more often located in the basilar artery [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/127\">",
"       127",
"      </a>",
"      ]. Histologic study from autopsy specimens of large artery aneurysms showed disappearance of internal elastic lamina and media [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/128\">",
"       128",
"      </a>",
"      ]. These findings are similar to those of the berry aneurysm commonly observed in primary subarachnoid hemorrhage.",
"     </li>",
"     <li>",
"      Aneurysms can also arise from the small collateral moyamoya vessels, choroidal arteries, or other peripheral collateral arteries [",
"      <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/127\">",
"       127",
"      </a>",
"      ]. These small vessel aneurysms are the major cause of parenchymal (intracerebral) hemorrhage in moyamoya disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Extracranial involvement",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with moyamoya disease, stenosis due to fibrocellular intimal thickening may also affect the extracranial and systemic arteries, including the cervical carotid, renal, pulmonary, and coronary vessels [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/118,129\">",
"     118,129",
"    </a>",
"    ]. Involvement of the renal arteries has been most frequently reported. In one study of 86 patients with moyamoya, six (7 percent) had renal artery stenosis, two had associated renovascular hypertension, and one had a renal artery aneurysm [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/62\">",
"     62",
"    </a>",
"    ]. Similarly, in a later study of 73 consecutive patients with moyamoya, four (5 percent) had renal artery stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/130\">",
"     130",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of moyamoya disease is based upon the characteristic angiographic appearance of bilateral stenoses affecting the distal internal carotid arteries and proximal circle of Willis vessels, along with the presence of prominent basal collateral vessels.",
"   </p>",
"   <p>",
"    Repeated ischemic attacks resulting from low perfusion in the same arterial territory,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    intracerebral hemorrhage in the region of the caudate, or intraventricular hemorrhage within the lateral ventricles, are patterns suggestive of moyamoya disease. However, some patients are clinically asymptomatic. Definitive diagnosis requires neurovascular imaging.",
"   </p>",
"   <p>",
"    Moyamoya disease is one of the differential diagnoses of stroke in children or young adults. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/61/23513?source=see_link&amp;anchor=H18#H18\">",
"     \"Ischemic stroke in children and young adults: Etiology and clinical features\", section on 'Differential diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Diagnostic criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnostic criteria for idiopathic moyamoya disease proposed by a Japanese research committee include the following major requirements [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/131\">",
"     131",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Stenosis or occlusion at the terminal portion of the internal carotid artery and at the proximal portion of the anterior and middle cerebral arteries on magnetic resonance angiography (MRA)",
"     </li>",
"     <li>",
"      Abnormal vascular networks in the basal ganglia on MRA; these networks can also be diagnosed by the presence of multiple flow voids on brain MRI",
"     </li>",
"     <li>",
"      Angiographic findings are present bilaterally; cases with unilateral angiographic findings are considered probable",
"     </li>",
"     <li>",
"      The following conditions should be excluded:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Arteriosclerosis",
"     </li>",
"     <li>",
"      Autoimmune disease",
"     </li>",
"     <li>",
"      Brain neoplasm",
"     </li>",
"     <li>",
"      A history of cranial irradiation",
"     </li>",
"     <li>",
"      Down syndrome",
"     </li>",
"     <li>",
"      Head trauma",
"     </li>",
"     <li>",
"      Neurofibromatosis",
"     </li>",
"     <li>",
"      Meningitis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The diagnostic criteria for conventional cerebral angiography are similar to those for MRA [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/131\">",
"     131",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Screening studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Indications for angiographic screening studies in family members of patients with moyamoya are not well defined. The 2008 AHA Stroke Council guidelines state that there is insufficient evidence to justify screening studies in asymptomatic individuals or in relatives of patients with moyamoya syndrome in the absence of a strong family history of moyamoya disease or medical conditions that predispose to moyamoya syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?3/44/3786/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Even in individuals with a strong family history of moyamoya disease or those with medical conditions that predispose to moyamoya syndrome, the utility of angiographic screening is unclear, particularly since available medical and surgical treatment of asymptomatic moyamoya disease is of uncertain benefit.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Moyamoya disease is a unique chronic progressive cerebrovascular disease characterized by bilateral stenosis or occlusion of the arteries around the circle of Willis with prominent arterial collateral circulation.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The etiology of moyamoya disease is unknown. The high incidence among the Japanese and Asian population, together with a familial occurrence of approximately 10 percent of cases, strongly suggests a genetic etiology. Accumulating evidence suggests that the RNF213 gene on chromosome 17q25.3 is an important susceptibility factor for moyamoya disease in East Asian populations. Patients with the angiographic appearance of moyamoya and no known risk factors are considered to have moyamoya disease, while those with one of the well-recognized associated conditions (neurofibromatosis type 1, cranial irradiation, Down syndrome, and sickle cell disease) are classified as having moyamoya syndrome. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Ischemic cerebrovascular events, either TIA or infarction, are more prevalent than hemorrhagic events in children with moyamoya, while hemorrhagic stroke is more common in adults. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cranial CT",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      MRI are useful for the detection of brain infarction and hemorrhage in patients with moyamoya. Vascular imaging with MRA, CTA, or conventional catheter angiography is essential to demonstrate stenotic or occlusive lesions in the distal internal carotid arteries and the arteries around the circle of Willis. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Neuroimaging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Transcranial Doppler ultrasonography (TCD) provides a noninvasive way to evaluate intracranial hemodynamics and large artery stenosis. Perfusion CT, xenon-enhanced CT, perfusion-weighted MRI, PET, and SPECT with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5752?source=see_link\">",
"       acetazolamide",
"      </a>",
"      challenge may be useful to estimate resting brain perfusion and blood flow reserve. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Hemodynamic studies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The pathologic hallmarks of moyamoya are (see",
"      <a class=\"local\" href=\"#H13\">",
"       'Pathology'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Concentric stenosis or occlusion in the distal internal carotid arteries and large vessels of the circle of Willis",
"     </li>",
"     <li>",
"      A collateral meshwork of overgrown and dilated small arteries, the moyamoya vessels, that branch from the circle of Willis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The diagnosis of moyamoya disease is based upon the characteristic angiographic appearance of bilateral stenoses affecting the distal internal carotid arteries and proximal circle of Willis vessels, along with the presence of prominent basal collateral vessels. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/1\">",
"      Suzuki J, Kodama N. Moyamoya disease--a review. Stroke 1983; 14:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/2\">",
"      Suzuki J, Takaku A. Cerebrovascular \"moyamoya\" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969; 20:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/3\">",
"      Kamada F, Aoki Y, Narisawa A, et al. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet 2011; 56:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/4\">",
"      Liu W, Morito D, Takashima S, et al. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One 2011; 6:e22542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/5\">",
"      Miyatake S, Miyake N, Touho H, et al. Homozygous c.14576G&gt;A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology 2012; 78:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/6\">",
"      Yamauchi T, Tada M, Houkin K, et al. Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke 2000; 31:930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/7\">",
"      Mineharu Y, Liu W, Inoue K, et al. Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology 2008; 70:2357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/8\">",
"      Miyawaki S, Imai H, Takayanagi S, et al. Identification of a genetic variant common to moyamoya disease and intracranial major artery stenosis/occlusion. Stroke 2012; 43:3371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/9\">",
"      Ikeda H, Sasaki T, Yoshimoto T, et al. Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet 1999; 64:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/10\">",
"      Inoue TK, Ikezaki K, Sasazuki T, et al. Linkage analysis of moyamoya disease on chromosome 6. J Child Neurol 2000; 15:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/11\">",
"      Sakurai K, Horiuchi Y, Ikeda H, et al. A novel susceptibility locus for moyamoya disease on chromosome 8q23. J Hum Genet 2004; 49:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/12\">",
"      Mineharu Y, Takenaka K, Yamakawa H, et al. Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprinting. J Neurol Neurosurg Psychiatry 2006; 77:1025.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/13\">",
"      Inoue TK, Ikezaki K, Sasazuki T, et al. Analysis of class II genes of human leukocyte antigen in patients with moyamoya disease. Clin Neurol Neurosurg 1997; 99 Suppl 2:S234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/14\">",
"      Suzui H, Hoshimaru M, Takahashi JA, et al. Immunohistochemical reactions for fibroblast growth factor receptor in arteries of patients with moyamoya disease. Neurosurgery 1994; 35:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/15\">",
"      Malek AM, Connors S, Robertson RL, et al. Elevation of cerebrospinal fluid levels of basic fibroblast growth factor in moyamoya and central nervous system disorders. Pediatr Neurosurg 1997; 27:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/16\">",
"      Yamamoto M, Aoyagi M, Tajima S, et al. Increase in elastin gene expression and protein synthesis in arterial smooth muscle cells derived from patients with Moyamoya disease. Stroke 1997; 28:1733.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/17\">",
"      Hojo M, Hoshimaru M, Miyamoto S, et al. Role of transforming growth factor-beta1 in the pathogenesis of moyamoya disease. J Neurosurg 1998; 89:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/18\">",
"      Nanba R, Kuroda S, Ishikawa T, et al. Increased expression of hepatocyte growth factor in cerebrospinal fluid and intracranial artery in moyamoya disease. Stroke 2004; 35:2837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/19\">",
"      Roach ES, Golomb MR, Adams R, et al. Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke 2008; 39:2644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/20\">",
"      Lee SJ, Ahn JY. Stenosis of the proximal external carotid artery in an adult with moyamoya disease: moyamoya or atherosclerotic change? Neurol Med Chir (Tokyo) 2007; 47:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/21\">",
"      Czartoski T, Hallam D, Lacy JM, et al. Postinfectious vasculopathy with evolution to moyamoya syndrome. J Neurol Neurosurg Psychiatry 2005; 76:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/22\">",
"      Yamada H, Deguchi K, Tanigawara T, et al. The relationship between moyamoya disease and bacterial infection. Clin Neurol Neurosurg 1997; 99 Suppl 2:S221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/23\">",
"      Sharfstein SR, Ahmed S, Islam MQ, et al. Case of moyamoya disease in a patient with advanced acquired immunodeficiency syndrome. J Stroke Cerebrovasc Dis 2007; 16:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/24\">",
"      Fryer RH, Anderson RC, Chiriboga CA, Feldstein NA. Sickle cell anemia with moyamoya disease: outcomes after EDAS procedure. Pediatr Neurol 2003; 29:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/25\">",
"      Dobson SR, Holden KR, Nietert PJ, et al. Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events. Blood 2002; 99:3144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/26\">",
"      Kirkham FJ, DeBaun MR. Stroke in Children with Sickle Cell Disease. Curr Treat Options Neurol 2004; 6:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/27\">",
"      Marden FA, Putman CM, Grant JM, Greenberg J. Moyamoya disease associated with hemoglobin Fairfax and beta-thalassemia. Pediatr Neurol 2008; 38:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/28\">",
"      Pavlakis SG, Verlander PC, Gould RJ, et al. Fanconi anemia and moyamoya: evidence for an association. Neurology 1995; 45:998.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/29\">",
"      Tokunaga Y, Ohga S, Suita S, et al. Moyamoya syndrome with spherocytosis: effect of splenectomy on strokes. Pediatr Neurol 2001; 25:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/30\">",
"      Cerrato P, Grasso M, Lentini A, et al. Atherosclerotic adult Moya-Moya disease in a patient with hyperhomocysteinaemia. Neurol Sci 2007; 28:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/31\">",
"      Dhopesh VP, Dunn DP, Schick P. Moyamoya and Hageman factor (Factor XII) deficiency in a black adult. Arch Neurol 1978; 35:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/32\">",
"      Kornblihtt LI, Cocorullo S, Miranda C, et al. Moyamoya syndrome in an adolescent with essential thrombocythemia: successful intracranial carotid stent placement. Stroke 2005; 36:E71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/33\">",
"      El Ramahi KM, Al Rayes HM. Systemic lupus erythematosus associated with moyamoya syndrome. Lupus 2000; 9:632.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/34\">",
"      Kendall B. Cerebral angiography in vasculitis affecting the nervous system. Eur Neurol 1984; 23:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/35\">",
"      Sasaki T, Nogawa S, Amano T. Co-morbidity of moyamoya disease with Graves' disease. report of three cases and a review of the literature. Intern Med 2006; 45:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/36\">",
"      Im SH, Oh CW, Kwon OK, et al. Moyamoya disease associated with Graves disease: special considerations regarding clinical significance and management. J Neurosurg 2005; 102:1013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/37\">",
"      Kushima K, Satoh Y, Ban Y, et al. Graves' thyrotoxicosis and Moyamoya disease. Can J Neurol Sci 1991; 18:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/38\">",
"      Carhuapoma JR, D'Olhaberriague L, Levine SR. Moyamoya syndrome associated with Sneddon's syndrome and antiphospholipid-protein antibodies. J Stroke Cerebrovasc Dis 1999; 8:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/39\">",
"      Bonduel M, Hepner M, Sciuccati G, et al. Prothrombotic disorders in children with moyamoya syndrome. Stroke 2001; 32:1786.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/40\">",
"      Provost TT, Moses H, Morris EL, et al. Cerebral vasculopathy associated with collateralization resembling moya moya phenomenon and with anti-Ro/SS-A and anti-La/SS-B antibodies. Arthritis Rheum 1991; 34:1052.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/41\">",
"      Khan M, Novakovic RL, Rosengart AJ. Intraventricular hemorrhage disclosing neurofibromatosis 1 and moyamoya phenomena. Arch Neurol 2006; 63:1653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/42\">",
"      Horikawa M, Utunomiya H, Hirotaka S, et al. Case of von Recklinghausen disease associated with cerebral infarction. J Child Neurol 1997; 12:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/43\">",
"      Rosser TL, Vezina G, Packer RJ. Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1. Neurology 2005; 64:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/44\">",
"      Imaizumi M, Nukada T, Yoneda S, et al. Tuberous sclerosis with moyamoya disease. Case report. Med J Osaka Univ 1978; 28:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/45\">",
"      Garcia JC, Roach ES, McLean WT. Recurrent thrombotic deterioration in the Sturge-Weber syndrome. Childs Brain 1981; 8:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/46\">",
"      Tsuruta D, Fukai K, Seto M, et al. Phakomatosis pigmentovascularis type IIIb associated with moyamoya disease. Pediatr Dermatol 1999; 16:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/47\">",
"      Rafay MF, Al-Futaisi A, Weiss S, Armstrong D. Hypomelanosis of Ito and Moyamoya disease. J Child Neurol 2005; 20:924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/48\">",
"      Meyer S, Zanardo L, Kaminski WE, et al. Elastosis perforans serpiginosa-like pseudoxanthoma elasticum in a child with severe Moya Moya disease. Br J Dermatol 2005; 153:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/49\">",
"      Terada T, Yokote H, Tsuura M, et al. Marfan syndrome associated with moyamoya phenomenon and aortic dissection. Acta Neurochir (Wien) 1999; 141:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/50\">",
"      Korematsu K, Yoshioka S, Maruyama T, et al. De novo appearance of cerebellar cavernous malformation in a patient with moyamoya disease: case report and review of the literature. Clin Neurol Neurosurg 2007; 109:708.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/51\">",
"      Jea A, Smith ER, Robertson R, Scott RM. Moyamoya syndrome associated with Down syndrome: outcome after surgical revascularization. Pediatrics 2005; 116:e694.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/52\">",
"      de Borchgrave V, Saussu F, Depre A, de Barsy T. Moyamoya disease and Down syndrome: case report and review of the literature. Acta Neurol Belg 2002; 102:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/53\">",
"      Spengos K, Kosmaidou-Aravidou Z, Tsivgoulis G, et al. Moyamoya syndrome in a Caucasian woman with Turner's syndrome. Eur J Neurol 2006; 13:e7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/54\">",
"      Kamath BM, Spinner NB, Emerick KM, et al. Vascular anomalies in Alagille syndrome: a significant cause of morbidity and mortality. Circulation 2004; 109:1354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/55\">",
"      Rocha R, Soro I, Leit&atilde;o A, et al. Moyamoya vascular pattern in Alagille syndrome. Pediatr Neurol 2012; 47:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/56\">",
"      Takeuchi K, Hara M, Yokota H, et al. Factors influencing the development of Moyamoya phenomenon. Acta Neurochir (Wien) 1981; 59:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/57\">",
"      Ullrich NJ, Robertson R, Kinnamon DD, et al. Moyamoya following cranial irradiation for primary brain tumors in children. Neurology 2007; 68:932.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/58\">",
"      de Vries RR, Nikkels PG, van der Laag J, et al. Moyamoya and extracranial vascular involvement: fibromuscular dysplasia? A report of two children. Neuropediatrics 2003; 34:318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/59\">",
"      Lutterman J, Scott M, Nass R, Geva T. Moyamoya syndrome associated with congenital heart disease. Pediatrics 1998; 101:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/60\">",
"      Kawai M, Nishikawa T, Tanaka M, et al. An autopsied case of Williams syndrome complicated by moyamoya disease. Acta Paediatr Jpn 1993; 35:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/61\">",
"      Christiaens FJ, Van den Broeck LK, Christophe C, Dan B. Moyamoya disease (moyamoya syndrome) and coarctation of the aorta. Neuropediatrics 2000; 31:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/62\">",
"      Yamada I, Himeno Y, Matsushima Y, Shibuya H. Renal artery lesions in patients with moyamoya disease: angiographic findings. Stroke 2000; 31:733.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/63\">",
"      Sunder TR. Moyamoya disease in a patient with type I glycogenosis. Arch Neurol 1981; 38:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/64\">",
"      Gouti&egrave;res F, Bourgeois M, Trioche P, et al. Moyamoya disease in a child with glycogen storage disease type Ia. Neuropediatrics 1997; 28:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/65\">",
"      Toku&ccedil; G, Minareci O, Yavuzer D, et al. Moya Moya syndrome in a child with hyperphosphatasia. Pediatr Int 1999; 41:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/66\">",
"      Lammie GA, Wardlaw J, Dennis M. Thrombo-embolic stroke, moya-moya phenomenon and primary oxalosis. Cerebrovasc Dis 1998; 8:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/67\">",
"      Fernandez-Alvarez E, Pineda M, Royo C, Manzanares R. \"Moya-moya' disease caused by cranial trauma. Brain Dev 1979; 1:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/68\">",
"      Kitano S, Sakamoto H, Fujitani K, Kobayashi Y. Moyamoya disease associated with a brain stem glioma. Childs Nerv Syst 2000; 16:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/69\">",
"      Arita K, Uozumi T, Oki S, et al. Moyamoya disease associated with pituitary adenoma--report of two cases. Neurol Med Chir (Tokyo) 1992; 32:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/70\">",
"      Tsuji N, Kuriyama T, Iwamoto M, Shizuki K. Moyamoya disease associated with craniopharyngioma. Surg Neurol 1984; 21:588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/71\">",
"      Kim JS, No YJ. Moyamoya-like vascular abnormality in pulmonary sarcoidosis. Cerebrovasc Dis 2006; 22:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/72\">",
"      Takenaka K, Ito M, Kumagai M, et al. Moyamoya disease associated with pulmonary sarcoidosis--case report. Neurol Med Chir (Tokyo) 1998; 38:566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/73\">",
"      Herv&eacute; D, Touraine P, Verloes A, et al. A hereditary moyamoya syndrome with multisystemic manifestations. Neurology 2010; 75:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/74\">",
"      Pracyk JB, Massey JM. Moyamoya disease associated with polycystic kidney disease and eosinophilic granuloma. Stroke 1989; 20:1092.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/75\">",
"      Nzwalo H, Santos V, Gradil C, et al. Caucasian familial moyamoya syndrome with rare multisystemic malformations. Pediatr Neurol 2013; 48:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/76\">",
"      Peerless SJ. Risk factors of moyamoya disease in Canada and the USA. Clin Neurol Neurosurg 1997; 99 Suppl 2:S45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/77\">",
"      Wakai K, Tamakoshi A, Ikezaki K, et al. Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol Neurosurg 1997; 99 Suppl 2:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/78\">",
"      Kuriyama S, Kusaka Y, Fujimura M, et al. Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke 2008; 39:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/79\">",
"      Baba T, Houkin K, Kuroda S. Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry 2008; 79:900.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/80\">",
"      Uchino K, Johnston SC, Becker KJ, Tirschwell DL. Moyamoya disease in Washington State and California. Neurology 2005; 65:956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/81\">",
"      Amlie-Lefond C, Zaidat OO, Lew SM. Moyamoya disease in early infancy: case report and literature review. Pediatr Neurol 2011; 44:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/82\">",
"      Duan L, Bao XY, Yang WZ, et al. Moyamoya disease in China: its clinical features and outcomes. Stroke 2012; 43:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/83\">",
"      Kitamura, K, Fukui, M, Oka, K, et al. Moyamoya disease. Handbook of Clinical Neurology 1989; 11:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/84\">",
"      Nah HW, Kwon SU, Kang DW, et al. Moyamoya disease-related versus primary intracerebral: hemorrhage location and outcomes are different. Stroke 2012; 43:1947.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/85\">",
"      Kraemer M, Heienbrok W, Berlit P. Moyamoya disease in Europeans. Stroke 2008; 39:3193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/86\">",
"      Choi JU, Kim DS, Kim EY, Lee KC. Natural history of moyamoya disease: comparison of activity of daily living in surgery and non surgery groups. Clin Neurol Neurosurg 1997; 99 Suppl 2:S11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/87\">",
"      Hung CC, Tu YK, Su CF, et al. Epidemiological study of moyamoya disease in Taiwan. Clin Neurol Neurosurg 1997; 99 Suppl 2:S23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/88\">",
"      Battistella PA, Carollo C. Clinical and neuroradiological findings of moyamoya disease in Italy. Clin Neurol Neurosurg 1997; 99 Suppl 2:S54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/89\">",
"      Li JY, Lai PH, Peng NJ. Moyamoya disease presenting with hemichoreoathetosis and hemidystonia. Mov Disord 2007; 22:1983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/90\">",
"      Kim YO, Kim TS, Woo YJ, et al. Moyamoya disease-induced hemichorea corrected by indirect bypass surgery. Pediatr Int 2006; 48:504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/91\">",
"      Baik JS, Lee MS. Movement disorders associated with moyamoya disease: a report of 4 new cases and a review of literatures. Mov Disord 2010; 25:1482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/92\">",
"      Quah BL, Hamilton J, Blaser S, et al. Morning glory disc anomaly, midline cranial defects and abnormal carotid circulation: an association worth looking for. Pediatr Radiol 2005; 35:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/93\">",
"      Komiyama M, Yasui T, Sakamoto H, et al. Basal meningoencephalocele, anomaly of optic disc and panhypopituitarism in association with moyamoya disease. Pediatr Neurosurg 2000; 33:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/94\">",
"      Krishnan C, Roy A, Traboulsi E. Morning glory disk anomaly, choroidal coloboma, and congenital constrictive malformations of the internal carotid arteries (moyamoya disease). Ophthalmic Genet 2000; 21:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/95\">",
"      Kim JM, Lee SH, Roh JK. Changing ischaemic lesion patterns in adult moyamoya disease. J Neurol Neurosurg Psychiatry 2009; 80:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/96\">",
"      Takahashi M, Miyauchi T, Kowada M. Computed tomography of Moyamoya disease: demonstration of occluded arteries and collateral vessels as important diagnostic signs. Radiology 1980; 134:671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/97\">",
"      Handa J, Nakano Y, Okuno T, et al. Computerized tomography in Moyamoya syndrome. Surg Neurol 1977; 7:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/98\">",
"      Kikuta K, Takagi Y, Nozaki K, et al. Asymptomatic microbleeds in moyamoya disease: T2*-weighted gradient-echo magnetic resonance imaging study. J Neurosurg 2005; 102:470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/99\">",
"      Ohta T, Tanaka H, Kuroiwa T. Diffuse leptomeningeal enhancement, \"ivy sign,\" in magnetic resonance images of moyamoya disease in childhood: case report. Neurosurgery 1995; 37:1009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/100\">",
"      Maeda M, Tsuchida C. \"Ivy sign\" on fluid-attenuated inversion-recovery images in childhood moyamoya disease. AJNR Am J Neuroradiol 1999; 20:1836.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/101\">",
"      Chung PW, Park KY. Leptomeningeal enhancement in petients with moyamoya disease: correlation with perfusion imaging. Neurology 2009; 72:1872.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/102\">",
"      Mori N, Mugikura S, Higano S, et al. The leptomeningeal \"ivy sign\" on fluid-attenuated inversion recovery MR imaging in Moyamoya disease: a sign of decreased cerebral vascular reserve? AJNR Am J Neuroradiol 2009; 30:930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/103\">",
"      Hasuo K, Mihara F, Matsushima T. MRI and MR angiography in moyamoya disease. J Magn Reson Imaging 1998; 8:762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/104\">",
"      Yamada I, Nakagawa T, Matsushima Y, Shibuya H. High-resolution turbo magnetic resonance angiography for diagnosis of Moyamoya disease. Stroke 2001; 32:1825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/105\">",
"      Tsuchiya K, Makita K, Furui S. Moyamoya disease: diagnosis with three-dimensional CT angiography. Neuroradiology 1994; 36:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/106\">",
"      Takase K, Kashihara M, Hashimoto T. Transcranial Doppler ultrasonography in patients with moyamoya disease. Clin Neurol Neurosurg 1997; 99 Suppl 2:S101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/107\">",
"      Lee YS, Jung KH, Roh JK. Diagnosis of moyamoya disease with transcranial Doppler sonography: correlation study with magnetic resonance angiography. J Neuroimaging 2004; 14:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/108\">",
"      Takeuchi S, Tanaka R, Ishii R, et al. Cerebral hemodynamics in patients with moyamoya disease. A study of regional cerebral blood flow by the 133Xe inhalation method. Surg Neurol 1985; 23:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/109\">",
"      Ikezaki K, Matsushima T, Kuwabara Y, et al. Cerebral circulation and oxygen metabolism in childhood moyamoya disease: a perioperative positron emission tomography study. J Neurosurg 1994; 81:843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/110\">",
"      Nambu K, Suzuki R, Hirakawa K. Cerebral blood flow: measurement with xenon-enhanced dynamic helical CT. Radiology 1995; 195:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/111\">",
"      Shirane R, Yoshida Y, Takahashi T, Yoshimoto T. Assessment of encephalo-galeo-myo-synangiosis with dural pedicle insertion in childhood moyamoya disease: characteristics of cerebral blood flow and oxygen metabolism. Clin Neurol Neurosurg 1997; 99 Suppl 2:S79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/112\">",
"      Khan N, Yonekawa Y. Moyamoya angiopathy in Europe. Acta Neurochir Suppl 2005; 94:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/113\">",
"      Tanaka Y, Nariai T, Nagaoka T, et al. Quantitative evaluation of cerebral hemodynamics in patients with moyamoya disease by dynamic susceptibility contrast magnetic resonance imaging--comparison with positron emission tomography. J Cereb Blood Flow Metab 2006; 26:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/114\">",
"      Oka K, Yamashita M, Sadoshima S, Tanaka K. Cerebral haemorrhage in Moyamoya disease at autopsy. Virchows Arch A Pathol Anat Histol 1981; 392:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/115\">",
"      Morgenlander JC, Goldstein LB. Recurrent transient ischemic attacks and stroke in association with an internal carotid artery web. Stroke 1991; 22:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/116\">",
"      Carlson CB, Harvey FH, Loop J. Progressive alternating hemiplegia in early childhood and basal arterial stenosis and telangiectasia (moyamoya syndrome). Neurology 1973; 23:734.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/117\">",
"      Yamashita M, Oka K, Tanaka K. Histopathology of the brain vascular network in moyamoya disease. Stroke 1983; 14:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/118\">",
"      Hosoda Y. Pathology of so-called \"spontaneous occlusion of the circle of Willis\". Pathol Annu 1984; 19 Pt 2:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/119\">",
"      Hosoda Y, Ikeda E, Hirose S. Histopathological studies on spontaneous occlusion of the circle of Willis (cerebrovascular moyamoya disease). Clin Neurol Neurosurg 1997; 99 Suppl 2:S203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/120\">",
"      Takagi Y, Kikuta K, Nozaki K, Hashimoto N. Histological features of middle cerebral arteries from patients treated for Moyamoya disease. Neurol Med Chir (Tokyo) 2007; 47:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/121\">",
"      Kodama N, Fujiwara S, Horie Y, et al. [Transdural anastomosis in moyamoya disease--vault moyamoy (author's transl)]. No Shinkei Geka 1980; 8:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/122\">",
"      Kodama N, Suzuki J. Moyamoya disease associated with aneurysm. J Neurosurg 1978; 48:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/123\">",
"      Adams HP Jr, Kassell NF, Wisoff HS, Drake CG. Intracranial saccular aneurysm and moyamoya disease. Stroke 1979; 10:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/124\">",
"      Nagamine Y, Takahashi S, Sonobe M. Multiple intracranial aneurysms associated with moyamoya disease. Case report. J Neurosurg 1981; 54:673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/125\">",
"      Yabumoto M, Funahashi K, Fujii T, et al. Moyamoya disease associated with intracranial aneurysms. Surg Neurol 1983; 20:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/126\">",
"      Konishi Y, Kadowaki C, Hara M, Takeuchi K. Aneurysms associated with moyamoya disease. Neurosurgery 1985; 16:484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/127\">",
"      Herreman, F, Nathal, E, Yasui, N, et al. Intracranial aneurysm in moyamoya disease: report of ten cases and review of the literature. Cerebrovasc Dis 1994; 4:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/128\">",
"      Goldstein M, Hanquinet P, Couvreur Y. [A case of fibromuscular dysplasia in an unusual location]. Acta Chir Belg 1984; 84:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/129\">",
"      Ikeda E. Systemic vascular changes in spontaneous occlusion of the circle of Willis. Stroke 1991; 22:1358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/130\">",
"      Togao O, Mihara F, Yoshiura T, et al. Prevalence of stenoocclusive lesions in the renal and abdominal arteries in moyamoya disease. AJR Am J Roentgenol 2004; 183:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/44/3786/abstract/131\">",
"      Fukui M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 1997; 99 Suppl 2:S238.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1131 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.96.59.103-1E13E97D75-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_44_3786=[""].join("\n");
var outline_f3_44_3786=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Associated conditions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Age distribution",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Suzuki stages",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      NEUROIMAGING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Head CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Brain MRI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Angiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Hemodynamic studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      PATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Vascular stenosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Collateral vessels",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Aneurysms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Extracranial involvement",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Diagnostic criteria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Screening studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/1131\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/1131|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?28/52/29506\" title=\"diagnostic image 1\">",
"      Moyamoya and ischemic stroke",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?8/51/9010\" title=\"diagnostic image 2\">",
"      Moyamoya with intraventricular hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?11/62/12256\" title=\"diagnostic image 3\">",
"      MRA moyamoya",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?23/34/24105\" title=\"diagnostic image 4\">",
"      25 year old woman with moyamoya",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?33/55/34678\" title=\"diagnostic image 5\">",
"      30 year old man with moyamoya",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/1131|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/31/40433\" title=\"picture 1\">",
"      Morning glory disc",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?13/34/13857\" title=\"picture 2\">",
"      Aneurysm in moyamoya disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/38/21097?source=related_link\">",
"      Basic principles of genetic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/11/31930?source=related_link\">",
"      Cerebrovascular complications of sickle cell disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/22/37226?source=related_link\">",
"      Complications of cranial irradiation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/47/6906?source=related_link\">",
"      Congenital anomalies and acquired abnormalities of the optic nerve",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/61/23513?source=related_link\">",
"      Ischemic stroke in children and young adults: Etiology and clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/36/7751?source=related_link\">",
"      Moyamoya disease: Prognosis and treatment",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_44_3787="Nonmotor symptoms of Parkinson disease";
var content_f3_44_3787=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F71879&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F71879&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Nonmotor symptoms of Parkinson disease",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td>",
"       Cognitive dysfunction",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Psychosis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Mood disorders (depression, anxiety, apathy/abulia)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Sleep disturbances",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Fatigue",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Autonomic dysfunction (urinary urgency/frequency, constipation, orthostasis, erectile dysfunction)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Olfactory dysfunction",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Pain and sensory disturbances",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Dermatologic findings (seborrhea)",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_44_3787=[""].join("\n");
var outline_f3_44_3787=null;
var title_f3_44_3788="Irritant contact dermatitis diagnosis";
var content_f3_44_3788=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F56560&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F56560&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Diagnostic criteria for irritant contact dermatitis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"2\" width=\"50%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Subjective major criteria",
"       </td>",
"       <td class=\"subtitle1\">",
"        Subjective minor criteria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <ol>",
"         <li>",
"          Onset of symptoms within minutes to hours of exposure",
"         </li>",
"         <li>",
"          Pain, burning, stinging, or discomfort exceeding itching, especially early in the clinical course",
"         </li>",
"        </ol>",
"       </td>",
"       <td>",
"        <ol>",
"         <li>",
"          Onset of dermatitis within two weeks of environmental exposure",
"         </li>",
"         <li>",
"          Many people in the environment similarly affected",
"         </li>",
"        </ol>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Objective major criteria",
"       </td>",
"       <td class=\"subtitle1\">",
"        Objective minor criteria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <ol>",
"         <li>",
"          Macular erythema, hyperkeratosis, or fissuring predominating over vesicular change",
"         </li>",
"         <li>",
"          Glazed, parched, or scalded appearance of the epidermis",
"         </li>",
"         <li>",
"          The healing process proceeds without plateau upon withdrawal of exposure to substance in question",
"         </li>",
"         <li>",
"          Patch testing with known environmentally relevant allergens is negative",
"         </li>",
"        </ol>",
"       </td>",
"       <td>",
"        <ol>",
"         <li>",
"          Sharp circumspection of the dermatitis",
"         </li>",
"         <li>",
"          Evidence of gravitational influence, such as a dripping effect",
"         </li>",
"         <li>",
"          Lack of tendency for spread of dermatitis",
"         </li>",
"         <li>",
"          Vesicles juxtaposed closely to patches of erythema, erosions, bullae, or other morphological changes which suggest that small differences in concentration or contact time produce large differences in skin damage",
"         </li>",
"        </ol>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission of: Informa Healthcare, from Irritant Contact Dermatitis, Jackson EM, Goldner R, New York 1990; permission conveyed through Copyright Clearance Center, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_44_3788=[""].join("\n");
var outline_f3_44_3788=null;
var title_f3_44_3789="CML treatment milestones";
var content_f3_44_3789=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F81376&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F81376&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Evaluation of overall response to first-line tyrosine kinase inhibitors in early chronic phase chronic myeloid leukemia",
"    <sup>",
"     [1]",
"    </sup>",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\" rowspan=\"2\">",
"       Evaluation time, months",
"      </td>",
"      <td class=\"subtitle1\" colspan=\"3\">",
"       Response",
"      </td>",
"      <td class=\"subtitle1\" rowspan=\"2\">",
"       Warnings",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2\">",
"       Optimal",
"      </td>",
"      <td class=\"subtitle2\">",
"       Suboptimal",
"      </td>",
"      <td class=\"subtitle2\">",
"       Failure",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Baseline",
"      </td>",
"      <td>",
"       NA",
"      </td>",
"      <td>",
"       NA",
"      </td>",
"      <td>",
"       NA",
"      </td>",
"      <td>",
"       High risk; CCA/Ph+*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       3",
"      </td>",
"      <td>",
"       CHR and at least minor CgR (Ph+ &le;65 percent)",
"      </td>",
"      <td>",
"       No CgR (Ph+ &gt;95 percent)",
"      </td>",
"      <td>",
"       Less than CHR",
"      </td>",
"      <td>",
"       NA",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       6",
"      </td>",
"      <td>",
"       At least PCgR (Ph+ &le;35 percent)",
"      </td>",
"      <td>",
"       Less than PCgR (Ph+ &gt;35 percent)",
"      </td>",
"      <td>",
"       No CgR (Ph+ &gt;95 percent)",
"      </td>",
"      <td>",
"       NA",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       12",
"      </td>",
"      <td>",
"       CCgR",
"      </td>",
"      <td>",
"       PCgR (Ph+ 1 percent to 35 percent)",
"      </td>",
"      <td>",
"       Less than PCgR (Ph+ &gt;35 percent)",
"      </td>",
"      <td>",
"       Less than MMolR&bull;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       18",
"      </td>",
"      <td>",
"       MMolR&bull;",
"      </td>",
"      <td>",
"       Less than MMolR&bull;",
"      </td>",
"      <td>",
"       Less than CCgR",
"      </td>",
"      <td>",
"       NA",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Any time during treatment",
"      </td>",
"      <td>",
"       Stable or improving MMolR&bull;",
"      </td>",
"      <td>",
"       Loss of MMolR&bull;; mutations&Delta;",
"      </td>",
"      <td>",
"       Loss of CHR; loss of CCgR; mutations&loz;; CCA/Ph+",
"      </td>",
"      <td>",
"       Increase in transcript levels&sect;; CCA/Ph-",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    With respect to prior recommendations",
"    <sup>",
"     [2]",
"    </sup>",
"    , a new definition of optimal response was introduced; an earlier definition of suboptimal response is recommended at 3 months in instances of cytogenetic resistance; an earlier definition of failure is recommended at 3 months in instances of hematologic resistance and at 6 months in instances of cytogenetic resistance; clonal progression (ie, CCA/Ph+) during treatment was identified as treatment failure; a deletion of the long arm of chromosome 9 (del9q+) is no longer recognized as a warning.",
"    <div class=\"footnotes\">",
"     NA: not applicable; CCA: clonal chromosome abnormalities; Ph+: Philadelphia chromosome positive; CHR: complete hematologic response; CgR: cytogenetic response; PCgR: partial cytogenetic response; MMolR: major molecular response; CCgR: complete cytogenetic response; Ph-: Philadelphia chromosome negative.",
"     <br>",
"      * CCA/Ph+ is a warning factor at diagnosis, although its occurrence during treatment (ie, clonal progression) is a marker of treatment failure. Two consecutive cytogenetic tests are required and must show the same CCA in at least two Ph+ cells.",
"      <br>",
"       &bull; MMolR indicates a ratio of BCR-ABL1 to ABL1 or other housekeeping genes of &le;0.1 percent on the international scale.",
"       <br>",
"        &Delta; BCR-ABL1 kinase domain mutations still sensitive to imatinib.",
"        <br>",
"         &loz; BCR-ABL1 kinase domain mutations poorly sensitive to imatinib.",
"         <br>",
"          &sect; The significance of the increase may vary by a factor of 2 to 10, depending on the laboratories.",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     1. Reprinted with permission from: Baccarani, M, Cortes, J, Pane, F, et al. Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. J Clin Oncol 2009; 27:6041. Copyright &copy; 2009 American Society of Clinical Oncology. All rights reserved.",
"     <br>",
"      2. Baccarani, M, Saglio, G, Goldman, J, et al. Evolving concepts in the management of chronic myeloid leukemia: Recommendations from an expert panel on behalf of the European LeukemiaNet. Blood 2006; 108:1809.",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_44_3789=[""].join("\n");
var outline_f3_44_3789=null;
var title_f3_44_3790="Time course PEG side effects";
var content_f3_44_3790=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F63602&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F63602&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    The time course of side effects associated with interferon",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 437px; height: 234px; background-image: url(data:image/gif;base64,R0lGODlhtQHqAOYAAP///4CAgAAAAMDAwEBAQP+AgICZzKCgoBAQEFBQUCAgIPDw8DAwMHBwcNDQ0GBgYP8gIP+goLCwsODg4JCQkP8AAPzz8M9AEP9AQOaZgP/AwNlmQPLNwN+AYOyzoPbZ0P/g4P8QEPD289ZZMKDGs//Q0P9gYP9QUP+wsP+QkBBwQP/w8P9wcPnm4DCDWf8wMNJNIGCggMwzANDj2QAzme/AsCB5TeKNcABmM8DZzYCzmVCWc9xzULDQwOmmkJC8pkCMZuDs5nCpjYCZjNDZ7DBZrGCAvwAzGXCNxuDm83BJLKCz2SBNprDA34Cmk+4mI0Bms1Bzud8AAN+AgM+AgHNNQLDAsABZLEBZTWwyIBBAn1B8ZiBfP38gIL9wcDBQP5Cm0wAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAAC1AeoAAAf/gACCg4SFhoeIiYqLjI2Oj5CRkpOUlZaXmJmam5ydnp+goaKjpKWmp6ipqqusra6vsLGys7S1tre4ubq7vL2+v8DBwsPExcbHyMnKy8zNzs/Q0dLT1NXW19jZ2tvc3d7f4OHi4+Tl5ufo6err7O3u7/Dx8vP09fb3+Pn6+/z9/v8AAwocSBDAgAEFEyoMFSDAwocQMTWMSLHio4kWM2oshJHVwQUAFgyYQKsBgY0oS3VcJUBAAoMCHDoiIGDUAZkpc35aqaqlgIMxBR0gQIACgAkBECI9qCDmwQAODiCUkKCo0KQEHoAEMNQqgAAHKGQFefPoA6INtupcS4lnKgEM/xAokBC0gYAGCQRQGBCUL1gEAgjcFAA4AN0EdhsAoPnA7svEeY22ZND0weKaAwgEeCDAMtvPkdyiCnwgcFC5DQP7hemQpqAAAiQIygsy7mVBDGqihn0ycEjfrrme9Q26eCPRp4C3dChAQUOwq1cHh43w9u3grps/PwCAuHIAifmeNE4+EXJTvvkGzZv0pgPCAWi2ju2AuiAKMQ9fHoD/JfsBZXl3kms0SVDaeKCJVF0mDghW0HmlEMeZQws8ABgCDtmlwIQASAAYBfYJ0gBgCYBEU1MEgFThhcyN950DgNGE4Gd2xabJUg/iFE1w5WHSVGeCDGDYWbKZlZUDBhmWQP+J8XGH4wBVedUPhMrw2GMldFEAGEiwIUCTABNMgAADASCAwFeE5TYmYBOstll8AnA3pY5XpsPZBJxxZ59d/HUGp5A/dXcSdastQEECudGZD5V1JhLCCSmUMM0CLRHQFANoIkQdbA88h1SgvhEaVFwU4KcoPow2ekgFrFYAgQkRgPAMfp2WKUB9gVL3HgMSDNAArgiF+tNqzfka1JwAFKDsssw26+yz0EYr7bTUVmvttdhmqy20rXZbwQssoMBMblslZp99EuQG16fBDjpsUKWZduo9E21r77345qvvvvt62yoGBUiqajSpDkxIt+CKa/A0BS8MwKuxOlxNwxJXPPH/vBZnjA3FGnfMDMcep6RFFGAQ4Q3IiThw0MpREYCkJgQodstQL4dMCg0408CEEUskoQ3KiHzpk2aBakKcJSFuIiRJohjg9NNQRy311FRXbfXVWGet9dZcd+211DmHTUMRSDRxDdCHqMzZAwPgSgGRRyVlIAAOnJVW3BKc5YAEMQsSWHwyLWDSAy8bShQFEgRAknuMcSf4kXibVCSekAuZNwGyLc0VUQkUucnXoIcu+uiklz662DlDYYDJ1qCNCGwydfllm4QFJiaZY8JkmlxNcUcYXnoBEFcAcZFEUwMjlmaUXA5cqtjwxfPlXG4O3F7mmbK3xC4AiAXQFNM2cxI2/9lm/4xxW8fu+a7M+Mlml8pBuUbsSZS6fFeHer3n2QQLjJllpnS7X5ZWQ5cA0OpP6gOUUuLTlAWFTxM769nJzjcJ2L0mV++KHQaBMh/WCMpvBIiOU44lCM6QC4AiTEpfYsIpT53rJ9S53QE448AH6sN1h7AgAEUlk/ckYAAKOJN0MBMUuAyAM8tTAJRuBQAzSSBdunsJmpLSRCXmBX5so96uevWrFyqQLz+kSQ1tiCoKSkKHXlyNUC6FpCF6sHb3o1tuFCAnB+SFOE2ZXFNe4oA5ckd6hJFTuiazvU0FijNjKhoZb2hGZFBKAY5Q4yJ1gsNemCqSJJxkSiqpyU66gv+TngxlKkApylKSgpSmTOVOGqnKVo6Sla6M5SlhKctartKWGluBBnaJAmVpgBeoxKU/QLBLDURgWSbAgDJf0C1lKtOXwKSlMPNRTA2kYFkncGYIWhUCZ55gWSmoZiFawIFyZiADHNhFMKfpDWIuy5kYQJgzTbCsCBRTVoWwQDk54IFzZmADAB2BDAZ6AYBu4AboVKc02TmOEvQymxXoJguUhYJirgAR+6yBPztg0IEO1KA88GcN9lmMdTLUGbo8JgYg4CqA2fOihviADzJwA4PCwKMjMKg/fbBPCzBsoSelRglSwAIMbBMD30SBwA7RghrUVAYw6MA59/kBcZg0qMH/AEEv4/mqAmgAn4nggA94cNMNZKAGPtXGANSiiKtidRfWPAFLAYYCmCaiBR64gUBH0AEPVPUbBEAA4Rbh1rfSQqtFdZUJIrUIfWaABxcoKDrTKo4DqEsBFGArIQprWFfEda4FqOsiPuCBDuz1Bh5owToGAJjl5BConb0FYuP5AlgtFREW0OgGLgCDkKazHZZtyYYUMKNBcDa2otBAAU4Qgm561a64LW1Zb1AD1caDMZ6r2WZhi9xVgCACLGBmbSNwW0V8oAMXGAFP77HW43C3u6VQLnOdqwHoNtYDI7hAB/6KjwbICUTmeS98PfHd8H6LBeSVxHnT6wHK3kMkDGAb/5SKu90Bu0KXBTDqo7xKCQvgV7/81Yd6fAKk1wnYwpIoQQRMIF4Eg3USCx5Bg/+BFOI2JLMBRvEoMKzhb/7yEh7O734JUj336tgTKmZxBTDgYk3EeMYDcZlJiNI3Ex8ZEyvYagggAKkfayLIIFbIT4R2NEMcl51DNcFcw/ViJ6NXxg5ey5nZsbKPLIJmwshyhl3VZVCAecgVIYqRNUJiRRIiOJrrxXfVvGQ2i+LJcY5IfAadkZasTCRRMgoQnaK5CmmGimB5jePi07lToIAFEHgUY0fx5xBnxC5UltlrN7KcibyJJgc4QIwGg5DcNIBDAhIehqgnChCk4AQH9vIoIP+tEzJT2LgnrvNaTdIIPPcNz9kodEgOlSjriMoy8wPhezTDoU5kWc2PilgpWi2xShY6MzVhxLn0ZGhrtIQQpLrkdDL4RheF8G8NGWMlhkrbgKGC2QkyiR09Z+YTW/ojrsERjjabK3ojBERkOVw07j2IYtllPhIA1iON5RDA/No3ZpIKBeRUiRWsONWwsi8pPgxo49zxiFKc9SVq3cEUcgRU7gIUdyATvGdwXCiVCoqH9GIfXcuLK2aCNd3uOBdKlKAAzMTAqlHhYRjAAMrl0UsIJ23lnZP4NimEjaXtIyxOCWI3ZQ6HVJbIcE0sessmEK0qLJCBgtZAVbEJIQFy3nD/TBwd7StU3KXZ7i4U+c05DWG5ODijHU5owMCQKi8qWtD3DfxWVRaSS5xybPZD1+Q9GJLPz9uFJqoE7z9lCch3mQuBcL2iBR2QQc0HtoC8IEDWOrfE4YOjoXIbF+iZ6t+tVgSff5w61ZBq8yrOq3vrOkyzpBelsZENLmW7ggO7zYD1JUYABhwA+xw5cZ3ODX11x6IG4Y+0w2rUGYG/Rv3kIfi3DE4LD3gd7B2zAHwTdxUWPi6HbjFXC133dQ/kAA3wI54RfBpzdVm3dbTAd35HRifyK22Ff5RAgPRwd6+id7bAeQX1eTaEOJTWCFSRFQOQOIsTACKhJEziIEghAZLD/xXaQRJiUWpJQhU1KEhVwTbecHnMlHm6gHu652qQ0CYHAT6l0CCSV20p4g2Ps3DZxwilkQABwIXKU0VokkhrAibSQzy3Yhde4oB3kRey0SVqEhdgsoVd6IG/MHtbZnu7QH0dMH4VRGJVWAoT9wjE9Q039wCEl36PgB9k4jj+EzyMlykEVETjkTuU8hKPSB2KGGrX8HyqJn23AH4XIH6ZYEH4MR4Tdjc3kRlawRWKQwGLo3EdMoRTIYtLUR8IISRtVBV3EySj5w1iJyTPdn+QACf3Y0ICwCXIx0P9BkLMeIm58iXA9wzbl2y/AH+hKH/oIxNNsTcu4RiX0RgucRmAYf8swLNyLjGHcsiFfjEB4ZgXE3AY3lhCZ/INgZcZh1iAjUABDQAg4ageUuSMQJFFTFQsE8CGsGEUAKmP/HiPycB+6eaJuVAD/4eNlaBDYsQe3lMTwZEbl7EVcFcUcBFqmfhH8XOMXsI9LNQUgkAp0bgNodc7WbgIEvAjJSIIeXRBrCcqTYEAcqJ2DtB7v4OTH0QdM9kSNbkM+vcC/BcMN3ABHgAKOvQ98vEc1kEg8dYdkBdqxKgYW7kapZEnl/EcMlEa2sUNQPl7HWgJj9QIklQOBwhzESBzvvABIzACfMgJnLJEitEfL2gZYtQf1oGS7WFA+7iFCrmFhdISCAASfJn/N7iBKe/gOpfECG0ZDhS4ZBY4DB4QiqOgdpX3GjR5GShiIlfJfBhSlC4hgDQpEseyNsYVmu8xhdrAN2vla2n5ECKYd3IZDBaAXij4ClaSChaCftjwAJhCf7IJbQphhBWAhMpAlxtAkasQnKiwcuCgGcIDJksSk/7gcrSHh8zgA5wpTDGzlmQngf2AAiaAmRB5DBZAVr9ZS4oIJNtZdq0gAiSgAzkQBMpQAiywZSnQnsjwAb0lnaIghcWxAGoSJkWHnqgwAzGgAi4QA0CAAzgABDHwAzkgDMb2AiFgAprXDD4gAz7gCoFYCCDYmfX2DSIBEm1CnF9Bh46Any6gAjEw/wOEEAQ5oAMx4AI4MKEaqgve2ZwKIw0WsAEwwISVMGFeARZioRX1IRtROnFdYRSl4Rz14SSGQQiPoxkLEGo3+BU3IRh2VJOpOBYT0Dh0YzdbARZNUqYqMmUy+gtzBgD4uQM4sAMkIAKMkAM/0KM/GgM9QAvqGQIvEJfVwAH6ZaCh0Sm41h1wURmLgQADQBmsmSFrqBdo6DJBBAD4IXlBFAAPCACd+qmQCocKkBt+2RmO0Txw0QDWkzunChipCiShOqrbcFx3mqd7Sgl+agNAwJ+u4J8QAAEFIKDN0HdP2QmGgiiS+Bv0E0RMtBof+UGtZxuEYCadQhKwkS7zKCyst/+RNWEf7QMeAxl0H6StisMNhQWhEtqrmCACOoADOsCnqbACKeChIIoNLbABI6CkmJBvz2qtnAFJb5SVvjMe7GibhGBHO8mgDAuuH4Qd47pBACSxvuGwhAGFZzOngtADNXqjnhAEQGADg2oKEYBsJxAB2lADF3ADjPqBSvRx1uobWwgkqwF7zKFExtMSZSkY8IYkX/IyGDsgPwGYsNM2LgFE34quwCEVNFGWreOxOqAC8AoKPaACQjAKGmAChpoCuzkNTfl3oRAvqicgMOIuUhEUpukQPqmDkEkIVCcnpRG3RSuageGie8QVbNSMyDe37CqjIrADLoCjpBAELuACwsr/CSCAarWHrNHQAnV5l8FgF8lpCJbbCNRpD6g0Ay6wA/ZqCkKgAieLZfn6od6XDS57A8lgJjCarYupuVe5KB6YtTqwCiSAAyRwCSigsizrDb15AWR7ZStoCVVbuqqQu7ubYl77AgEKDtAZs8QrjJcwuIX7Csr7CCBQAMXKAiG6DZuZAdM7jALmuaAbC7mLvIfgcvpapODwnhcQn+N7m76qArc7CySgAoZrCL3bnIg6DgTKA9I7v9Q7CTNgtbagAy4QugDgnwAKudowoiVKwORLCSLgAlt7CzuwAwBgbKnmvefwnklKwaEBWxSaCyKgBE9QAXmXDooqwCRcwpPwAyrA/8C0EAHFqgRWoA7KGsNntFAzgAP7e8PFyrJZO8TjcKT/6sM/HAkioAI/YAs4DAG/KwhCsMDloKgdMMBMrJyQgKG1MMVVTAhgPA5NuaxdLMOPcMU27ApinAhPHMXgILl2mcYVBEtHLAtvvAhBjMQt+7J23BasdMDqywp73Ag03MbWYAFjG8iC3AgXnMFuXMSScMLaAJ2U68jFiwiW3AqH7MQYnA3hq8kVaUaJ7MmUbAmEvMi+ScqlzMdCbMipjAkkYAPVQKDR6cqvDMdQvAqfnAk2sLzRIMG6jDTnU8ao8MuaUMvRIMIAW8yOcB5snMyz/AnB/AwBzMXQXHiHkMcoW//NoMDMyUqi23wJyOECwjwKyhwK16wMSvzM5RzNp5IDtkwK6ywK4owMWqzN8czNhbAD9xsK90wK7WwMPdzP5qwoQVDDAg3OqZDPw0DH8IzQ8mwIMRADoDDQqFDQwbCZrEvREkEnT7y4m6DRD+0CvJkBXje8IG3MhaADHMwJJq0KT+zHuNACTel5La0JPGEDG6oJM80KF80LepjJO33HhEACKJ0JQd0KB6zIsgCKonjUm7ASQJDOlNDUr4DOt+B/MOAD/EzVhIUTCw3VjqDVsKDUF9h3MibWtyQIPFoJaB0LNR0LuHcBPCC/bj2KOOHTkzDXszDU35d7e7jXDCET9Cz/CYBNC0/NCtaYAWFt2BchEzEQ0I2w2LbA1Vzn1QAo2bc00mft0MXwp6eAgRuAxp4tChNBAkBw2aJtDDmw1KOghB2g16ntCQ3xxIVcCJjNCzgwChwAWYV926bQEBusCL3dCy7w057gAfFH3KgQAF/A0IeQ3L6QoZ1gAT7wf9CtCgFwBJY9CNb9C6StCSa4ASzd3afw3eE93sAQ25lA2xOt3gxxBcLs3sLw25YAijdg1PRNCk5Qz/g9DMtNCRwwAjAA2f/tCkOABVQAAVLQBWI54RRe4RZ+4Rie4Rq+4RjOBVvA4RReBVkA4iRe4iZ+4iie4iq+4ize4iduf8AQH14w/wUuThQu3hA2XuOfZuFDMAQknuM6fuPxseMtDuRFTuQrbuQsruRJjuRNLpYwTqd0iEqkROVTfuV4ieU8reVbnuXNYOVe3uVVzeV8HeZiXuZjbuZovgxgnuZnvuZwHtJqLudvTud1ntBfTuZ2vud8judufucuDei7LOiP/DF67udxjuiJHuiEjtSN3sR/vujGcBCcQOlKE+WRYOmaoOmZwOmY4OmXAOqWIOqUQOqljumZjuqQYOoL3uqu/uqwHuuyPuu0Xuu2LjELcBPnpzRSSwkTACI4hgkOACK7rgkqw7GTIG2akOuVpCCXhgnMHuyXwOx1l+w1w+zFLgltUwjbXv/qNfPrBvS6vJAbNBG3loArwSgJQmPuleCHxl4Yhnd2wh4jBjvq7zbt5E4Y4s4ICgoXcTQJ6D4I+c7ujRDwgmDwkYDw614M+sGGmPAl6R4JErAAC9BAmOAkh2cJ6uJww6LqjLCNy34Q8YLsmQ4X+3EJ+KEY30MJEC8IDW8jkNDygiDzkUDzE1/xK+oLFqRDoZ6ilbDyn06zEvF7mfSBgfFDwt4ce6sJronvkRqBFXk/YrSkxLHzRc+WZSYepU6AQC8MVq9+Wr8JKa8JQ/HvlfAeiXP1ksCFiETyq25EuXG5kcCOYALtFnIp+74IdB9YOY9J4/H12p71Pr8IYT8IY0//DGNvF0bx6YMfCXYB9Zkw9UhTaPgn+WffdpnQ9Ci/Hmqf8GChklQ/HonfoI9Q+DAR8Ypg+o9vDOyoRF1/9orYXpeQF5Dn8YlQqaKqPZfghGvj9pFEJoiU94uQR7lh+7ev+xcP971oCVKRFy35CMNuRAvQ+pvm+4gQ/QzQXtgv+9Af+yBB+wFXDAfQFHQU+SRm/IhA+bt/WdUe9QI2AerCAL0uCX0USOb//JQwIp9pds4BCACCg4SFhgAEAooCAwAHCgIKB4eUg4mLjZeKjZWHmowAi4oBnaWmp6ipqqusra6vsLGys7S1tre4ubq7vL2+v8DBwsPExcbHyMnKy8zN/87P0NHS09TV1tfY2drb3N3e3+Dh4uPk5ebn6Onq6+zt7u/w8fLz9OUTA/iN9/kOAPgLABYMmFCPQIN6CBMqCyAKAMNFBEIJSOBPAKlBAyy6ynhRFkNOuAREVEiyZLCMIxk+wNcPE0dCD0SSOhBgAoUJCwIQSCBBUAMCBB70i0lgZgAJBhc8INDPX4Kkjo4mSOBgQqIHkwwNCNCPZsAAkyYsFSroAFAKgkQCcHAUgISnK03KnfsKpSCGRQM0EsAAgQIJGgcxiBQxEQJGfQMM7qcgQAO/AAYrKBwJEoJECtxObDARUSTJDiAxOGjIgYCDkBwAvomAQQAECABwbpBAAP9akQtaLzgwMUCCjnSDC69k16EoUiJ5JwL+0jNA00Vjkhrw83DFi4muewZQO0AASNsjCzAO0pACBqZdc7Yp4IFORn69qxVJAEE/CnzBDt/Pn1BxhsCpdQlzgWVXUV56AcbTYNpt91J2y3lHioHZfVRJTA2MxsCGxrnn3QSRSDiJIpBw8t5p/aUYHHsMNAIgIWplFJggGfEUHgCwHTAABTRZJAF4NfaU3YPj4ZfAABI8EF6FFjWSAAIADQKYbTIelJ4E1DnQ3QBe8WWaAgtQ0ACXnaloZkkPKWJcgCNJV4hhN2pJogQLSAaeZ7ENqZGB3ylCEYXjTQAJRQgoWchh/SB0KogEg/GF0wOHIYBcRAzxBMlEUZ6p6abVmEYQp6CGWo8EwIlq6qmopqrqqqy26uqrsMYq66y01mrrrbjmquuuvPbq66/ABivssMQWa+yxyCar7LLMNuvss9BGK+201FZr7bXYZqvtttx26+234IYr7rj9BQIAOw==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Nezam H Afdhal, MD and T Barry Kelleher, MD, MRCPI.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_44_3790=[""].join("\n");
var outline_f3_44_3790=null;
var title_f3_44_3791="Contents: CNS infections";
var content_f3_44_3791=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?0/63/1022\">",
"       Neurology",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       CNS infections",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			CNS infections",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Encephalitis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/10/41128\">",
"           Approach to HIV-infected patients with central nervous system lesions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/54/38760\">",
"           Arthropod-borne encephalitides",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/42/38568\">",
"           Clinical management and monitoring during antifungal therapy of the HIV-infected patient with cryptococcal meningoencephalitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/47/22264\">",
"           Clinical manifestations and diagnosis of West Nile virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/2/19494\">",
"           Clinical manifestations and diagnosis of cryptococcal meningoencephalitis in HIV seronegative patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/45/16088\">",
"           Epidemiology and pathogenesis of West Nile virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/61/40919\">",
"           Epidemiology, clinical manifestations, and diagnosis of cryptococcal meningoencephalitis in HIV-infected patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/62/1001\">",
"           Herpes simplex virus type 1 encephalitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/1/25622\">",
"           Nipah and Hendra viral encephalitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/62/34789\">",
"           PCR testing for the diagnosis of herpes simplex virus in patients with encephalitis or meningitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/8/38023\">",
"           St. Louis encephalitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/10/33958\">",
"           Treatment and prevention of West Nile virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/23/23929\">",
"           Treatment of cryptococcal meningoencephalitis in HIV-infected patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/3/38968\">",
"           Viral encephalitis in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         General approach",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/10/17576\">",
"           Cerebrospinal fluid: Physiology and utility of an examination in disease states",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/6/19561\">",
"           Lumbar puncture: Technique; indications; contraindications; and complications in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/10/36006\">",
"           Molecular diagnosis of central nervous system infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/3/38968\">",
"           Viral encephalitis in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Meningitis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/20/4424\">",
"           Approach to the patient with chronic meningitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/3/15417\">",
"           Aseptic meningitis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/40/39559\">",
"           Candida infections of the central nervous system",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/2/28713\">",
"           Central nervous system tuberculosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/37/23129\">",
"           Clinical features and diagnosis of acute bacterial meningitis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/42/38568\">",
"           Clinical management and monitoring during antifungal therapy of the HIV-infected patient with cryptococcal meningoencephalitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/44/1736\">",
"           Clinical manifestations and diagnosis of Listeria monocytogenes infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/2/19494\">",
"           Clinical manifestations and diagnosis of cryptococcal meningoencephalitis in HIV seronegative patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/52/37704\">",
"           Clinical manifestations of meningococcal infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/27/28081\">",
"           Clinical microbiology review: Meningeal infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/55/17271\">",
"           Coccidioidal meningitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/34/23080\">",
"           Dexamethasone to prevent neurologic complications of bacterial meningitis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/6/9321\">",
"           Diagnosis and treatment of disseminated histoplasmosis in non-HIV-infected patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/20/25930\">",
"           Diagnosis and treatment of gram-negative bacillary meningitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/41/27285\">",
"           Diagnosis of meningococcal infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/43/40632\">",
"           Eosinophilic meningitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/13/16600\">",
"           Epidemiology and clinical features of gram-negative bacillary meningitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/48/9993\">",
"           Epidemiology and pathogenesis of Listeria monocytogenes infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/50/27432\">",
"           Epidemiology of Neisseria meningitidis infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/38/31335\">",
"           Epidemiology of bacterial meningitis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/61/40919\">",
"           Epidemiology, clinical manifestations, and diagnosis of cryptococcal meningoencephalitis in HIV-infected patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/32/44552\">",
"           Infections of central nervous system shunts and other devices",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/17/22810\">",
"           Initial therapy and prognosis of bacterial meningitis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/32/7688\">",
"           Microbiology and pathobiology of Neisseria meningitidis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/46/6890\">",
"           Mucormycosis (zygomycosis)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/54/18280\">",
"           Neurologic complications of bacterial meningitis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/44/26312\">",
"           Neurosyphilis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/6/43112\">",
"           Pathogenesis and clinical manifestations of disseminated histoplasmosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/41/38549\">",
"           Pathogenesis and pathophysiology of bacterial meningitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/48/776\">",
"           Pathogenesis, clinical manifestations, and treatment of late syphilis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/0/25609\">",
"           Treatment and prevention of meningococcal infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/60/15306\">",
"           Treatment of bacterial meningitis caused by specific pathogens in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/23/23929\">",
"           Treatment of cryptococcal meningoencephalitis in HIV-infected patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/46/745\">",
"           Treatment, prognosis, and prevention of Listeria monocytogenes infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/3/38968\">",
"           Viral encephalitis in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Parameningeal infection",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/40/17033\">",
"           Epidural abscess",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/13/38104\">",
"           Pathogenesis, clinical manifestations, and diagnosis of brain abscess",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/38/23145\">",
"           Septic dural sinus thrombosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/43/32438\">",
"           Treatment and prognosis of brain abscess",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Prions",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/54/7017\">",
"           Biology and genetics of prions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/28/31176\">",
"           Diseases of the central nervous system caused by prions",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-B3F83EC1CD-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f3_44_3791=[""].join("\n");
var outline_f3_44_3791=null;
